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Zusammenfassung 
Kleine GTPasen regulieren eine Vielzahl an hoch dynamischen Prozessen, welche von Signaltransduktion 
und Cytoskelettorganisation bis zum nuklearen und vesikulären Transport reichen. Sie erfüllen ihre 
regulatorische Rolle indem Sie als molekulare Schalter agieren, die zwischen einer aktiven, GTP-gebunden 
Form und einer inaktiven, GDP-gebundenen Form hin- und herwechseln. Der Wechsel zwischen der aktiven 
und der inaktiven Form geht mit einer Konformationsänderung der Proteinstruktur einher und wird durch 
GTPase-aktivierende Proteine (GAPs) und Guaninnukleotidaustauschfaktoren (GEFs) gesteuert. Zudem 
weisen die meisten GTPasen eine charakteristische subzelluläre Lokalisation auf und zirkulieren zwischen 
verschiedenen Zellkompartimenten.  
Aufgrund ihrer Schlüsselrolle in komplexen zellulären Vorgängen sind GTPasen ein beliebtes Ziel für die 
Entwicklung von Biosensoren, die einen Einblick in die zeitlichen und räumlichen Aspekte ihrer Aktivität 
ermöglichen. Die meisten der bisher etablieren Sensoren basieren auf der spezifischen Bindung einer 
modifizierten Effektordomäne an die aktivierte GTPase. Ein Nachteil dieser Strategie ist, dass zunächst für 
jede GTPase eine passende Effektordomäne identifiziert und optimiert werden muss und daher einmal 
etablierte Sensoren nicht einfach auf andere GTPasen übertragen werden können. Zudem erfordern 
konventionelle Sensorkonstrukte häufig die Modifikation der Proteintermini, was die native Lokalisation der 
GTPase beeinträchtigen kann. 
Im Rahmen dieser Arbeit wurde ein neuartiger Ansatz zur Entwicklung von GTPase-Sensoren verfolgt, der 
auf alle GTPasen übertragbar ist und nur eine minimale Modifikation der Proteine erfordert. Der Sensor 
basiert auf einem intramolekularen Förster-Resonanzenergietransfer (FRET) Paar, das es ermöglicht die 
Konformationsänderung der GTPase im Zuge des Nukleotidaustausches direkt auszulesen. Das Sensordesign 
wurde zunächst auf Rab1 und später auf KRas angewandt. 
Der Erhalt der nativen Funktionalität von Rab1 im Sensorkonstrukt wurde zunächst durch die eingehende 
Charakterisierung der Interaktion mit dem GEF DrrA, dem GAP TBC1D20 und den Effektorproteinen OCRL 
und LidA überprüft. Anschließend wurde in Zellstudien der Anteil an aktivem Rab1 im Cytoplasma und am 
Golgi quantifiziert. Der für KRas entwickelte Sensor offenbarte ein polarisiertes Aktivitätsprofil von KRas in 
COS7 Zellen mit geringerer Aktivität an der freien Zellkante. Zudem zeigte der KRas Sensor, dass 
EGF-Stimulation zu einem globalen Anstieg der intrazellulären KRas-Aktivität führt. 
Ergänzend wurde der dynamische Austausch von Rab1 zwischen Cytoplasma und Golgi durch Fluorescence 
Recovery after Photobleaching (FRAP)-Studien und Experimente mit photoaktivierbarem GFP quantifiziert. 
Die Versuche weisen darauf hin, dass der Übergang von Rab1 zwischen Cytoplasma und Golgimembran eng 
mit der Fähigkeit verknüpft ist zwischen aktivem und inaktivem Zustand zu wechseln.  
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Abstract 
Small GTPases regulate a variety of highly dynamic biological processes ranging from signal transduction, 
cytoskeleton rearrangement and gene expression to nuclear and vesicular transport. They exert their 
regulatory role by acting as molecular switches, cycling between an active GTP-bound and an inactive 
GDP-bound form. The switching between the active and the inactive state involves distinct conformational 
changes in the GTPase structure and is tightly regulated by guanine nucleotide exchange factors (GEFs) and 
GTPase-activating proteins (GAPs). Most small GTPases exhibit a characteristic subcellular localization and 
cycle between different cellular compartments. This spatial cycle constitutes an additional level of 
regulation. 
Due to their key role in highly dynamic processes, GTPases have been a popular target for the development 
of biosensors that provide insight into the spatiotemporal aspects of their functioning. Most GTPase sensors 
rely on an indirect signal read out, generated through binding of an engineered effector domain to the 
activated, GTP-bound GTPase. However, the versatility of this approach is limited. It requires a suitable 
effector domain, which has to be identified and optimized for each target GTPase. Moreover, these 
conventional sensor designs often involve modification of the protein’s termini, affecting native GTPase 
functioning and localization. 
In the course of this thesis a new GTPase activation sensor that avoids the aforementioned drawbacks of 
conventional designs was established. By employing Förster energy transfer (FRET) between a N-terminal 
fluorescent protein and an organic dye, the intrinsic conformational change of the GTPase-fold can be used 
as the primary indicator for GTPase activation. The sensor design was first applied to Rab1 and later 
extended to KRas. 
Retained native behavior and sensitivity of Rab1 in the sensor constructs was assessed by monitoring their 
interaction with GEFs, GAPs and effector proteins. In cellular studies, using fluorescence lifetime imaging 
microscopy (FLIM), the ratio of active to inactive Rab1 in the cytoplasm and on the Golgi was quantified. 
Rab1 was found to be mostly active in the cytoplasm and largely inactive when localized on the Golgi, 
suggesting that the Golgi organelle serves as the terminal of the Rab1 functional cycle. The KRas sensor 
revealed polarized KRas activity at the plasma membrane with lower KRas activity at the cell edges. Upon 
EGF-stimulation the sensor indicated a global increase in activated KRas. 
The work based on the GTPase activation sensor in this thesis is complemented with an analysis of the 
dynamics of Rab1 trafficking between the cytoplasmic pool and the Golgi organelle. Using fluorescence 
recovery after photobleaching (FRAP) and photoactivation experiments, the effect of impaired Rab1 
function on Rab1’s spatial cycling was assessed. These experiments indicate, that the ability to cycle 
between its active and inactive state is essential for sustained Rab1 trafficking between cytoplasm and Golgi. 
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1 Introduction 
1.1 Small GTPase function and cycle 
The small GTPases of the Ras superfamily are responsible for the regulation of a variety of biological 
processes ranging from signal transduction, gene expression, cytoskeletal organization and cell motility to 
nuclear and membrane trafficking.1  
Based on their specific structure and function the members of the Ras superfamily can be assigned to five 
different subfamilies: the Ras, Rho/Rac/Cdc42, Rab, Ran and Sar/Arf family. The Ras family proteins are 
involved in signal transduction, gene expression, cell proliferation and differentiation. Due to their role in 
these critical signaling pathways they play a substantial part in human oncogenesis.2 Rho proteins are key 
regulators of the cytoskeletal actin organization, cell cycle progression and gene expression. Thus, members 
of this family are involved in the regulation of cell polarity, movement, shape, and cell-cell and cell-matrix 
interactions.3 The Rab proteins constitute the largest of the five subfamilies with over 60 identified members 
in humans.4 Rab GTPases are involved in all stages of vesicular transport and regulate endocytic and 
secretory trafficking.5 The only member of the Ran family is the most abundant small GTPase in cells. Ran 
GTPase is involved in import and export of nuclear cargo6 as well as the mitotic spindle assembly, DNA 
replication and assembly of the nuclear envelope.7 Like Rab proteins, the members of the Sar/Arf family are 
involved in the organization of vesicular transport. More specifically they regulate vesicle budding, coat 
assembly and cargo sorting.8 
All small GTPases feature a conserved, approximately 20 kDa guanosine nucleotide binding-domain that 
governs the proteins activation state by binding to either GDP or GTP. The so called ‘G-domain’ is unique 
for this superfamily and exerts the proteins regulatory role by acting as a molecular switch, cycling between 
the active GTP-bound and the inactive GDP-bound form.9 This cycling is an earmark of the GTPase’s 
functional mode and is tightly regulated by guanine nucleotide exchange factors (GEFs) and GTPase-
activating proteins (GAPs) (Figure 1-1).10,11 Only in the GTP-bound form the small GTPases can bind to 
effector proteins to activate downstream signaling.1  
GEFs catalyze the reversible exchange of the bound nucleotide by forming a stable nucleotide free complex 
with the GTPase.12 Because most GTPases bind GDP and GTP with similar affinity 13, nucleotide binding after 
GEF complex formation largely depends on the surrounding nucleotide concentration. In cells, GTP is 
generally present in a ten-fold higher concentration than GDP ([GTP] = 0.3-0.5 mM; [GDP] = 0.03-
0.06 mM)14, thus GEF-mediated nucleotide exchange typically leads to the formation of the activated GTP-
bound GTPase.  
Deactivation can occur through the slow intrinsic GTPase activity that leads to hydrolysis of the bound GTP 
to GDP. However, in most cases the inherent hydrolysis rate is not sufficient to effectively silence 
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downstream signaling by the GTP-bound protein.15 GAPs facilitate coordinated deactivation by accelerating 
the slow intrinsic hydrolysis.11 The transition between the two nucleotide configurations involves structural 
changes in the so-called ‘switch regions’ of the proteins.12 The structural basis of this switching mechanism 
is discussed in more detail in section 1.1.1. 
 
Figure 1-1: Small GTPases activation and deactivation cycle. 
Inactive, GDP-bound GTPase is converted through GEF-mediated nucleotide exchange, to the active, GTP-bound form. 
The active GTPase can then bind to effector proteins and initiate downstream signaling. Deactivation is facilitated 
through GAP-induced GTP hydrolysis. 
1.1.1 Structural basis for small GTPase functioning and regulation 
The structural basis for the functioning of the small GTPases as molecular switches is centered around the 
conserved G-domain that facilitates binding to the guanosine nucleotides GDP and GTP. The conformational 
difference between the two nucleotide states are the decisive factor for specific effector binding and 
subsequent downstream signaling. In this section the structure-function relationship of the G-domain, the 
nucleotide dependent conformational changes in the GTPase-fold and the structural basis of GTPases 
regulation by GEFs and GAPs will be discussed. 
The G-domain 
The small GTPase fold was first described for the protein HRas and features a central 6-stranded mixed -
sheet surrounded by 5 -helices.16,17 Guanine nucleotide binding and hydrolysis is conveyed through five 
conserved sequence motifs (G1-G5) located in the loop regions connecting the -sheets and -helices 
(Figure 1-2). 
The G1-motif (GxxxxGKS/T), also termed Walker A motif18 or P-loop, is a glycine-rich loop that binds to the 
nucleotides phosphates and a Mg2+ located in the binding pocket. The GTPase backbone nitrogen atoms 
interact with the negatively charged - and -phosphate groups of the bound nucleotide. The side chain 
amino group of the conserved lysine contacts the oxygen atoms of the nucleotide phosphates (-phosphate 
for GDP, - and -phosphate for GTP). 
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Figure 1-2: G-domain topology, structure and sequence based on HRas (PDB ID: 5P21)/KRas/Rab1b. 
HRas was the first small G-domain protein to be characterized.16,17 Rab1b and KRas were chosen as they are central to 
the work described in this thesis. (A) Topology diagram of the G-domain9 with -sheets and -helices colored in light 
blue and orange, respectively. The G-motifs and switch regions are labeled and colored as follows: G1/P-loop in green, 
G2/switch I in red, G3 in blue, switch II in orange, G4 in purple and G5 in yellow. (B) Crystal structure of HRas: GppNHp 
(PDB ID:5P21) with the G-domain motifs highlighted in the same color scheme as in (A). Mg2+ is shown as a sphere in 
light purple. The bound guanine nucleotide is depicted in beige with atoms highlighted in red (oxygen), blue (nitrogen) 
and orange (phosphorous). (C) Sequence alignment of HRas, KRas and Rab1b. The G-motifs and switch regions are 
colored in the same scheme as described in (A). Conserved residues are highlighted in bold outlined letters. 
The hydroxyl group of the serine/threonine, contacts the -phosphate oxygen and coordinates the Mg2+ in 
the nucleotide binding pocket. Due to the two conserved glycine residues, the P-loop features a highly 
defined and rigid conformation, that is preserved throughout GTP hydrolysis. Together with the G4 and G5, 
G1 mediates the high binding affinity of the small GTPases towards the guanine nucleotides.19 The G2-motif, 
is located in the switch I region, one of the two regions of the protein fold that undergo significant 
conformational changes upon nucleotide exchange. This motif features a highly conserved Threonine (T35 
in HRas) that senses the presence of the -phosphate when GTP is bound and contacts the Mg2+ located in 
the binding pocket. G3 (DxxGQ) lies in ‘switch II’, the second region that changes its conformation and 
flexibility most considerably depending on the bound nucleotide. Besides a glycine (G60 in HRas) the 
switch II region itself does not feature a conserved sequence motif. Similar to switch I, switch II senses the 
-phosphate of the bound nucleotide. G3 is often involved in effector binding, interaction with GEFs and 
GAP-induced GTP-hydrolysis. G4 ((N/T)KxD) and the less conserved G5 motifs are mainly involved in sensing 
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of the guanine base and thus are responsible for discriminating against other nucleotides such as ATP.20 
Attached to the G-domain is a hypervariable C-terminus that can be posttranslationally modified with 
isoprenyl- or palmitoyl moieties. These lipophilic anchors facilitate membrane attachment of the small 
GTPases. In case of some members of the Arf family, membrane interaction is mediated by a myristoylated 
N-terminus.21,22 
Small GTPases as molecular switches – structural changes upon nucleotide exchange 
The basis of small GTPases functioning as molecular switches are the conformational differences between 
their GDP and their GTP-bound state. The structural changes associated with the exchange of GTP to GDP 
can be described by a “loaded-spring mechanism”.12 The conformational changes are mostly limited to the 
G2/switch I and G3/switch II region of the G-domain.23 In the active, GTP-bound configuration, the 
additional interactions with the -phosphate force the switch I and switch II regions into a position close to 
the nucleotide. The main contacts contributing to this active conformation are formed through hydrogen 
bonds between the -phosphate of GTP with the side chain hydroxyl group of the conserved Threonine 
residue in the G1/switch I motif (T35 in HRas) and the backbone nitrogen of the glycine in the switch II region 
(G60 in HRas).16,17 The conformation induced through these interactions allows for high affinity effector 
binding. When these contacts are missing, e.g. when the GTPase is bound to GDP, the switch regions 
become more flexible and disordered. 
Figure 1-3: “Loaded-spring 
mechanism”12 of the small 
GTPase switch. 
Conformational changes in the 
small GTPase structure are most 
distinct in the switch I (red) and 
switch II (orange) region of the 
G-domain.  
In the active GTP-bound 
configuration the -phosphate 
of the nucleotide interacts with 
main-chain atoms of a highly 
conserved Threonine (T35 in 
HRas) in switch I and a glycine 
(G60 in HRas) in switch II. When 
GTP is hydrolyzed the hydrogen 
bonds are released and the 
switch I and II regions relax into 
a more flexible conformation. 
 
This structurally relaxed state is evidenced by numerous crystal structures of GDP-bound GTPases lacking 
well-defined density in the switch regions24 and NMR-based studies that show intrinsic mobility in these 
areas.25 The loss in structural definition is the cause for effector binding becoming less favorable. The 
binding enthalpy has to compensate the reduction in entropy caused by restricting the flexible switch 
regions to the fixed conformation in the GTPase:effector complex. It should be noted that, even in the GTP-
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bound state the switch regions remain slightly flexible and are not completely locked in a defined 
conformation. It has been shown by H-26,27 and P-NMR28,29, as well as EPR30,31 and FTIR-studies32 that the 
active, GTP-/GppNHp-bound GTPase features distinguishable conformational sub-states. 
In case of the members of the Arf and Ran family, the general assignment of the GDP-bound form as an 
open and undefined conformation has to be qualified. In this case the switch I changes its position and 
secondary structure when bound to GDP to form an additional -strand extending the central -sheet. Thus, 
their switch regions are in a fixed conformation when bound to GDP, albeit different from the GTP-bound 
structure.33,34 
Regulation by GEFs/GAPs 
In their nature of molecular switches, small GTPases alternate between the inactive, GDP-bound and the 
active, GTP-bound configuration. Due to their low rate of spontaneous nucleotide release15,35 and the slow 
intrinsic GTP hydrolysis15, the proteins generally remain in their respective activation state until they 
encounter one of their regulatory partners, GEF and GAP proteins. The tight regulation of GTPase switching 
through the interaction with GEFs and GAPs is crucial to achieve the level of spatiotemporal control required 
to govern such diverse cellular processes as observed for the members of the Ras superfamily.11 
GTPase activation by GEFs  
Small GTPases exhibit high affinity binding (nano to picomolar range) to either guanine nucleotide 
(GDP/GTP).15,35 As a consequence, once the nucleotide:GTPase complex is formed, the dissociation of the 
nucleotide is very slow. The rate of spontaneous nucleotide exchange is too low to be relevant for GTPases 
governed signaling (ranging from t1/2, Rho ≈ 1 h36 to t1/2, Ran ≈ 13 h13). Thus, efficient GTPase activation requires 
a catalyst to accelerate the slow intrinsic nucleotide exchange.  
Numerous structural studies of GTPase-GEF pairs illustrate that the catalytic domains of different GEF 
families are structurally unrelated, but function through the common mechanism of accelerating the 
nucleotide release through distorting the GTPase nucleotide binding site.10,11 Typically, the conformational 
changes are restricted to the switch I, switch II regions and the P-loop of the GTPase. As described 
previously, these regions form the primary contacts with the nucleotide’s phosphate groups and the Mg2+ 
in the interaction site, thus mediating the high affinity binding of the guanine nucleotide. Perturbation of 
these crucial interaction sites reduces the affinity of the GTPases towards the bound nucleotide and leads 
to its subsequent release.  
On the molecular level, crystal structures of nucleotide-free GTPase:GEF complexes revealed that a common 
feature is the displacement of the flexible switch I region from the nucleotide-binding site (Figure 1-4). 
Furthermore, GEFs form extensive interactions with the switch II region of the small GTPase, likely in order 
to compensate the loss in structural stability upon nucleotide release. 
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Figure 1-4: Binding of GEF distorts the nucleotide binding site. 
Overlay of the complex structures of the nucleotide-free GTPase:GEF complexes, (A) HRas:SOS (PDB ID: 1NVW) and (B) 
YPT1:TRAPP (PDB ID: 3CUE) with the respective GppNHp-bound structures of HRas (PDB ID: 5P21) and YPT1 
(PDB ID: 1YZN) (displayed in the same color scheme but semitransparent). In complex with the GEF, the switch I (red) is 
displaced from the nucleotide binding site. The switch II (orange) structure is stabilized by the GTPase:GEF interaction. 
GEF-mediated nucleotide exchange can be described through a succession of multiple reversible association 
and dissociations steps.11,13,37 In the initial stage, a low-affinity ternary GDP:GTPase:GEF-complex is formed 
that leads to the release of the bound nucleotide. Subsequently, a new nucleotide can bind, weakening the 
nucleotide-free GTPase:GEF-complex. Finally, the newly associated nucleotide allows for the dissociation of 
the GEF from the GTPase:GEF complex to complete the nucleotide exchange. As the affinity of the 
GTPase:GEF complex towards GDP and GTP is comparable13,38, the nature of the newly bound nucleotide 
depends largely on the local GDP and GTP concentration. In the cellular context the concentration of GTP is 
usually 10-fold higher than GDP14, thus GEF-mediated nucleotide exchange in vivo typically leads to the 
formation of the active, GTP-bound GTPase. 
GTPase deactivation by GAPs 
The intrinsic GTP hydrolysis rate is too slow to efficiently silence GTPase signaling. In order to effectively 
deactivate small GTPase signaling, the intrinsic GTPase activity is accelerated through interaction with GAP 
proteins. The first two GTPase-GAP pairs that were characterized on a structural and mechanistic level are 
HRas:RasGAP39 and Cdc42:RhoGAP40. In these studies the GDP-bound GTPase:GAP complex is stabilized by 
AlF3, mimicking the transition state of the GTP hydrolysis.  
GAPs primarily interact with the switch I and switch II regions of the GTPase. In contrast to their regulatory 
counterpart, GAPs do not convey their function by inducing large structural changes in these regions. The 
enhanced GTP hydrolysis activity is based on the GAPs ability to: (1) counterbalance the negative charges 
of the transition state and (2) activate/position a water molecule for nucleophilic attack at the -phosphate. 
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Analogous to GEFs, GAPs are structurally diverse and the aforementioned requirements for induced GTP 
hydrolysis are met through different molecular mechanism depending on the specific GTPase and its 
cognate GAP (Figure 1-5). 
In the HRas:RasGAP complex the GAP domain inserts an “arginine finger” at the nucleotide binding site that 
counters the partial negative charges and positions the conserved glutamine residue (Q61 in HRas) of the 
G3 (DxxGQ) motif/switch II to activate a water molecule for the nucleophilic attack on the -phosphate 
(Figure 1-5 A). The same combination of charge stabilization and water activation is found for Rab GTPases 
and their cognate TBC-domain containing GAPs. However, in this case the positioning and activation of the 
water molecule is mediated by a glutamine residue provided by the GAP instead of the switch II glutamine 
of the Rab protein(Figure 1-5 B).  
 
Figure 1-5: Molecular mechanism of the GAP-stimulated GTP hydrolysis HRas:RasGAP (PDB ID: 4HL4) and 
Rab1:TBC1D20 (1WQ1). 
(A) The HRas:RasGAP mechanism features a arginine finger and the GTPase switch II glutamine.39 (B) Rab1:TBC1D20 
employs a GAP arginine finger and a GAP domain a glutamine, while the switch II glutamine is contacting the GAP 
domain.41 
It is important to keep in mind that for some small GTPase-GAP pairs, the often utilized “dominant-active” 
switch II glutamine mutants do not necessarily completely abolish GAP induced GTP-hydrolysis (e.g. 
Rab33/RUTBC142, Rab5/RUTBC343 and Rab1/TBC1D2041). The use of these constitutively active/inactive 
small GTPase mutants becomes even more problematic when considering the involvement of some of these 
critical residues in both GEF-mediated activation and GAP-mediated deactivation.43 
In RapGAP and RanGAP-induced GTP hydrolysis, a different combination of residues is involved. Both GAPs 
utilize a switch I tyrosine and different second residues for water activation and positioning. RapGAP 
provides an asparagine from its GAP domain44, whereas RanGAP exploits the GTPase’s conserved switch II 
glutamine residue45 similar to the mechanism described for HRas:RasGAP. 
  
  
1 Introduction  
 
 -8- 
1.1.2 The Rab subfamily and their role in vesicular transport 
With over 60 identified members in humans, Rab proteins constitute the largest branch of the Ras 
superfamily of small GTPases.46 The term Rab originates from Ras-related in brain, as mammalian Rab 
proteins were first discovered in a rat brain DNA library.47 
Besides sharing the conserved motifs of the G-domain, Rab proteins feature five additional conserved 
sequence motifs that distinguish them from other members of the Ras superfamily.48 These Rab family 
motifs (RabF1-RabF5) were identified through sequence alignment and are located in or around the switch 
and interswitch regions. Rab proteins can further be grouped into subfamilies based on four Rab subfamily-
conserved sequences (RabSF1-RabSF4). The RabSF motifs are believed to convey the proteins specificity 
towards their respective GEFs, GAPs and effector proteins while the RabF motifs are thought to be mainly 
responsible for the discrimination of the active/inactive state and/or involved in binding to universal 
regulators such as Rab escort protein (REP) and GDP dissociation inhibitor (GDI). The largest heterogeneity 
between Rab structures can be found in their switch domains and the loop between the third -helix and 
the fifth -sheet, close to switch II and likely mediates effector specificity.49,50  
The greatest divergence in primary sequence is displayed by the ~30-40 amino acid long hypervariable 
region at the proteins C-termini. This region is primarily unstructured and plays an important role in 
targeting Rab proteins to specific subcellular locations.51,52 It is, however, not the sole decisive factor. 
Membrane targeting is also mediated through several other factors such as other regions of the protein53 
and the interaction with GEFs, GAPs and effector proteins.53-58 Generally, Rab membrane attachment is 
facilitated through the posttranslational modification of one or two cysteines at the proteins C-terminus 
with geranylgeranyl moieties. Unlike members of the Ras and Rho family, Rabs do not share a consensus 
prenylation motif. Most common are the C-terminal amino acid sequences XXCC, XCXC and CCXX with other 
permutations occurring as well. Specificity for geranylgeranylation is exerted through an additional protein 
factor, REP. Newly synthesized, unmodified GDP-bound Rab associates to REP, which in turn presents the 
Rab to RabGGTase.59 The RabGGTase then covalently attaches (two) geranylgeranyl groups at the C-terminal 
cysteines of Rab.60 After dissociation from the complex, REP is assumed to deliver the modified protein to 
its specific target membrane.61 REP binds the unprenylated as well as the lipidated protein with high 
affinity.62 In contrast, the structurally and functionally closely related GDI binds to the geranylgeranylated 
Rab with high affinity and only poorly to the unprenylated protein. Thus, both proteins fulfill distinctive roles 
in Rab regulation. While REP facilitates Rab prenylation by RabGGTase, GDI’s main function is the extraction 
of prenylated Rab proteins from membranes. The affinity of GDI towards Rab is reduced by three orders of 
magnitude when GDP is exchanged for GTP.63 Hence, Rab activation is believed to stabilize membrane 
attachment by impeding GDI-mediated membrane extraction. Because of the high affinity of GDI towards 
prenylated Rab63,64 it has been speculated that an additional factor, termed GDI dissociation factor (GDF), is 
necessary to assist in releasing and targeting the GDI-bound Rab to a specific membrane. So far only 
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Pra1/Yip3 (in yeast), has displayed genuine GDF activity by catalyzing the dissociation of Rab:GDI 
complexes.65,66 However, the exact mechanisms of how GDI is displaced by this GDF remains unclear. 
The cycling of Rab between different membrane compartment is linked to its interaction with GEFs, GAPs 
and effector proteins. A more detailed description of how Rab activation and deactivation is connected to 
the Rab proteins spatial cycle in vesicular transport is given in Figure 1-6. 
 
Figure 1-6: Rab cycling regulates vesicular transport. 
Newly synthesized Rab binds to REP, which then presents the protein to RabGGTase (a heterodimer consisting of an α 
and a β–subunit) for prenylation at its C-terminus. Subsequently, REP delivers the now prenylated Rab to its target 
membrane. Following membrane attachment at the donor membrane, GEFs facilitate activation of the Rab protein 
through GDP to GTP exchange. The GTP-bound Rab can now bind to effector proteins that are involved in vesicle 
budding and cargo selection and initiate vesicular transport. After the vesicle is transported to the target compartment, 
Rab proteins recruit tethering factors, SNAREs, and other effectors involved in docking and fusion. After fusion with the 
acceptor membrane, the Rab protein is deactivated through interaction with GAPs that accelerate the intrinsic GTP 
hydrolysis. Following deactivation, the Rab can be extracted from the membrane through the solubilization factor GDI. 
From the cytosol the Rab protein can re-enter the spatial cycle through delivery to the donor membrane. 
Rab activity is regulated through interacting with GEFs and GAPs. The number of characterized Rab GEFs is 
relatively small, when compared to the over 60 identified proteins of the Rab family. Rab GEFs show a high 
diversity in their primary and tertiary structure and hence cannot be easily identified by sequence analysis.10 
Available structures of Rab:GEF complexes (YPT1:TRAPP67 (yeast homolog of Rab1:TRAPP), Sec4:Sec268 
(yeast homolog of Rab8:Rabin8), Rab21:Rabex-569, Rab35:DENND1B70 and Rab1:DrrA71) indicate that the 
general mechanism of GEF-mediated Rab activation is similar to the one observed for other small GTPase 
families (1.1.1). The nucleotide/Mg2+-binding site is deformed through direct insertion of residues from the 
GEF domain or indirect conformational change upon binding to the GEF, ultimately resulting in displacement 
of the bound nucleotide.11 Rab GEFs can be divided into a number of discrete families with the Vps9 family72 
and DENN domain-containing GEFs73 being the largest. Other GEFs are comprised of two or more subunits 
such as the multisubunit TRAPP complex that specifically interacts with Rab1/YPT1 and also acts as a vesicle 
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tethering complex.67,74-76 Another notable Rab GEF is DrrA, the first identified bacterial GEF from the 
organism Legionella pneumophila with highly specific nucleotide exchange activity towards Rab1.71,77,78 
Recent studies demonstrate that GEFs are important factors in Rab membrane targeting. Ectopic 
mislocalization of a GEF leads to mistargeting of its cognate Rab to the same membrane compartment.54 
In contrast to the diversity of the catalytic motifs of Rab GEFs, most known Rab GAPs share a conserved 
catalytic TBC (Tre2/Bub2/Cdc16) domain. Like GAPs for members of the Ras and Rho family, Rab GAPs 
feature a conserved catalytic arginine finger and were believed to induce GTP hydrolysis through a similar 
mechanism. However, structures of the transition state of Rab33:Gyp179 and Rab1:TBC1D2041 revealed that 
instead of utilizing the conserved glutamine residue of the G3 (DXXGQ) motif, Rab GAPs insert a glutamine 
from their GAP domain to activate the attacking water molecule (Figure 1-5). 
The Rab activation/deactivation cycle is directly linked to Rab membrane localization and their interaction 
with effector proteins.80,81 Effectors are defined as proteins that specifically interact with the active, GTP-
bound form of the small GTPase. While some effectors bind specifically to only one Rab, other effectors can 
bind to multiple members of the Rab family82,83 and some Rabs can bind to a multitude of effector proteins.84 
Through their interaction with diverse effector proteins, Rabs are involved in all steps of vesicular transport. 
This includes vesicle budding and cargo selection, motility as well as vesicle tethering and fusion of transport 
vesicle with their target membrane. 
Examples for Rab proteins that are involved in cargo selection during vesicle formation include Rab5, Rab7 
and Rab9. Rab5 and Rab7 are required for the recruitment of the Vps26-Vps19-Vps35 trimer complex which, 
as part of the retromer complex, is responsible for cargo selection.85,86 Rab9 enhances the interaction 
between its effector protein TIP47 and the mannose-6-phosphate receptor during vesicle formation, 
thereby facilitating recycling from the endosome to the trans-Golgi network.87,88 
Besides cargo selection, Rab proteins take part in the regulation of the vesicular movement. In mammalian 
cells vesicular trafficking often relies on motor proteins that move along microtubules. Rabs have been 
shown to regulate traffic in either microtubule transport direction by interacting with members of the 
kinesin and dynein family. Rab6 for instance, directly interacts with Rabkinesin-6 to facilitate intra-Golgi 
transport.89,90 Another example is Rab7 which regulates trafficking between late endosomes and lysosomes 
by recruiting the dynein-dynactin motor complex through interacting with Rab-interacting lysosomal 
protein (RILP).91,92 
Most transport pathways require tethering prior to vesicle fusion. This initial recognition ensures proper 
association of cargo and target membrane. Tethering factors can be divided into two categories: long coiled-
coiled tethers and multisubunit protein complexes. Effectors of Rab proteins can be found in both 
categories. Notable members of the coiled-coil tethers are the family of Golgins. This includes p115, giantin 
and GM130, that all have been linked to Rab1 and its effectors. Rab1 is essential for the assembly of the 
accessory factors that tether ER-derived vesicles to the Golgi membrane. p115 is a homodimer that binds 
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to GM130 (localized at the cis-Golgi) and giantin (localized at COPI vesicles) through its coiled-coil tail while 
associating to Rab1 through its globular head domain.56,93-95 GM130 localization to the cis-Golgi is mediated 
through the interaction with the Rab1 effector GRASP65. This interaction regulates tethering of COPII 
vesicles at the cis-Golgi.94,96 The Rab1 effector p115 has also been shown to interact with SNARE proteins, 
the driving force for vesicular fusion.97,98 Among the multisubunit complexes involved in vesicle tethering 
are the TRAPP complexes, which are critical for endoplasmic reticulum (ER) to Golgi transport in yeast and 
mammalian cells.74 In contrast to other tether complexes, the TRAPP complexes do not function as effector 
proteins but act as GEFs towards Rab1/YPT1. In yeast, two TRAPP complexes have been described that 
regulate two aspects of the ER-Golgi transport76, while in mammalian cells, only one TRAPP complex has 
been identified so far.74 The function of the TRAPP complexes as tethers can be derived from their 
interactions with Sec23 and the SNARE proteins Bet1, Sed5 and Sec22, as well as its GEF activity towards 
Rab1, that leads to the recruitment to the aforementioned coiled-coil tethering factors. Sec23, a subunit of 
the COPII coat, has been shown to interact with the Bet3 subunit of the TRAPP complex.99 Bet3 has also 
been implicated to interact with the SNARE proteins Bet1, Sed5 and Sec22, that are involved in ER to Golgi 
trafficking.76,100  
Other large multisubunit tether complexes include COG (conserved oligomeric Golgi; endosome-Golgi and 
intra-Golgi transport), exocyst (Golgi-plasma membrane transport), HOPS (homotypic fusion and vacuole 
protein sorting; vacuole-vacuole and endosome-vacuole transport), CORVET (class C core 
vacuole/endosome tethering; endosome-Golgi transport), Dsl1 (dependence on Sly1, Golgi-ER transport) 
and GARP (Golgi-associated retrograde protein; recycling from endosome to Golgi).46,101,102 
The final step of vesicular trafficking is fusion of the transport vesicle with the target membrane. Rabs are 
involved in this process by either directly interacting with the SNARE proteins or indirectly through 
interaction with proteins that regulate SNARE function. Examples for Rab proteins involved in regulation of 
vesicular fusion are Sec4 (the yeast analogue of Rab8) and Rab5. Sec4 is involved in the final stage of the 
secretory pathway and has been shown to interact with Sro7, which interacts with Sec9 and regulates SNARE 
function.103 Rab5 is important for targeting endosomal traffic towards lysosomes. Its effectors EEA1 and 
rabenosyn-5 interact with the SNARE protein syntaxin-6 and VPS45, respectively.104,105 
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1.1.3 The Ras subfamily and their role in signal transduction and cancer 
The term Ras originates from Rat sarcoma, as Ras genes were initially discovered in studies of cancer-
causing viruses in rats.106,107 In humans, the three Ras genes encode four highly homologous Ras proteins: 
HRas (Harvey-Ras, first discovered by Jennifer Harvey106), NRas (first identified in human neuroblastoma 
cells108,109) and two KRas isoforms (Kirsten-Ras, first discovered by Werner Kirsten107). The two KRas proteins 
result from two alternative splice variants and are termed KRas4a and KRas4b. All four Ras proteins feature 
an exceptionally high sequence similarity within the G-domain. Their lipidated C-terminal hypervariable 
region however, is different for each isoform and critical for the proteins specific membrane localization 
and subsequent activation. 
The lipid moieties are introduced through a series of posttranslational modification. All isoforms are initially 
farnesylated at the C-terminal cysteine residue followed by cleavage of the last three amino acids (-AAX) of 
the -CAAX box motif and transformation of the C-terminal carboxyl into a methyl ester (Figure 1-7 A). While 
HRas, NRas and KRas4a are additionally modified with one or two palmitoyl groups that further stabilize 
attachment to endomembranes, KRas4b features a polybasic lysine stretch that mediates association to the 
negatively charged plasma membrane (Figure 1-7 B).  
Ras proteins play a crucial role in the regulation of cell proliferation, differentiation and survival. They are 
vital to a number of important cellular signaling pathways such as the RAF-MEK-ERK110-112 and the PI3K-AKT-
mTor113,114 pathway. Commonly, Ras signaling is initiated through recruitment of the cognate Ras GEFs to 
the specific Ras membrane localization sites. Following GEF mediated GDP to GTP exchange, the activated 
Ras protein can bind to its respective effector proteins, thereby triggering downstream signaling. A classic 
example of this mechanism is the activation of KRas through translocation of the son of sevenless (SOS) 
homologue 1 and 2 to the plasma membrane (Figure 1-7 C).115,116  
As a consequence of their role as central signaling nodes, Ras mutations that lead to protein hyper 
activation, e.g. through impairment of the intrinsic or GAP-mediated GTP hydrolysis, are among the most 
common mutations found in tumors. The sites most frequently affected are the conserved residues 
G12/G13 in the G1 and Q61 in the G3 motif of the G-domain (Figure 1-2 C). 
Mutation at G12 or G13, leads to steric occlusion of the insertion site of the GAP arginine finger and prevents 
the correct orientation of the residues involved in GTP hydrolysis in the Ras:GAP complex.39 Mutation at the 
critical Q61 residue interferes with the positioning of the activated H2O molecule (Figure 1-5 A) that is 
required for GTP hydrolysis.117 
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Figure 1-7: Posttranslational processing of Ras isoforms118 and Grb2-mediated EGF-induced Ras activation116. 
(A) All Ras isoforms are farnesylated at their C-terminal cysteine by farnesyltransferase (FTase). Subsequently Ras-
converting enzyme 1 (RCE1) cleaves the three –AAX residues of the farnesylated –CAAX motif and isoprenylcysteine 
carboxylmethyltransferase 1 (ICMT1) converts the C-terminal carboxyl-moiety into a methyl ester. (B) Left: 
Posttranslational C-terminal modifications for the four Ras isoforms. Palmitoylation is indicated in orange, farnesylation 
in green and the positively charged polylysine stretch of the KRas4b isoform in blue. Right: Structures of the lipophilic 
moieties. (C) Mediated by its farnesylated C-terminus in combination with its positively charged polylysine tail, Ras 
localizes to the negatively charged plasma membrane. The GEF son of sevenless (SOS) and the adaptor protein growth 
factor receptor-bound protein 2 (Grb2) are localized in the cytosol. Upon stimulation, e.g. by EGF, the EGF receptor 
(EGFR) is phosphorylated leading to binding of Grb2. Grb2 in turn recruits SOS to the plasma membrane, prompting Ras 
activation through GEF-mediated GDP to GTP exchange. The GTP-bound Ras protein can then bind to effector proteins, 
activating downstream signaling. 
These constitutively active Ras mutations are powerful cancer drivers and thus high-profile targets for drug 
development.119-121 However, due to a combination of the high affinity towards its native substrates 
(GDP/GTP), the lack of alternative accessible binding sites, redundancy and feedback loops in Ras-mediated 
signaling and the high similarity within the small GTPase family, drugs that directly target Ras remain 
ineffective to the extent that the proteins have been denoted “undruggable” by conventional 
approaches.118,121,122. While mutations in each of the isoforms can lead to cancer, different tumor types are 
associated with individual Ras isoforms and mutations in KRas are by far the most common found in human 
cancer.2,123 New approaches such as specific and covalent targeting of the aforementioned hyperactive KRas 
mutants124,125 or interference with the KRas-PDEinteraction126, has led to a resurgence in the effort to 
directly target Ras signaling recently.121,122,127  
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1.2 Fluorescence as a tool to study dynamic processes 
Fluorescence microscopy is one of the few techniques that is able to reach the spatial and temporal 
resolution necessary to observe the highly dynamic functioning of proteins in cells. It allows for the 
simultaneous observation of multiple components and is largely noninvasive.  
When used in combination with FRET it is exceptionally well-suited to reliably observe and quantify protein 
interactions. Specialized fluorescent biosensors can facilitate the direct observation of protein functioning 
in the cellular environment. Furthermore, other advanced techniques such as fluorescence recovery after 
photobleaching and photo activatable fluorescent proteins can be used to assess protein mobility and 
diffusion within cells.  
1.2.1 Förster Resonance Energy Transfer (FRET) 
Luminescence is the emission of light that is associated with the return of a molecule from an electronically 
excited state to its ground state. Depending on the nature of the excited state, this process can be 
categorized as fluorescence or phosphorescence. In fluorescence the molecule (fluorophore) relaxes from 
an excited singlet state. This spin allowed transition occurs rapidly and typically proceed within less than 
10 ns. In contrast, emission in phosphorescence is slow (~10−4 - 102 s) as the molecule relaxes from an 
excited triplet state, a spin forbidden transition. 
The term fluorescence was coined by George Stokes in 1852.128 Two important characteristics of this process 
are the fluorescence lifetime and the quantum yield. The quantum yield is the ratio of photons emitted to 
the number of photons absorbed during excitation of the fluorophore. The fluorescence lifetime of the 
excited state is the average time the molecule remains in the excited state until it relaxes to the ground 
state. The depopulation of the excited state can occur through radiative and non-radiative processes. One 
of these non-radiative processes is the Förster resonance energy transfer (FRET), termed after Theodor 
Förster who first described the phenomenon in 1940.129 
In general terms FRET can occur when the emission spectrum of the fluorophore (donor) overlaps with the 
absorption spectrum of another molecule (acceptor) that is in close proximity (Figure 1-8). The energy 
transfer occurs through coupling of the respective dipoles and thus does not involve the 
emission/absorption of a photon, it is radiationless. The extent of the energy transfer depends on the 
distance of the involved donor and acceptor molecules (typically 1-10 nm), their relative orientation and 
the spectral overlap of their emission/absorption spectra. The exceptional spatial sensitivity of FRET is the 
main reason for its widespread application in molecular biology. The typical FRET range (< 10 nm) is in line 
with the size of biomolecules and below the optical resolution limit.  
Any process that influences relative distance/orientation of the two dipoles will affect the energy transfer 
rate and thus can be assessed by fluorescence spectroscopic methods. Consequently, FRET has been 
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extensively used to observe protein-protein interactions or to monitor conformational changes within 
proteins. 
More precisely the spatial sensitivity of the FRET can be derived from the following relations. The rate of 
energy transfer kFRET is given by Eq. 1-1: 
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and closely related to the FRET efficiency (EFRET). Here D is the average lifetime of the excited state of the 
donor in absence of a FRET acceptor, R0 is the Förster radius, the distance where the transfer efficiency EFRET 
is 50 %, and r is the distance between the donor fluorophore and the acceptor.  
EFRET is a quantitative measure of the ratio of photons that are transferred through FRET to the total amount 
of photons absorbed by the donor fluorophore and defined as: 
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The strong dependence of the FRET efficiency from the donor-acceptor distance, is the reason for its spatial 
resolution, especially close to R0 (Figure 1-8 B).  
 
Figure 1-8: Factors in FRET efficiency. Spectral overlap integral and donor-acceptor distance. 
(A) Spectral overlap integral J() between the donor emission and the acceptor absorption spectrum. (B) Dependency 
of the FRET efficiency from the donor-acceptor distance. R0 marks where the FRET efficiency is 50 %. 
R0 can be obtained from the following relation: 
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n is the refractive index of the surrounding medium, QD is the fluorescence quantum yield of the donor dye, 
2 is the dipole orientation factor and J(λ) is the overlap integral of the donor emission and acceptor 
excitation integrated over the wavelengths λ. The overlap integral J(λ) depends on the spectral overlap of 
the donor emission and acceptor excitation spectrum and is determined by the chosen fluorophores (Figure 
1-8 A). 
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The sensitivity towards the relative orientation of the donor acceptor dipoles is founded in 2 and can be 
quantified using Eq. 1-4: 
 2ADDA
2 coscos3cos   Eq. 1-4 
θDA is the angle between the emission dipole of the donor and the absorption dipole of the acceptor (Figure 
1-9). θD and θA are the angles between these dipoles and the vector joining the donor and the acceptor 
dipoles. The value of 2 can range between 0 to 4. For most approaches a value of 2/3 is assumed based on 
averaging the donor and acceptor orientations for freely rotating dyes. However, this approximation may 
be inappropriate for FRET pairs that are constricted in their rotational freedom.  
 
Figure 1-9: Factors in FRET efficiency. Orientation factor 2. 
(A) The factors determining the value of 2 are the angles between the transitioning dipoles of the donor emission and 
the acceptor absorption and their joining vector. (B) Depending on the relative orientation 2 can range between 0 to 
4. When the transitioning dipoles of the FRET donor and acceptor are parallel, 2 has the value 1. When the transitioning 
dipoles are orthogonal, 2 has the value 0 and no FRET occurs. A value of 4 is reached when the dipoles are collinear. 
1.2.2 FRET imaging by Fluorescence Lifetime Imaging Microscopy (FLIM) 
FRET can be assessed by several imaging techniques such as acceptor photobleaching, fluorescence 
polarization, sensitized emission and fluorescence lifetime imaging. The advantage of using fluorescence 
lifetime based FRET quantification is that it is based on an intrinsic molecular property and thus independent 
of the concentration of the involved fluorophores. Furthermore, FLIM analysis does not suffer from artifacts 
commonly encountered when using sensitized emission approaches, such as signal cross contamination 
through acceptor spectral bleed through and cross-talk.130 These traits make FLIM a powerful tool for 
mapping FRET quantitatively in vivo.  
The fluorescence lifetime  is defined as the average time that a fluorophore remains in its excited state 
before returning to its ground state and is the key parameter characterizing the fluorescence decay. The 
intensity decay of the excited fluorophore population can be expressed as: 
 10 eI)t(I  Eq. 1-5 
Here I0 is the initial intensity directly after excitation. The fluorescence lifetime is determined by the rate 
constants of the processes contributing to fluorophore relaxation from the excited state: 
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kr and knr are the rate constants for radiative and non-radiative deactivation, respectively. D is the 
fluorescence lifetime of the donor in the absence of the acceptor and DA is the fluorescence lifetime in the 
presence of the FRET acceptor. The radiative rate constant is determined by the spectroscopic properties 
of the fluorophore and the refractive index of the surrounding medium.131 The non-radiative rate constant 
depends on the local environment of the fluorophore such as pH and ion concentration and includes the 
rates for vibrational relaxation and intersystem crossing. FRET contributes an additional channel of excited 
state depopulation (kFRET) and therefore reduces its average fluorescence lifetime of the donor fluorophore. 
From this drop in fluorescence lifetime, the efficiency of FRET can be determined using Eq. 1-7: 
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Eq. 1-7 
There are two standard approaches to fluorescence lifetime imaging: time-domain and frequency-domain 
FLIM. In this thesis, time-correlated single photon counting (TCSPC) was used to determine the lifetime of a 
FRET based biosensor.  
 
Figure 1-10: Principle of TCSPC-FLIM. 
(A) A short, intense excitation pulse excites the fluorophore population. After excitation the arrival time of the 
subsequently emitted photons is measured. (B) The photon arrival times are binned and the histogram of the number 
of photons over the time after the excitation pulse yields the fluorescence decay curve. (C) The average fluorescence 
lifetime is reduced through FRET. 
The general principle of TCSPC is based on detecting the arrival times of emitted photons after 
simultaneously excitation of the whole fluorophore population. Excitation is typically achieved by a short, 
intense laser pulse. The excitation pulse starts the photon timing and is subsequently stopped upon arrival 
of an emitted photon at a detector, e.g. an avalanche photodiode (APD). The excitation-emission cycle is 
repeated and the detected arrival times are sorted into time bins, amounting to the fluorescence decay 
curve of the fluorescent species. The obtained histogram can then be fitted with a (multi)-exponential curve. 
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For fluorophores exhibiting single exponential decay kinetics and if the population of the excited 
fluorophore is homogenous, the decay kinetics can be described by a single exponential function. If a 
fraction of the fluorophore population undergoes FRET, the decay curve features a second lifetime 
component that can be quantified by fitting the obtained histograms with a multi-exponential model.  
1.2.3 Protein dynamics resolved by photobleaching and photoactivation 
When using standard fluorescence microscopy, only the steady state distribution of a fluorescently tagged 
protein can be observed. By photobleaching or –activation of a defined subcellular compartment, a specific 
protein pool can be selected and its redistribution over time can then be monitored by time-lapse imaging. 
This allows the observation and quantification of a proteins kinetic behavior, such as association and 
dissociation from membranes, binding to interaction partners or diffusion inside and in between different 
cellular compartments. 
Fluorescence recovery after photobleaching (FRAP) 
Established almost 40 years ago, FRAP was developed to examine the lateral diffusion properties of 
molecules in living cells.132-135 For a typical FRAP experiment the fluorophores in a specific region of interest 
(ROI) are bleached through irradiation with a high intensity laser beam. The subsequent recovery of the 
fluorescence intensity is then followed by time-lapse imaging. The time-course of a representative FRAP 
experiment is depicted in Figure 1-11. 
 
Figure 1-11: Scheme depicting a typical FRAP experiment. 
(A) A cell expressing a fluorescently tagged protein. The fluorophores in a 
designated area are irreversibly bleached through intensive laser 
irradiation. The fluorescence in the region of interest (ROI) recovers 
through diffusion of unaffected fluorophores from the neighboring areas. 
(B) Exemplary FRAP curve. Before bleaching the average intensity in the 
ROI is recorded. Upon irradiation the fluorescence is depleted. After 
bleaching the fluorescence partially recovers through diffusion of 
fluorescent molecules from the surrounding area into the photobleached 
ROI. 
 
Depending on the nature of the fluorescently labeled molecule and the bleached region the observed 
recovery can originate from diffusion, association and dissociation or transport processes. Thus, 
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quantitative analysis of the recovery curve contains information regarding the kinetic parameters of the 
movement of the labeled molecule and can be employed to determine the diffusion constants and transport 
rates of proteins.  
FRAP has been used to study protein dynamics in the cytoplasm, nucleus and other cell organelles such as 
mitochondria, Golgi and the ER.136 Furthermore photobleaching has been used to analyze the dynamics of 
protein trafficking.137-140 
Fluorescence localization after photoactivation (FLAP) 
Photoactivation experiments can be used to complement FRAP measurements. The most commonly used 
photoactivatable fluorescent protein is photoactivatable GFP (paGFP).141 Before activation paGFP displays 
only very low fluorescence at typical GFP imaging settings. Upon intense UV irradiation the chromophore 
undergoes irreversible photoconversion, changing its spectral properties and leading to a more than 
100-fold increase in fluorescence. 
The procedure of a typical photoactivation experiments is similar to the previously described FRAP setup. 
Instead of a bleaching step, a fluorophore population is activated at a predefined ROI through irradiation at 
a specific wavelength (usually in the UV range) and the subsequent depletion from this area and/or the 
resulting increase in fluorescence at a different site is monitored (Figure 1-12).  
 
 
Figure 1-12: Scheme depicting a typical FLAP experiment. 
Before photoactivation cells expressing a paGFP-tagged protein display negligible fluorescence. After irradiation with 
the appropriate wavelength, the fluorophores in the exposed area show a marked increase in fluorescence. 
Subsequently, the fluorophores diffuse through the cytoplasm and later into the cell nucleus.  
In contrast to photobleaching, newly synthesized protein that is generated over the course of the 
measurement does not affect photoactivation experiments. Like FRAP, photoactivation can be utilized to 
examine protein kinetics and determine properties such as the diffusion coefficient or the residence time 
of a protein at a specific organelle.  
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1.3  Small GTPase biosensors 
Due to their involvement in a plethora of highly dynamic processes, small GTPases have been among the 
first targets for biosensor development. GTPase biosensors are primarily focused on spatially resolving 
GTPase activation in cells.142  
The common methodology of most GTPase sensors is based on utilizing effector domains as affinity tags. 
These tags report on GTPase activation through specifically binding to the GTP-bound protein. This concept 
was first exploited in a bimolecular FRET biosensor to visualize Rac1 activity in cells143 and is derived from 
biochemical assays used to quantify GTPase activity in cell lysates.144 In this approach, a fluorescently 
labeled affinity tag, based on the p21-activated kinase 1 (Pak1) effector domain, binds to activated GFP-
tagged Rac1, bringing the two fluorophores in close proximity to generate a FRET signal read out at locations 
of high Rac1 activity.(Figure 1-13 A).  
A different bimolecular sensor design that does not rely on FRET, is the translocation sensor strategy. In this 
case, the read out is generated by fluorescently labeled effector domains that bind and enrich at sites with 
a high concentration of active, GTP-bound GTPase (Figure 1-13 B). This methodology also allows for the 
observation of endogenous GTPase activity.145-148 
 
Figure 1-13: Bimolecular sensor approaches. 
(A) Bimolecular FRET sensor. Binding of the fluorescently labeled affinity tag (AT) to the activated, labeled GTPase leads 
to FRET. (B) Translocation sensor. A labeled AT locates to the sites of high GTPase activity through specific interaction 
with the active GTPase. 
These dual-chain approaches, where the affinity-tag and the GTPase are located in two separate molecules, 
were later complemented by single-chain FRET constructs that can be purely genetically encoded. The first 
of these small GTPase single-chain FRET sensors was developed to monitor Rap1 and HRas activation in 
cells.149 In this case, the GTPase and the affinity tag are directly linked and sandwiched between two 
fluorescent proteins. Upon binding of the affinity tag to the activated, GTP-bound GTPase, the two 
fluorescent proteins are brought in close proximity and form an efficient FRET pair. This sensor principle is 
also referred to as “Ras and interacting protein chimaeric unit” (Raichu) sensors and variations have been 
applied to multiple other small GTPases, including members of the Rho150-154, Ras149,155, Rab156,157, and the 
Ran family158 (Figure 1-14). 
  
1 Introduction 
 
-21- 
Both approaches have specific advantages and weaknesses. Dual-chain designs are more accessible as they 
only require optimization of one component, while single-chain constructs have to be optimized for their 
linker regions, topology and relative orientation.157,159,160  
 
Figure 1-14: Unimolecular FRET sensors. 
(A) “Raichu” sensor design that sandwiches the GTPase and the affinity tag (AT) between two fluorescent proteins. 
Upon activation the fluorescent proteins are brought in close proximity resulting in FRET. (B) A variation of the 
unimolecular FRET sensor design that preserves the GTPase’s C-terminus. The C-terminal region is often critical for 
native membrane localization.  
Furthermore, dual chain constructs usually allow for a higher dynamic range as they do not exhibit the basal 
FRET-signal on their off state as often the case for single-chain constructs. However, ratiometric imaging of 
these dual chain constructs is susceptible to artifacts that can arise from inhomogeneous cellular 
distribution of the two sensory units or differences in their expression levels. For single chain constructs the 
distribution and concentration of the two fluorophores is identical by design. However, in this case 
inhomogeneous bleaching of the two fluorophores can be problematic for FRET quantification. The impact 
of the sensor designs on the endogenous interactions has to be considered as well. For the single chain 
design, binding of the intramolecular affinity tag competes with the endogenous interaction partners of the 
GTPase, e.g. GEFs, GAPs and GDI. In dual chain sensors the affinity tag can be outcompeted by the 
endogenous effector proteins, leading to a false “inactive” signal. 
Membrane localization is another important aspect of GTPase signaling. Small GTPases membrane 
interaction is generally mediated through lipid moieties that are posttranslationally attached to the proteins 
C-terminal region. Thus, single chain sensors, where the GTPase is positioned in the interior of the chain, 
often lack the native membrane localization signal161 or have to be artificially anchored to the 
membrane149,151,152, e.g. through appending a –CAAX motif. 
A FRET-based approach that reports on endogenous GTPase activity employs affinity tags with two 
fluorescent proteins attached. In this case, binding to the activated endogenous GTPase leads to a change 
in the relative position of the fluorescent proteins and thus to a change in the observed FRET signal (Figure 
1-15).158,162,163 
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Figure 1-15: FRET sensor for endogenous 
GTPase activity. 
A unimolecular FRET probe that reports 
on the endogenous GTPase activity. Upon 
binding of the affinity domain (AT) to the 
GTPase, the position/orientation of the 
two attached fluorescent proteins is 
distorted, leading to a change in FRET 
signal. 
 
Another group of sensors utilizes environment sensitive dyes to report on small GTPase activity. In one of 
these approaches the read out is generated through a solvatochromic dye attached to an affinity tag.164-166 
The tag binds to the activated GTPase, changing the dye’s local environment resulting in a change in 
fluorescence signal.  
In a different methodology the GTPase is directly labeled with the environment-sensitive dye. The 
conformational changes of the GTPase upon nucleotide exchange and effector binding lead to a changed 
local environment that surrounds the dye. So far the latter method has been restricted to in vitro 
measurements. 
 
Figure 1-16: GTPase Biosensors based on environment-sensitive dyes. 
(A) The GTPase affinity tag (AT) is labeled with a solvatochromic dye that changes its fluorescence due to a change in 
local environment upon binding to the activated GTPase. (B) The GTPase is labeled with an environment-sensitive dye. 
Nucleotide exchange leads to changes in the local dye environment and thus a change in fluorescence signal. 
Recently, a novel small GTPase biosensor has been described that reports on the GTPase-GDI interaction.167 
For this purpose, the GTPase is equipped with two fluorescent proteins that form a FRET antenna. Upon 
binding to GDI, the relative position of the two fluorophores is altered, which in turn leads to a change in 
FRET signal. This probe can be used in combination with traditional GTPase activations sensors to examine 
the interdependence of GDI and GEF/GAP-mediated GTPase regulation. 
Figure 1-17: Sensor for 
endogenous GDI interaction. 
A unimolecular FRET probe that 
reports on the endogenous 
GTPase-GDI interaction. 
Binding of the GTPase to GDI 
leads to change in relative 
orientation of the two attached 
fluorescent proteins and thus to 
a change in the FRET signal. 
  
  
2 Materials and methods 
 
-23- 
2 Materials and methods 
2.1 Materials 
2.1.1 Chemicals 
Chemicals used in this thesis are listed below (Table 2-1). 
Table 2-1: Used chemicals. 
Chemical Supplier 
2’/3’‐O‐(N‐methyl-anthraniloyl)‐guanosin‐5’‐
diphosphate 
Jena Bioscience (Jena, Germany) 
2-Propanol Sigma‐Aldrich (Munich, Germany) 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid 
Gerbu (Gaiberg, Germany) 
4-Mercaptophenylacetic acid Sigma‐Aldrich (Munich, Germany) 
Acetic acid Merck (Darmstadt, Germany) 
Acetone JT Baker (Deventer, Netherlands) 
Acetonitrile JT Baker (Deventer, Netherlands) 
Acrylamid 4K-solution (30 %, Mix 37.5 : 1) Applichem (Darmstadt, Germany) 
Agarose Invitrogen (Darmstadt, Germany) 
Alexa Fluor 594 C5 maleimide Thermo Fisher Scientific (Waltham, USA) 
Ampicillin Serva (Heidelberg, Germany) 
Bovine serum albumine Sigma‐Aldrich (Munich, Germany) 
Bradford reagent Bio-Rad (Munich, Gernamy) 
Bromphenol blue Serva Serva (Heidelberg, Germany) 
Carbenicillin Biomol GmbH (Hamburg, Germany) 
Chloramphenicol Merck (Darmstadt, Germany) 
Coomassie Brilliant Blue G250+R250 Serva (Heidelberg, Germany) 
Dimethylsulfoxide Fluka - Sigma‐Aldrich (Munich, Germany) 
Disodium hydrogenphosphate JT Baker (Deventer, Netherlands) 
Dithioerythritol Gerbu (Gaiberg, Germany) 
Dithiothreitol Gerbu (Gaiberg, Germany) 
Dimethyl sulfoxide Sigma‐Aldrich (Munich, Germany) 
Ethanol JT Baker (Deventer, Netherlands) 
Ethylenediaminetetraacetic adic Gerbu (Gaiberg, Germany) 
Glycine Carl Roth GmbH (Karlsruhe, Germany) 
Guanosine-5’-β,γ-imidotriphosphate Sigma‐Aldrich (Munich, Germany) 
Guanosine diphosphate Sigma‐Aldrich (Munich, Germany) 
Guanosine triphosphate Sigma‐Aldrich (Munich, Germany) 
Hydrochloric acid JT Baker (Deventer, Netherlands) 
Imidazol Merck (Darmstadt, Germany) 
Isopropyl-β-D-thiogalactopyranoside Gerbu (Gaiberg, Germany) 
Kanamycin Gerbu (Gaiberg, Germany) 
Magnesium chloride JT Baker (Deventer, Netherlands) 
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Methanol Applichem (Darmstadt, Germany) 
N,N,N’,N’-tetramethylethylenediamine Carl Roth GmbH (Karlsruhe, Germany) 
Phenylmethylsulfonylfluoride Sigma‐Aldrich (Munich, Germany) 
Potassium chloride JT Baker (Deventer, Netherlands) 
Potassium dihydrogenphosphate JT Baker (Deventer, Netherlands) 
Potassium hydroxide JT Baker (Deventer, Netherlands) 
RedSafe Nucleic Acid Staining Solution 
iNtRON Biotechnology (Sangdaewon-dong, South 
Korea) 
Sodium 2-mercaptoethanesulfonate Sigma‐Aldrich (Munich, Germany) 
Sodium chloride Sigma‐Aldrich (Munich, Germany) 
Sodium dihydrogenphosphate JT Baker (Deventer, Netherlands) 
Sodium dodecylsulphate Gerbu (Gaiberg, Germany) 
Sodium hydroxide JT Baker (Deventer, Netherlands) 
Tide Fluor 3 maleimide  Aat Bioquest (Sunnyvale, USA) 
Tide Fluor 4 maleimide  Aat Bioquest (Sunnyvale, USA) 
Tris(2-carboxyethyl)phosphine Fluka - Sigma‐Aldrich (Munich, Germany) 
Triton X-100 Sigma‐Aldrich (Munich, Germany) 
β-mercaptoethanol Serva (Heidelberg, Germany) 
2.1.2 Biomolecular reagents  
Biomolecular reagents and kits used in this thesis are listed below (Table 2-2). 
Table 2-2: Biomolecular reagents and kits. 
Reagent Supplier 
FastAP Thermosensitive Alkaline Phosphatase Thermo Fisher Scientific (Waltham, USA) 
E.Z.N.A. Cycle Pure Kit Omega Bio-Tek (Norcross, USA) 
E.Z.N.A. Gel Extraction Kit  Omega Bio-Tek (Norcross, USA) 
E.Z.N.A. Plasmid Midi Kit Omega Bio-Tek (Norcross, USA) 
E.Z.N.A. Plasmid Mini Kit Omega Bio-Tek (Norcross, USA) 
FastDigest restriction enzymes Thermo Fisher Scientific (Waltham, USA) 
Gene Ruler 1 kb DNA Ladder Fermentas (St. Leon‐Rot, Germany) 
LMW (low molecular weight) marker GE Healthcare (Munich, Germany) 
Phusion High‐Fidelity PCR Master Mix Finnzymes (Vantaa, Finland) 
Protease Inhibitor Cocktail cOmplete ULTRA  
EDTA-free 
Roche Diagnostics (Risch-Rotkreuz, Switzerland) 
PreScission Protease 
Dortmund Protein Facility  
MPI of Molecular Physiology (Dortmund, Germany) 
QIAprep Spin Miniprep Kit Qiagen (Hilden, Germany) 
REDTaq DNA Polymerase Sigma‐Aldrich (Munich, Germany) 
T4 DNA Ligase  Fermentas (St. Leon‐Rot, Germany) 
TEV‐Protease 
Dortmund Protein Facility  
MPI of Molecular Physiology (Dortmund, Germany) 
BigDye Terminator v 3.1. Cycle Sequencing Kit 
Applied Biosystems (Darmstadt, 
Germany) 
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2.1.3 Buffers and solutions 
Buffers and solutions used in this thesis are listed below (Table 2-3). 
Table 2-3: Buffers and solutions. 
Buffer Composition Buffer/solution Composition 
PBS buffer 
13.7 mM NaCl,  
0.27 mM KCl, 
10 mM Na2HPO4, 
2 mM KH2PO4,  
pH 7.4 
SDS stacking gel 
buffer 
0.5 M Tris-HCl pH 6.8,  
0.4 % (w/v) SDS 
 
Buffer A*# 
 
50 mM HEPES pH 8.0,  
500 mM LiCl,  
2 mM β-mercaptoethanol,  
1 mM MgCl2, 10 µM GDP 
SDS resolving gel 
buffer 
0.5 M Tris-HCl pH 6.8,  
0.4 % (w/v) SDS 
Buffer B*# buffer A + 0.5 M imidazol SDS running buffer 
25 mM Tris 
0.2 M glycine 
0.1 % (w/v) SDS 
TEV buffer# 
 
50 mM HEPES pH 8.0,  
100 mM NaCl,  
2 mM β-mercaptoethanol,  
10 µM GDP 
4x SDS loading 
buffer 
200 mM Tris, pH 6.8, 
4 % (w/v) SDS,  
20 % (w/v) glycerol, 
5 % (w/v) 200 mM DTT, 
0.2 % (w/v) bromophenol 
blue 
Gel filtration buffer*# 
20 mM HEPES pH 7.5,  
50 mM NaCl, 2 mM DTE,  
1 mM MgCl2, 10 µM GDP 
Coomassie staining 
solution 
10 % (v/v) acetic acid 
40 % (v/v) ethanol 
0.1 % (v/v) Coomassie 
Brilliant Blue R250 
Labeling buffer 
20 mM HEPES pH 7.5,  
20 mM NaCl, 1 mM MgCl2,  
10 µM GDP 
SDS destaining 
solution 
10 % (v/v) acetic acid 
Fluorescence buffer 
20 mM HEPES pH 7.5,  
20 mM NaCl, 1 mM MgCl2,  
2 mM DTE 
TAE buffer 
40 mM Tris-HCl pH 8.5, 
1 mM EDTA 
20 mM acetic acid 
NCL buffer 
20 mM HEPES pH 7.5,  
50 mM NaCl, 1 mM MgCl2,  
10 µM GDP, 50 mM MPAA, 
 20 mM TCEP 
Antibiotic  
solutions 
125 mg/l ampicillin 
34 mg/l chloramphenicol 
125 mg/l kanamycin 
  
5x DNA loading 
buffer 
30 % (w/v) sucrose 
20 % (v/v) glycerol 
0.2 % (w/v) Orange G 
*For protein purification of protein thioester constructs the indicated buffers were used without thiol 
additives (e.g. DTE, β-mercaptoethanol). # Non-GTPase proteins were purified without GDP and MgCl2. 
  
2 Materials and methods  
 
 -26- 
2.1.4 Cell culture media, additives and reagents 
Cell culture media, additives and reagents used in this thesis are listed below (Table 2-4). 
Table 2-4: Cell culture media, additives and reagents. 
Medium, additive or reagent Supplier 
Dulbecco's phosphate-buffered saline (DPBS) Thermo Fisher Scientific (Waltham, USA) 
Earle's balanced salt solution (EBSS) Sigma‐Aldrich (Munich, Germany) 
Fetal bovine serum (FBS) Thermo Fisher Scientific (Waltham, USA) 
GlutaMAX Thermo Fisher Scientific (Waltham, USA) 
Insulin solution, human Sigma‐Aldrich (Munich, Germany) 
Minimum essential medium (MEM) Thermo Fisher Scientific (Waltham, USA) 
Clear minimum essential medium  
(without phenol red) 
Thermo Fisher Scientific (Waltham, USA) 
Minimum essential medium  
Non-essential amino acid solution (100×) 
Sigma‐Aldrich (Munich, Germany) 
Opti-MEM Thermo Fisher Scientific (Waltham, USA) 
Sodium pyruvate solution (100 mM) Sigma‐Aldrich (Munich, Germany) 
Transfection reagent X-tremeGENE HP DNA  
Trypsin-EDTA (0,25 %) 
Roche Diagnostic (Risch-Rotkreuz, Switzerland) 
Thermo Fisher Scientific (Waltham, USA) 
2.1.5 Bacterial strains 
Bacterial strains used for plasmid amplification, protein expression (2.3) or transformation of ligation (2.2.4) 
and site-directed mutagenesis (2.2.1.3) products are listed below (Table 2-5). 
Table 2-5: Bacterial strains. 
Strain Genotype Supplier 
E. coli XL1‐Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F' proAB lacIqZDeltaM15 Tn10 (Tetr)] 
Merck (Darmstadt, 
Germany) 
E. coli BL21(DE3) 
E. coli B F ompT hsdS(rB mB) dcm+ Tetr gal 
lambda(DE3) endA Hte 
Agilent Technologies 
(Santa Clara, USA) 
E. coli BL21-
CodonPlus(DE3)-RIL 
E. coli B F ompT hsdS(rB mB) dcm+ Tetr gal 
lambda(DE3) endA Hte [argU ileY leuW Camr] 
Agilent Technologies 
(Santa Clara, USA) 
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2.1.6 Eukaryotic cell lines 
Cell lines used for transfection (2.6.2), microinjection (2.6.4) and live cell microscopy (2.7) are listed below 
(Table 2-6). 
Table 2-6: Eukaryotic cell lines. 
Cell line Characteristics ATCC number 
HeLa 
organism: Homo sapiens   tissue: cervix 
cell type: epithelial   morphology: epithelial 
culture properties: adherent 
CCL-2 
COS-7 
organism: Cercopithecus aethiops tissue: kidney 
cell type: SV40 transformed morphology: fibroblast 
culture properties: adherent 
CRL-1651 
MDCK 
organism: Canis familiaris  tissue: kidney 
cell type: epithelial  morphology: epithelial 
culture properties: adherent 
CCL-34 
2.1.7 Plasmids 
Plasmid used for bacterial protein expression (Table 2-7) and mammalian cell transfection (  
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Table 2-8) are listed below. 
Table 2-7: Plasmids for bacterial expression. 
Expressed protein Plasmid Plasmid source 
Rab1b3-174 w0294 pMAL Rab1b 3-174 opti 
AG Goody,  
MPI Dortmund 
Rab1b3-174_G18C w0836 pMAL Rab1b 3-174 opti G18C this thesis 
Rab1b3-174_W102C 
w0382 pMAL Rab1b 3-174 opti 
W102C 
this thesis 
Rab1b3-174_W62C w0308 pMAL Rab1b 3-174 opti W62C this thesis 
EGFP-Rab1bD2_T34C 
w0316 pET19TEV-EGFP-
Rab1bD2_T34C 
AG Wu, 
MPI Dortmund 
EGFP-Rab1bD2_T34C-thioester w0722 pTwin EGFP-Rab1bT34C_D2 this thesis 
EGFP-Rab1bD2_G18C-thioester w1049 pTwin EGFP-Rab1bG18C_D2 this thesis 
EGFP-Rab1bD2_I41C w1150 pET-EGFP-Rab1bD2_I41C this thesis 
EGFP-Rab1bD2_S36C w1151 pTwin_EGFP-Rab1bD2_S36C this thesis 
EGFP-Rab1bD2_T34C 
w1273 pET EGFP-
Rab1b_T34C_C23S_D2 
this thesis 
EGFP-Rab1bD2_S36C 
w1274 pET EGFP-
Rab1b_S36C_C23S_D2 
this thesis 
EGFP-Rab1bD2_D53C 
w1275 pET EGFP-
Rab1b_D53C_C23S_D2 
this thesis 
EGFP-Rab1bD2_G54C 
w1276 pET EGFP-
Rab1b_G54C_C23S_D2 
this thesis 
EGFP-Rab1bD2_G54C-thioester 
w1301 pTwin EGFP-
Rab1b_C23S_G54C 
this thesis 
EGFP-Rab1bD2_S36C-thioester 
w1320 pTwin EGFP-
Rab1b_C23S_S36C 
this thesis 
EGFP-Rab1bD2_D53C-thioester 
w1321 pTwin-EGFP-
Rab1b_C23S_D53C 
this thesis 
EGFP-Rab1bD2_W102C-thioester 
w1340 pET EGFP-
Rab1b_W102C_C23S_D2 
this thesis 
EGFP-Rab1bD2_G18C-thioester 
w1368 pTwin EGFP-
Rab1bC23S_G18C_D2 
this thesis 
EGFP_D11-Rab1bD2_T34C 
w1429 pET-EGFP_D11-
Rab1bT34C_C23S_D2 
this thesis 
EGFP_D11-linker-Rab1bD2_T34C 
w1430 pET-EGFP_D11-linker-
Rab1bT34C_C23S_D2 
this thesis 
EGFP_D11-Rab1bD2_D53C 
w1431 pET-EGFP_D11-
Rab1b_D53C_C23S_D2 
this thesis 
EGFP_D11-linker-Rab1bD2_D53C 
w1432 pET-EGFP_D11-linker-
Rab1b_D53C_C23S_D2 
this thesis 
EGFP_D11-Rab1bD2_T34C-thioester 
w1532 pTwin EGFPD11-
Rab1bC23S_T34C_D2 
this thesis 
YPT71-182G18C w1179 pET19mod Ypt7_G18C 1-182 this thesis 
EGFP-YPT71-182S34C w1390 pET-EGFP-YPT7_S34C this thesis 
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TBC1D20 1-362 w1013 pET19mod TBC1D20 1-362 
AG Goody,  
MPI Dortmund 
LidA201-583 w1127 LidA_201-583 
AG Goody,  
MPI Dortmund 
OCRL539-901 w1029 pMAL OCRL opti 
AG Goody,  
MPI Dortmund 
EGFP-KRas_C51S_C80L_C118S -thioester w1589 pTwin EGFP-KRas_cyslight this thesis 
EGFP-KRas_Clight_D30C-thioester 
w1564 pTwin EGFP-
KRas_cyslight_D30C_DC 
this thesis 
EGFP-KRas_Clight_E31C -thioester 
w1565 pTwin EGFP-
KRas_cyslight_E31C_DC 
this thesis 
EGFP-KRas_Clight_D33C-thioester 
w1566 pTwin EGFP-
KRas_cyslight_D33C_DC 
this thesis 
EGFP-KRas_Clight_D47C-thioester 
w1567pTwin EGFP-
KRas_cyslight_D47C_DC 
this thesis 
EGFP-KRas_Clight_G48 -thioester 
w1568 pTwin EGFP-
KRas_cyslight_G48C_DC 
this thesis 
EGFP-KRas_Clight_Y96 -thioester 
w1569 pTwin EGFP-
KRas_cyslight_Y96C_DC 
this thesis 
CitrineD11-KRas_Clight_E31C_DC 
w1577 pTwin CitrineD11-
KRas_cyslight_E31C_DC 
this thesis 
EGFPD11-KRas_Clight_E107C-thioester 
w1590 pTwin EGFPD11-
KRas_cyslight_E107C_DC 
this thesis 
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Table 2-8: Plasmids for mammalian cell transfection. 
Expressed protein Plasmid Plasmid source 
BFP-OCRL w1277 pTagBFP-OCRL this thesis 
BFP-2xFKBPF37V-DrrA w1170 pBFP-2xFKBPF37V-Drra this thesis 
EGFP-Rab1b w0083 pOPINE(n)EGFP-Rab1b 
AG Wu, 
MPI Dortmund 
mKate2-giantin w0599 mKate2-giantin-N1 
AG Wu, MPI 
Dortmund 
paGFP-Rab1b w1319 paGFP-Rab1b this thesis 
paGFP-Rab1b_Q67L w1609 paGFP-Rab1b_Q67L this thesis 
paGFP-Rab1b_S22N w1610 paGFP-Rab1b_S22N this thesis 
paGFP-Rab1b_N121I w1611 paGFP-Rab1b_N1211 this thesis 
2.1.8 Columns and other materials 
Columns for protein purification and other materials used in this thesis are listed below (Table 2-9). 
Table 2-9: Columns and other materials. 
Columns and other materials Supplier 
HisTrap HP 5 ml GE Healthcare (Munich, Germany) 
HiLoad 16/600 Superdex 75 pg  GE Healthcare (Munich, Germany) 
HiLoad 16/600 Superdex 200 pg GE Healthcare (Munich, Germany) 
HiLoad 26/600 Superdex 75 pg GE Healthcare (Munich, Germany) 
illustra NAP-5 Column 
Ni-NTA Superflow (25 ml)  
GE Healthcare (Munich, Germany) 
Qiagen (Hilden, Germany) 
Amicon Ultra-15 (10000 Da MWCO), 30000 Da 
MWCO, 50000 Da MWCO) 
Millipore (Schwalbaach, Germany) 
Amicon Ultra-4 (10000 Da MWCO, 30000 Da 
MWCO, 50000 Da MWCO) 
Millipore (Schwalbach, Germany) 
Dialysis membranes Spectra/Por 1-4 Carl Roth (Karlsruhe, Germany 
Electroporation cuvettes VWR International (Erlangen, Germany) 
Glass bottom dishes 35 mm uncoated MatTek (Ashland, USA) 
Membrane filters mixed cellulose ester 24 VWR International (Erlangen, Germany) 
pH-indicator strips pH 5.0 - 10.0 Merck Millipore (Billerica, USA) 
Pipette tips  
(1-10 ml, 20-200 ml, 100-1000 ml) 
Nerbe (Winsen/Luhe, Germany) 
Rapid-Flow Bottle Top Filter Nalgene Labware (Roskilde, Denmark) 
Safe-Lock Tubes (0.5 ml, 1 ml, 2. 5 ml) Eppendorf (Hamburg, Germany) 
Semi-micro cuvette Sarstedt (Nümbrecht, Germany) 
Serological pipette (5 ml, 10 ml, 25 ml) Sarstedt (Nümbrecht, Germany) 
Tissue culture dish (100 x 20 mm) Sarstedt (Nümbrecht, Germany) 
Reaction Tube (15ml, 50ml) Sarstedt (Nümbrecht, Germany) 
Vivaspin 500 Protein Concentrators  
(3000 Da MWCO, 10000 Da MWCO, 30000 Da 
MWCO) 
GE Healthcare (Munich, Germany) 
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2.1.9 Instruments 
Microscopes, laser instruments and other equipment used in this thesis are listed below in Table 2-10 and  
Table 2-11.  
Table 2-10: Microscopes, laser and FLIM equipment. 
Microscopes and FLIM equipment Supplier 
Leica TCS SP2 Leica Microsystems (Wetzlar, Germany) 
Leica TCS SP5 Leica Microsystems (Wetzlar, Germany) 
Cube 1162002/AF (405 nm) Coherent (Santa Clara, USA) 
Argon Laser LGK 7872 ML05 (458/488/514 nm) Lasos (Jena, Germany) 
561 DPSS YLK 6120 T02 (561 nm) Lasos (Jena, Germany) 
Koheras White Light Laser (470-670 mn) NKT Photonics A/S (Birkerød, Denmark) 
Olympus FluoView FV1000 Olympus (Tokyo, Japan) 
FV5-LD405 (405 nm) Olympus (Tokyo, Japan) 
Argon Laser GLG 3135 (458/488/514 nm) Showa Optronics (Tokyo, Japan) 
561 DPSS 85-YCA-020-230 (561 nm) Melles Griot (Carlsbad, USA) 
PicoHarp 300 PicoQuant (Berlin, Germany) 
Single-photon counting avalanche photodiode PDM Series PicoQuant (Berlin, Germany) 
 
Table 2-11: Instruments and equipment. 
Instrument and equipment Supplier 
ÄKTAprime plus GE Healthcare (Munich, Germany) 
Balance CP224S Sartorius (Göttingen, Germany) 
Balance PM480  Mettler (Columbus, USA) 
Centrifuge 5415 R Eppendorf (Hamburg, Germany) 
Centrifuge 5424 Eppendorf (Hamburg, Germany) 
Centrifuge 5804 R Eppendorf (Hamburg, Germany) 
Centrifuge Avanti J-25 Beckman Coulter (Brea, USA) 
Centrifuge avanti J-26XP Beckman Coulter (Brea, USA) 
Dry block heating system QBT Grant Instruments (Shepreth, UK) 
Electrophoresis Apparatus Horizon 58 Life Technologies (Carlsbad, USA) 
EPS 301 Power Supply GE Healthcare (Munich, Germany) 
Eppendorf Micro manipulator 5171 Eppendorf (Hamburg, Germany) 
Eppendorf Transjector 5246 Eppendorf (Hamburg, Germany) 
Finnigan LCQ Advantage Max mass spectrometer Thermo Fisher Scientific (Waltham, USA) 
FluorChem Q imaging system Alpha Innotech (San Leandro, USA) 
FluoroMax‐3 Horiba Jobin Yvon (Edison, USA) 
High Performance Transilluminators UVP (Upland, USA) 
IKA HS 250 shaker IKA (Staufen, Germany) 
IKA RCT basic IKA (Staufen, Germany) 
Incubator Series ED  Binder (Tuttlingen, Germany) 
Incubator shaker Innova 42 Eppendorf (Hamburg, Germany) 
Incubator shaker Innova 43 Eppendorf (Hamburg, Germany) 
  
2 Materials and methods  
 
 -32- 
inoLab pH Level 1 pH meter WTW (Weilheim, Germany) 
Microfluidizer M-110S Microfluidics (Newton, USA) 
Microinjection needle puller PD-5 Narishige (Tokyo, Japan) 
Milli-Q Water Purification System Merck Millipore (Billerica, USA) 
Nanodrop Micro Volume Fluorospectrophotometer 
PeqLab Biotechnology GmbH (Erlangen, 
Germany) 
Peristaltic Pump P-1 
Amersham Pharmacia Biotech (Uppsala, 
Sweden) 
Personal Thermocycler Analytic Jena AG (Jena, Germany) 
Pipette PIPETMAN Classic (2 l, 10 l, 100 l, 200 l, 
1000 l) 
Gilson (Middleton, USA) 
PowerPAC 300 Biorad (Hercules, USA) 
QIAcube Qiagen (Hilden, Germany 
Rotilabo-mini-centrifuge Carl Roth (Karlsruhe, Germany) 
Rotor JA-10 Beckman Coulter (Brea, USA) 
Rotor JLA-8.1000 Beckman Coulter (Brea, USA) 
Rotor JA-25.50 Beckman Coulter (Brea, USA) 
Thermomixer Comfort Eppendorf (Hamburg, Germany) 
Vacuum Diaphragm Pump Ilmvac (Ilmenau, Germany) 
Vortex Genie 2 Scientific Industries (Bohemia, USA) 
Water purification system Q-POD Merck Millipore (Billerica, USA) 
2.1.10 Software  
Software and programs used in this thesis are listed below (Table 2-12). 
Table 2-12: Software and programs. 
Software and programs Supplier 
a|e - UV-Vis-IR Spectral Software 1.2  FluorTools (www.fluortools.com) 
ChemBioDraw Office 2014  PerkinElmer (Waltham, USA) 
EndNote X7 Thomas Reuter (New York, USA) 
GraFit 5 Erithacus Software (Horley, UK) 
IGOR Pro 6.2 WaveMetrics (Tigard, USA) 
ImageJ 1.44p Wayne Rasband, NIH (Bethesda, USA) 
Leica LAS AF Lite 2.6.0 Leica Microsystem (Wetzlar, Germany) 
MagTran 1.02 Zhongqi Zhang, Amgen (Thousand Oaks, USA) 
MATLAB R2012b The MathWorks (Natick, USA) 
Origin 8.6 OriginLab (Northampton, USA) 
PyMOL 1.7.4 Schrödinger (New York, USA) 
SnapGene Viewer 2.8.3 GSL Biotech (Chicago, USA) 
Xcalibur 1.4 SR1 Thermo Electron (San Jose, USA) 
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2.2 Biomolecular methods 
2.2.1 Polymerase chain reaction (PCR) 
Polymerase chain reaction is a method for DNA amplification based on repeated heating and cooling cycles. 
The cycling program, primer design and reaction composition are adjusted based on the intended purpose 
of the DNA amplification (e.g. insert amplification, sequencing or colony PCR). PCR protocols used in this 
thesis are described below. 
 Insert amplification 
Table 2-13: PCR for insert amplification. 
PCR composition PCR program 
Vtotal = 50 l 
25 l 2x Phusion High-Fidelity PCR Master Mix with 
HF Buffer 
+ 2 x 0.5 l forward and reverse primer (100 M) 
+ 2 l DNA template with desired insert (1 ng/l) 
+ H2O (up to 50 l) 
98 °C 30 s 
98 °C 10 s 
50 °C  30 s       x 25-45 cycles (Tm) 
72 °C 30 s     (15-30 s/ 1 kb) 
72 °C 5 min    
8 °C ∞  
After completion the PCR product was purified by using the E.Z.N.A. Cycle Pure Kit. 
 Colony PCR 
Colony PCR was used after insert ligation to identify bacterial colonies carrying the desired ligation products.  
Table 2-14: Colony PCR. 
PCR composition PCR program 
Vtotal = 11 l 
5 l Taq DNA Polymerase 2x Master Mix Red 
+ 2 x 1 l forward and reverse primer (1 M) 
+ 2 l DNA template (1 ng/l) 
+ H2O (up to 10 l) 
+ 1 l of bacterial colony suspended in 50 L H2O 
96 °C 120 s 
96 °C 30 s 
57 °C  30 s       x 25-35 cycles (Tm) 
72 °C 90 s     (60 s/ 1 kb) 
72 °C 4 min    
8 °C ∞  
After completion the PCR products were analyzed by agarose gel electrophoresis (2.2.3). 
 Site-directed mutagenesis 
Site-directed mutagenesis was used to introduce specific mutations into a DNA sequence.  
Table 2-15: Site-directed mutagenesis. 
PCR composition PCR program 
Vtotal = 50 l 
25 l 2x Phusion High-Fidelity PCR Master Mix 
with HF buffer 
+ 0.5 l forward Primer containing the desired 
mutation site (100 M) 
+ 1 l DNA template (150-200 ng/l) 
+ H2O (up to 50 l) 
98 °C 30 s 
98 °C 15 s 
55 °C  30 s       x 29 cycles (Tm) 
72 °C 4 min      
72 °C 10 min    
8 °C ∞  
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After completion 2 l DpnI (Thermo Fisher Scientific) was added and the mixture incubated for at least 1 h 
at 37 °C to digest remaining template DNA. DpnI was inactivated at 80 °C and 4 l of the PCR mixture was 
transformed into competent E. coli cells (2.2.5). Successful introduction of the mutation was confirmed by 
subsequent sequencing (2.2.1.4). 
 Sequencing PCR 
Sequencing was used to confirm successful DNA ligation or introduction of site-specific mutations into DNA 
sequences. 
Table 2-16: Sequencing PCR. 
PCR composition PCR program 
Vtotal = 10 L 
500 ng DNA template 
+ 0.5 l primer (100 M) 
+ 2 l BigDye Terminator Mix 
+ 2 l 5x BigDye Terminator Mix buffer 
+ H2O (up to 10 l) 
96 °C 4 min 
96 °C 10 s 
50 °C  5 s       x 25 cycles (Tm) 
60 °C 3 min   
8 °C ∞ 
After completion the DNA was precipitated and sequenced by the sequencing facility of the MPI of 
Molecular Physiology. 
2.2.2 Restriction enzyme digestion 
For sequence-specific DNA digestion FastDigest enzymes (Thermo Fisher Scientific) were used according to 
the manufacturer’s instructions. For a typical digestion 0.1–1 g of DNA was mixed with water, 2 l of 10x 
FastDigest buffer (Thermo Fisher Scientific) and the restriction enzymes to a total volume of 20 l or 30 l. 
The mixture was incubated at 37 °C until digestion was completed as recommended in the specifications of 
the specific enzyme. If applicable the enzyme was heat-inactivated. The DNA was purified by using the 
E.Z.N.A. Cycle Pure Kit (Omega Bio-Tek).  
In Order to prevent religation of the cut vector in subsequent ligation, the digested vector DNA was 
additionally incubated with FastAP Thermosensitive Alkaline Phosphatase (Thermo Fisher Scientific) 
according to the manufacturer’s instructions. 
2.2.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate, identify and purify DNA by its size. In this thesis agarose 
gels with 1 % w/v agarose in TAE buffer mixed with RedSafe Nucleic Acid Staining Solution (iNtRON 
Biotechnology) were used. For loading the samples on the gel, 3-20 l DNA sample was mixed with 5x DNA 
loading buffer. As a reference 7 l of the size standard Gene Ruler 1 kb DNA (Fermentas) was used. The 
agarose gels were run at 100 V immersed in TAE buffer. After separation the DNA bands were visualized 
with the FluorChem Q imaging system (Alpha Innotech) at 302 nm. 
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For subsequent purification the desired DNA bands were excised from the gel and recovered from the 
agarose gel by using the E.Z.N.A. Gel Extraction Kit (Omega Bio-Tek).  
2.2.4 Ligation 
Vector constructs for bacterial or mammalian cell expression were generated through ligation of the desired 
insert into a linearized vector. The DNA insert was amplified by insert PCR (2.2.1.1), purified using the 
E.Z.N.A. Cycle Pure Kit and digested with the appropriate restriction enzymes (2.2.2). For the vector about 
1 g of the chosen donor plasmid was digested with the appropriate restriction enzymes (2.2.2) and purified 
by using the E.Z.N.A. Cycle Pure Kit. Successful insert amplification and DNA digestion was confirmed by 
agarose gel electrophoresis (2.2.3). 
Ligation was performed overnight at 16 °C. A typical ligation mixture with a total volume of 20 l mixture 
contained a 3:1 molar ratio of DNA insert to vector, 2 l 10x T4 DNA Ligase buffer and 1 l T4 DNA Ligase 
(1 Weiss unit/l) as recommended by the manufacturer. After overnight ligation, 4 l of the ligation mixture 
were transformed into competent cells (2.2.5), plated overnight on selective medium and single colonies 
analyzed by colony PCR (2.2.1.2). 
2.2.5 Transformation of competent cells 
Transformation of competent cells for plasmid amplification, protein expression (4.3) or selection of ligation 
(4.2.4) and site-directed mutagenesis (4.2.1.3) products was performed as described below. 
 Transformation of chemical competent cells 
1-4 l of plasmid DNA or ligation/site-directed mutagenesis mixture was added to 300 l chemically 
competent cells on ice and incubated for 30 min. The cells were heated to 42 °C for 1 min and immediately 
cooled on ice for 10 min. After addition of 1 ml of LB medium the transformed cells were incubated for 1 h 
at 37 °C in a shaker at 160 rpm. Finally, the cells were plated on selective medium and incubated overnight 
at 37 °C. 
 Transformation of electrocompetent cells 
1-4 l of plasmid DNA or ligation/site-directed mutagenesis mixture was added to 80 l electrocompetent 
cells on ice and the mixture transferred into a precooled electroporation cuvette. After electroporation at 
1.8 kV, 200 Ω and 25 μF, 1 ml LB medium was added and the cells incubated for 30-45 min at 37 °C in a 
shaker at 160 rpm. Finally, the cells were plated on selective medium and incubated overnight at 37 °C. 
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2.3 Protein expression and purification 
2.3.1 Protein expression 
For expression of recombinant proteins the respective plasmid was transformed into E. coli BL21(DE3) or 
E. coli BL21-CodonPlus(DE3)-RIL cells (2.1.5), plated on selective medium and inoculated overnight at 37 °C. 
The colonies were suspended in 5 ml LB medium and added to 5 l LB-medium supplemented with the 
appropriate selection antibiotic. The cultures were incubated in a shaker at 37 °C and 130-160 rpm until an 
absorbance of 0.5-0.8 at 600 nm (OD600) was reached. For induction IPTG was added to a final concentration 
of 0.2 mM and the cultures were further incubated overnight at 22 °C (18 °C for N-terminally His-EGFP-
tagged proteins). The cells were harvested by centrifugation using an Avanti J-26XP centrifuge (Beckman 
Coulter) with a JLA-8.1000 rotor (4000 rpm, 30 min, 4 °C). Finally, the cell pellet was washed with PBS buffer 
and directly used for protein purification or stored at -80 °C. 
2.3.2 Purification of His-tagged proteins 
Proteins expressed from a pET or pMAL vector with a N-terminal-His or N-terminal-His-MPB tag were 
purified as described below. 
The bacterial cell pellet was suspended in buffer A (50 mM HEPES pH 8.0, 500 mM LiCl, 2 mM β-
mercaptoethanol; for small GTPases additionally: 1 mM MgCl2 and 10 µM GDP) supplemented with 
cOmplete ULTRA Protease Inhibitor Cocktail (Roche) and 2 mM PMSF. The cells were lysed by passing them 
through a Microfluidizer (Microfluidics) three times. Insoluble cell fragments were removed by 
centrifugation in an Avanti J-25 centrifuge (Beckman Coulter) using a JA-25.50 rotor (25000 rpm, 40 min, 
10 °C). For specific protein extraction the supernatant was applied to a HisTrap HP (5 ml, GE Healthcare) 
using an ÄKTAprime plus system (GE Healthcare) after filtration through a Rapid-Flow Bottle Top Filter 
(Nalgene Labware). Unspecifically bound proteins were removed by a wash step with 4 % buffer B (0.5 M 
imidazole, 50 mM HEPES pH 8.0, 500 mM LiCl, 2 mM β-mercaptoethanol; for small GTPases additionally: 
1 mM MgCl2 and 10 µM GDP). The His-tagged target protein was obtained by fractionated elution with a 
linear gradient of 100 ml from 4 % to 100 % buffer B. Fractions containing the target protein were identified 
by measuring the absorption at 280 nm and further analyzed by SDS-PAGE (2.5.1). Protein fractions were 
pooled and His-tagged TEV-protease was added to remove the affinity-tag. The mixture was dialyzed 
overnight against Mg2+-free buffer A (50 mM HEPES pH 8.0, 500 mM LiCl, 2 mM β-mercaptoethanol; for 
small GTPases additionally: 10 µM GDP) at 8° C. The affinity tag, uncleaved protein and TEV-protease were 
removed in an additional Ni-affinity chromatography step. The protein present in the flow-through was 
concentrated to 2-5 ml and subjected to size exclusion chromatography on a HiLoad Superdex 75 26/600 or 
16/600 gel filtration column (GE Healthcare) using gel filtration buffer (20 mM HEPES pH 7.5, 50 mM NaCl, 
2 mM DTE; for small GTPases additionally 1 mM MgCl2 and 10 µM GDP). The fractions containing the target 
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protein were identified by monitoring absorption at 280 nm and subsequently analyzed by SDS-PAGE. 
Fractions containing pure protein were pooled, concentrated, frozen in liquid nitrogen and stored at -80 °C. 
2.3.3 Purification of small GTPases as thioesters 
Proteins expressed from a pTwin vector as a C-terminal-intein fusion proteins were purified as described 
below. 
The bacterial cell pellet was suspended in thiol-free buffer A (50 mM HEPES pH 8.0, 500 mM LiCl; for small 
GTPases additionally: 1 mM MgCl2 and 10 µM GDP) supplemented with cOmplete ULTRA Protease Inhibitor 
Cocktail (Roche) and 2 mM PMSF. The cells were lysed by passing them through a Microfluidizer 
(Microfluidics) three times. Insoluble cell fragments were removed by centrifugation in an Avanti J-25 
(Beckman Coulter) with a JA-25.50 rotor (25000 rpm, 40 min, 10 °C) and subsequent filtration through a 
Rapid-Flow Bottle Top Filter (Nalgene Labware). For specific protein extraction the supernatant was applied 
to a HisTrap HP (5 ml, GE Healthcare) using a ÄKTAprime plus (GE Healthcare). Nonspecifically bound 
proteins were eluted with 4 % thiol-free buffer B (0.5 M imidazole, 50 mM HEPES pH 8.0, 500 mM LiCl; for 
small GTPases additionally: 1 mM MgCl2 and 10 µM GDP). The His-tagged protein was obtained by 
fractionated elution with a linear gradient of 100 ml from 4 % to 100 % buffer B. Fractions containing the 
target protein were identified by measuring the absorption at 280 nm, analyzed by SDS-PAGE (2.5.3) and 
pooled. To the pooled protein, MESNA was added to a final concentration of 0.5 M to generate the protein-
MESNA thioester through thiolysis. The mixture was gently stirred overnight at room temperature. The 
protein solution was diluted with thiol-free buffer 1:5 and the intein tag, uncut protein and impurities 
containing a His-tag were removed in an additional Ni-affinity chromatography step.  
The protein present in the flow-through was concentrated to 2-5 ml and subjected to size exclusion 
chromatography on a HiLoad Superdex 75 26/600 or 16/600 gel filtration column (GE Healthcare) using 
MESNA containing gel filtration buffer (20 mM HEPES pH 7.5, 50 mM NaCl, 0.1 M MESNA, 1 mM MgCl2 and 
10 µM GDP). The fractions containing the target protein were identified by monitoring absorption at 280 nm 
and subsequently analyzed by SDS-PAGE. Fractions containing pure protein were pooled, concentrated, 
frozen in liquid nitrogen and stored at -80 °C. 
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2.4 Protein chemical methods 
2.4.1 Labeling of small GTPases with reactive maleimide dyes  
Thiol-reactive dyes carrying a maleimide moiety used in this thesis include Tide Fluor 3, Tide Fluor 4 (AAT 
Bioquest) and Alexa Fluor 594 C5 (Thermo Fisher Scientific). The dyes were stored and used from a stock 
solution with a concentration of 10 mM dissolved in DMSO. 
For labeling with the acceptor dye, the protein was transferred into thiol-free labeling buffer (20 mM HEPES 
pH 7.5, 50 mM NaCl, 1 mM MgCl2, 10 µM GDP) using a gravity flow NAP-5 Column (GE Healthcare). The 
protein concentration was determined and the reactive dye added stepwise to a final molar ratio of 
1:1.5 - 1:3. The typical reaction volume was 200-500 l with a protein concentration of 2-6 mg/ml. The 
DMSO concentration through dye addition did not exceed 5 % of the total reaction volume. The mixture 
was flushed with argon, shielded from light and incubated for 30-120 min at room temperature. Incubation 
time and dye to protein ratio were optimized by a SDS-Page labeling assay and observation of the protein 
labeling progression with a FluoroMax‐3 spectrofluorometer (2.5.4.1). For proteins without C-terminal 
thioester modification the reaction was quenched after appropriate incubation time by addition of 2 mM 
β-mercaptoethanol. Finally, unreacted dye was removed by buffer exchange using a NAP-5 Column. 
Depending on the subsequent experimental setup, the labeled proteins were further concentrated using 
Vivaspin 500 Protein Concentrators (GE Healthcare).  
2.4.2 Labeling of small GTPases with environment-sensitive iodoacetamide dyes 
Thiol-reactive dyes carrying an iodoacetamide moiety used in this thesis include N-((2-(iodoacetoxy)ethyl)-
N-Methyl)amino-7-Nitrobenz-2-Oxa-1,3-Diazole (IANBD), I-BA-s-IA (Mero61) and I-SO-s-IA (Mero87) from 
the group of Prof. Dr. Klaus Hahn (University of North Carolina at Chapel Hill, USA)168. IANBD was stored and 
used from a stock solution of 10 mM in DMSO. Mero dyes are instable in solution and were stored as 
crystalline powders. For labeling, a fresh stock solution was prepared by dissolving a small amount in 20 l 
DMSO. To determine the dye concentration 1 l of the stock solution was diluted 1:100-1:1000 in DMSO 
and the absorbance A was determined at the wavelength  corresponding to maximal absorption for the 
dyes (570 nm for Mero61, 592 nm for Mero87). With the respective extinction coefficient  the 
concentration was calculated using the Lambert–Beer law (Eq. 2-1). 
dcεA    Eq. 2-1 
Protein labeling was carried out under similar conditions as described for the maleimide probes (2.4.1). To 
accommodate for the reduced labeling kinetics, the molar dye to protein ratio was increased (1:3-1:6) and 
incubation prolonged to 2-10 h. Exact incubation times and dye to protein ratio were optimized using a 
SDS-Page labeling assay and LC-ESI-MS analysis as described previously (2.4.1). 
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2.4.3 Reintroduction of C-terminal amino acids by native chemical ligation 
For site-specific cysteine labeling, the Rab1b and KRas4b protein termini, -CC and -CVIM respectively, had 
to be removed. For native protein function however, these C-terminal amino acids are crucial, as they allow 
membrane attachment through C-terminal prenylation. Thus, the C-termini were reintroduced to restore 
full protein functionality by native chemical ligation (NCL) after completed protein labeling. 
The protein was transferred into thiol-free labeling buffer (20 mM HEPES pH 7.5, 50 mM NaCl, 1 mM MgCl2, 
10 µM GDP) using a NAP-5 Column. Then it was concentrated to about 100 l (6-10 mg/ml) and mixed with 
50 l thiol-free labeling buffer containing 150 mM MPAA and 60 mM TCEP. The final NCL buffer composition 
was 20 mM HEPES pH 7.5, 50 mM NaCl, 1 mM MgCl2, 10 µM GDP, 50 mM MPAA and 20 mM TCEP. Accurate 
calibration of buffer pH after TCEP and MPAA addition is crucial for protein stability and ligation efficiency 
and was monitored using pH-test stripes (Merck Millipore). 
The NCL mixture was incubated on ice overnight. MPAA was removed prior to microinjection experiments 
by repeated concentration in a Vivaspin 500 Protein Concentrator and dilution with MPAA free buffer (20 
mM HEPES pH 7.5, 20 mM NaCl, 1 mM MgCl2, 10 µM GDP). Successful ligation was confirmed by LC-ESI-MS 
(2.5.4). 
2.4.4 Quantitative nucleotide exchange 
After purification small GTPases are usually obtained in GDP-bound form. For quantitative nucleotide 
exchange to GTP or nucleotide analogs such as mantGDP and GppNHP (Jena Bioscience) the following 
protocol was used. 
EDTA was added in a five times molar excess to the buffer Mg2+ concentration to reduce the GTPase’s affinity 
to the bound nucleotide by Mg2+ chelation. The desired target nucleotide was added, to this mixture in a 
5- (for mantGDP) or 20-times (for GTP and GppNHp) molar excess to the GDP buffer concentration and 
incubated at room temperature for at least 2 h. Finally, EDTA was removed by transferring the protein into 
buffer containing 20 mM HEPES pH 7.5, 50 mM NaCl, 1 mM MgCl2, 2 mM DTE and the desired nucleotide at 
a concentration of 1 M for mantGDP or 10 µM for GppNHp and GTP respectively, using a NAP-5 Column. 
2.4.5 Immobilization of His-tagged sensor constructs on Ni-NTA beads 
For in vitro fluorescence lifetime microscopy (2.7.1) small GTPase sensor constructs carrying a His-tag were 
immobilized in the surface of Ni-NTA superflow beads (Qiagen) and imaged on an object slide (Figure 2-1). 
For immobilization of the Rab1 sensor constructs, 50 l of Ni-NTA beads were washed by suspending the 
beads in 500 l GTPase buffer (20 mM HEPES pH 7.5, 20 mM NaCl, 2 mM DTE, 1 mM MgCl2) and spinned 
down to remove the supernatant. The washing process was repeated three times with fresh buffer. 10-20 
l (1-3 mg/ml) of the protein solution was added to 10 l of the suspended beads and incubated for 30-
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60 min. After incubation the suspension was spun down, the supernatant was removed and the beads were 
washed twice with 200 l fresh GTPase buffer.  
Figure 2-1: Immobilization of FRET-sensor on Ni-NTA beads. 
(A) Scheme illustrating the procedure of immobilizing His-tagged Rab1 FRET-sensor on Ni-NTA beads. (B) Scheme 
depicting binding of the His-tagged protein sensor on the Ni-NTA surface. 
To test the sensors response towards GEF-mediated nucleotide exchange the protein was incubated with 
DrrA340-533 (1-2 l, 14 mg/ml, 0.64 mM) in buffer containing 100 M GTP prior to immobilization. For effector 
binding in addition to GEF and GTP, OCRL1539–901 (50 l, 11 mg/ml, 0.26 mM) and LidA201-583 (10 l, 12 mg/ml, 
0.27 mM) were added. Finally, 20-50 l of the bead suspension was transferred onto an object slide and 
imaged by FLIM through a 40x/1.35 UPlanSApo air objective (2.7.1).  
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2.5 Analytical and biophysical methods 
2.5.1 Determination of protein concentration 
To determine the concentration of a protein in solution the absorbance of the aromatic amino acid side 
chains at 280 nm was measured. For a protein of known sequence the mass and extinction coefficients at 
280 nm were calculated by using the ProtParam tool of the ExPasy bioinformatics server.169 The solution 
absorbance at 280 nm was measured using a Nanodrop Micro Volume Fluorospectrophotometer (PeqLab 
Biotechnology) according to the manufacturer’s specification. The protein concentration was then obtained 
from the absorbance using the Lambert–Beer law (Eq. 2-1, section 2.4.2), here c is the protein 
concentration, Ais the absorbance at 280 nm, is the corresponding extinction coefficient at 280 nm and 
d the light path length. 
2.5.2 Determination of labeling efficiency by absorption spectroscopy 
In addition to ESI-LC-MS and fluorescence spectroscopy the labeling efficiency of the fluorescent protein-
tagged GTPases was determined by measuring the absorption of the labeled protein solution at different 
wavelengths. Using the spectral parameters listed in Table 2-17 and Eq. 2-1 the labeling efficiency can be 
obtained as the ratio of fluorescent protein to acceptor dye concentration. 
Table 2-17: Spectral properties of fluorophores. 
Fluorophore  (cm.-1·M-1) ex(nm) CF at 260 nm CF at 280 nm 
EGFP 56000  488   
mCitrine 77000 516   
Tide Fluor 3 85000  584 0.489 0.201 
Tide Fluor 4 90000  618 0.331 0.436 
The solution absorbance was measured using a Nanodrop Micro Volume Fluorospectrophotometer (PeqLab 
Biotechnology) according to the manufacturer’s specification.  
2.5.3 SDS-Polyacrylamide gel electrophoresis 
SDS-Polyacrylamide gel electrophoresis is a preparative and analytical method used to separate and identify 
proteins by their size.  
SDS-PAGE gels were obtained by polymerizing a layer of 5 % SDS stacking gel buffer on top of a previously 
polymerized 15 % SDS resolving gel buffer (2.1.3). The SDS samples were prepared by mixing 10-30 l of the 
protein sample with the appropriate amount of 4x SDS loading buffer (2.1.3). The sample mixture was 
heated at 95 °C for 5 min to ensure homogenous denaturation. 10 l of the denatured protein samples were 
loaded into the gel wells and the samples separated at a current of 60 mA immersed in SDS running buffer 
(2.1.3) until the leading bromophenol blue front reached the bottom of the gel. As a size reference low 
molecular weight (LMW) marker (GE Healthcare) was used. After completed separation the gels were 
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heated in Coomassie staining solution (2.1.3) and the background subsequently destained by repeated 
heating in 10 % (v/v) acetic acid. 
2.5.4 Liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) 
Electrospray ionization mass spectrometry is a highly sensitive detection technique that separates 
molecules after ionization based on their mass-to-charge ratio. For LC-ESI-MS, the mass spectrometer is 
combined with a liquid chromatography (LC) setup which separates molecules (e.g. proteins) based on 
differences in their affinity to a stationary phase (e.g. silica gel and alumina columns) and a mobile phase 
(e.g. eluents such as acetonitrile and water). 
LC-ESI-MS measurements were performed on a LCQ Advantage Max mass spectrometer (Finnigan) coupled 
with an Agilent 1100 Series HPLC system (Agilent Technologies Inc.) equipped with a Grace Vydac 214TP 
C4-HPLC column (Thermo Fisher Scientific). Sample separation and desalting was achieved by elution from 
the HPLC column with a gradient of 20 % to 80 % acetonitrile with 0.08 % (v/v) TFA against aqueous buffer 
with 0.1 % (v/v) TFA. Data analysis and deconvolution was carried out by using the analysis software Xcalibur 
(Thermo Electron) and MagTran (Zhongqi Zhang, Amgen). 
Fluorescence spectroscopy 
 Collection of fluorescence spectra 
Fluorescence measurements were performed with a FluoroMax‐3 (Horiba Jobin Yvon) spectrofluorometer 
in a 1 ml cuvette at 25 °C. Fluorescence spectra were obtained by setting the excitation monochromators 
at a suitable wavelength and detecting the fluorophore emission over a set wavelength range. Typical 
emission/excitation settings used for the fluorophores in this thesis are listed below in Table 2-18. All 
spectra were background corrected through subtraction of a blank buffer spectrum collected with identical 
settings. 
Table 2-18: Fluorescence spectra. 
Fluorophore ex (nm) em (nm) 
EGFP 480 490-700 
Mant 367 400-650 
mCitrine 490 500-800 
Mero61 (I-BA-s-IA) 560 570-750 
Mero87 (I-SO-s-IA) 590 600-750 
NBD 480 500-800 
Tide Fluor 3 535 545-800 
Tryptophan 298 310-500 
  
2 Materials and methods 
 
-43- 
 Characterization of GEF-mediated nucleotide exchange and GAP induced GTP 
hydrolysis by fluorescence spectroscopy 
The interaction of the small GTPases with their regulatory GEF and GAP proteins was assessed by 
fluorescence spectroscopy.  
To monitor GEF-mediated nucleotide exchange three spectroscopic setups were employed: (1) using the 
fluorescently labeled GDP analog mantGDP, (2) measuring the FRET signal response for FRET sensor 
constructs and (3) by following the changes in fluorescence intensity of the environment sensitive dyes 
Mero61 and Mero87 attached at prominent positions in the small GTPases.  
MantGDP-bound GTPase was obtained by quantitative nucleotide exchange as described in 2.4.4. GEF-
mediated nucleotide exchange was then observed as a decrease of mant fluorescence intensity upon 
addition of GEF, 10 - 200 nM for DrrA or 0.125 - 2 M for SOS respectively, to 100 or 200 nM mantGDP-
bound GTPase in the presence of 100 M GTP.  
Similarly, the responses of FRET and ratiometric sensor constructs were characterized by monitoring the 
respective signal change after addition of varying amounts of GEF (10 - 200 nM for DrrA and 0.125 - 2 M 
for SOS), to 100-200 nM mantGDP-bound GTPase in the presence of 100 M GTP. 
GAP induced GTP hydrolysis was observed for the FRET and ratiometric sensor constructs through addition 
of an excess of 1-2 M TBC1D20 to preparatively GTP-loaded GTPase. Typical emission and excitation 
settings used for the described assays are summarized in Table 2-19. 
Table 2-19: Fluorescence measurements settings for GEF and GAP assay. 
Fluorophore ex (nm) em (nm) 
EGFP 480 508 
MantGDP 367 438 
mCitrine 480 525 
Mero61 (I-BA-s-IA) 565 590 
Mero87 (I-SO-s-IA) 596 620 
NBD 480 530 
Sensitized emission ex (nm) em (nm) 
EGFP → Tide Fluor 3 480 580 
mCitrine → Tide Fluor 4 480 614 
 
To determine the catalytic efficiency of the used GEFs and GAPs the following relations were used. 
The Michaelis–Menten equation (Eq. 2-2), describing the rate of enzymatic reactions: 
 
  maxM
v
SK
S
v 

  
Eq. 2-2 
maxv  is the maximum reaction rate,  S is the substrate concentration and MK  is the Michaelis constant.  
The relation for maxv  and v can be described as: 
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 0catmax Ekv            Eq. 2-3              
 
     ESkESk
dt
Sd
v 11    Eq. 2-4 
In this context  0E corresponds to the total enzyme concentration,  ES  is the enzyme-substrate complex 
concentration and kcat is the turnover rate. With    ESkESk 11    and        EEESE 0  , Eq. 2-4 
reduces to: 
   01 ESkv  , using    SEk 0obs    
 Skv obs   
Eq. 2-5 
With  S << MK , Eq. 2-2 can be simplified to Eq. 2-6: 
 
max
M
v
K
S
v   
Eq. 2-6 
Combining Eq. 2-5 and Eq. 2-6 yields the following relation: 
 0
obs
M
cat
E
k
K
k
  Eq. 2-7 
Using this equation, the catalytic efficiency, kcat/KM, can be obtained as the slope of a linear fit of kobs plotted 
against the total enzyme concentration. Under pseudo-first order conditions , kobs can be obtained by fitting 
the fluorescence signal with the mono-exponential equation Eq. 2-8: 
tkobseAII    Eq. 2-8 
here I is the fluorescence intensity at time t, 
I  is the intensity after signal saturation and kobs the observed 
rate. For exponential and linear curve fitting the analysis software Origin 8.6 (OriginLab) was used. 
 Effector binding assay using fluorescence spectroscopy and fluorescence 
polarization 
To assess the binding of effector proteins to the small GTPase sensor constructs fluorescence and 
fluorescence polarization spectroscopy were used. 
Effector binding was analyzed by three different spectroscopic approaches: (1) by observing the changes in 
fluorescence polarization of a dye (e.g. EGFP) attached to the small GTPase upon effector binding, (2) by 
measuring the FRET signal response of the respective sensor constructs or (3) by monitoring the changes in 
fluorescence intensity of the environment sensitive dyes Mero61 and Mero87 attached to the small 
GTPases. Titration of increasing amounts of effector (e.g. OCRL1 or LidA) to a fixed concentration of GTPase 
(100-500 nM) resulted in an effector concentration dependent change in fluorescence polarization, FRET 
signal or fluorescence intensity. After correcting the signal for dilution effects, the observed signal change 
was plotted as a function of the effector concentration. This, allows the determination of KD using the 
following expressions for a reversible second order reaction (Eq. 2-9),  
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GTPase + E ⇌ GTPase:E               
   
 E:GTPase
EGTPase
KD

  Eq. 2-9 
Here [GTPase], [GTPase:E] and [E] are the concentrations at equilibrium and [GTPase]0 and [E]0 represent 
the initial concentration of GTPase and effector, respectively. 
Using      E:GTPaseGTPaseGTPase 0   and      E:GTPaseEE 0   one obtains: 
         
 E:GTPase
E:GTPaseEE:GTPaseGTPase
K 00D

  
which can be rearranged and solved as a quadratic equation for the concentration of the GTPase-effector 
complex  E:GTPase  : 
            EGTPaseEGTPaseKE:GTPaseE:GTPase0 000D
2   
                




  00
2
00D00D EGTPase4EGTPaseKEGTPaseK
2
1
E:GTPase  
Using the above relation with the following equation (Eq. 2-10) describing the binding fraction in equilibrium 
as a change in fluorescence/polarization signal upon effector titration: 
 
  










 0
0
0 II
II
GTPase
E:GTPase
 Eq. 2-10 
equation Eq. 2-11 can be derived: 
 
 
              




 


  00
2
00D00D
0
0
0 EGTPase4EGTPaseKEGTPaseK
GTPase2
II
II  Eq. 2-11 
Eq. 2-11 was then used to fit the measured titration curves with the program GraFit 5 (Erithacus Software) 
to obtain KD values for the respective GTPase-effector complex. 
 Calculation of R0 for FRET pairs  
As discussed in section (1.2.1) factors determining the efficiency of energy transfer for a FRET pair (EFRET) 
include the spectral overlap integral of donor emission and acceptor excitation (J ()), the refractive index 
of the surrounding medium (n), the dipole orientation factor (), the fluorescence quantum yield of the 
donor dye (QD) and the distances of the donor and acceptor fluorophore (r). This relation is described in Eq. 
1-3 and Eq. 1-2. 
6
0
FRET
R
r
1
1
E









  
Eq. 1-2 
4
D
2
236
0
n
)(JQ
1079.8R

  Eq. 1-3 
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To obtain R0 (Förster radius, distance where EFRET=0.5) for a specific fluorophore pair, the overlap integral of 
the donor emission and acceptor excitation integrated over the wavelengths λ has to be determined (Eq. 
2-12).  
 

 d)(F)()(J D
4
0
 Eq. 2-12 
In Eq. 2-12 FD represents the normalized donor emission spectrum and  the molar extinction coefficient of 
the acceptor fluorophore. For the FRET pairs used in this thesis the respective overlap integrals were 
calculated using a|e - UV-Vis-IR Spectral Software (FluorTools). Used constants and calculated J values are 
listed below in Table 2-20 and Table 2-21.  
Table 2-20: Overlap integrals.              Table 2-21: Quantum yields and extinction coefficients. 
J (nm4·M-1·cm-1) EGFP mCitrine  Fluorophore Q  (cm-1·M-1) at ((nm)) 
Alexa Fluor 594 3.11·10
15
 4.22·10
15
  Alexa Fluor 594 0.66 105 000 (588) 
Tide Fluor 3 2.85·10
15
 4.52·10
15
  Tide Fluor 3 0.80 85 000 (555) 
Tide Fluor 4 2.54·10
15
 4.36·10
15
  Tide Fluor 4 0.91 90 000 (590) 
    EGFP 0.60 56 000 (484) 
    mCitrine 0.61 83 400 (514) 
 
R0 was calculated with a value of 2=0.66. Which is an approximation based on unrestricted, freely diffusing 
fluorophores. For the intramolecular FRET pair used in thesis this assumption might be inaccurate as the 
dyes are covalently attached to a protein and thereby restricted in their movement. However, it has been 
shown before, that assuming an orientation factor of 0.66 yields accurate R0 values even for intramolecular 
FRET pairs.170 The obtained R0 for the FRET partners used in this thesis are summarized in Table 2-22. 
Table 2-22: Förster radii. 
R0 (Å) EGFP mCitrine 
Alexa Fluor 594 53.4 59.4 
Tide Fluor 3 53.7 59.9 
Tide Fluor 4 51.7 56.7 
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2.6 Cell biological methods 
2.6.1 Cultivation of eukaryotic cell lines 
All cell lines were cultured in 100 mm tissue culture dishes (Sarstedt) and 7-8 ml minimum essential medium 
(MEM) supplemented with 10 % (v/v) fetal bovine serum (FBS), 1 % (v/v) sodium pyruvate solution 
(100 mM), 1 % GlutaMAX and 1 % (v/v) non-essential amino acids (all Thermo Fisher Scientific) at 37 °C and 
5 % CO2. Cells were split every two to three days at a confluency of 70-80 %. After washing with 5 ml 
dulbecco's phosphate-buffered saline (DPBS) (Thermo Fisher Scientific) cells were detached by incubation 
with 1 ml 0,25 % (v/v) trypsin-EDTA (Thermo Fisher Scientific) at 37 °C and 5 % CO2. Complete detachment 
was confirmed by microscopy and the cells were suspended in 4-9 ml supplemented MEM. Finally, 1 ml of 
the cell suspension were added to 7 ml supplemented MEM in a new 100 mm tissue culture dish. 
2.6.2 Transient transfection of eukaryotic cells 
Transient transfection was used to introduce exogenous transgenic DNA into cells to initiate expression of 
desired recombinant proteins. In this thesis the transfection reagent X-tremeGENE HP DNA (Roche 
diagnostics) was applied according to the manufacturer’s recommendation. For transfection 0.5-1 ml cell 
suspension was added to a mixture of 1-3 g plasmid DNA preincubated for 15-20 min in 200 l Opti-MEM 
(Thermo Fisher Scientific) with 1-2 l X-tremeGENE HP transfection reagent in a 35 mm glass bottom dish 
(MatTek). After transfection the cells were incubated overnight at 37 °C and 5 % CO2 and subsequently used 
for microscopy (2.7) or microinjection (2.6.4). 
2.6.3 Cell treatments 
EGF induced KRas activation 
To test the KRas sensor sensitivity in vivo MDCK cells were serum starved overnight through incubation with 
MEM containing 0.5 % FBS. The following day the respective GTPase sensor constructs were introduced 
through microinjection (2.6.4) and the injected cells incubated for 2-3 h at 37 °C and 5 % CO2. KRas activation 
was then induced through addition of EGF to a final concentration of 100 ng/ml. The FRET sensor response 
was monitored by fluorescence lifetime image microscopy (2.7.3). 
Microtubule disruption with nocodazole 
To observe the effects of abolished microtubule dependent vesicular transport, cells were cooled on ice for 
30 min and treated with 5 g/ml nocodazole in imaging medium prior to FRAP and live cell imaging. 
Treatment with EGFR kinase inhibitor Erlotinib 
To test the KRas sensor’s specificity towards EGF induced KRas activation, cells were treated with 5 M of 
the tyrosine kinase inhibitor Erlotinib for at least 3 h before microinjection and EGF stimulation. 
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2.6.4 Microinjection 
Microinjection is a technique for introducing non-cell permeable reagents into single cells. In this thesis 
microinjection was used to inject small amounts of GTPase sensors into wild type and transiently transfected 
HeLa, COS-7 and MDCK cells (2.1.6). After injection, the cells were examined by confocal (2.7.1) and 
fluorescence lifetime microscopy (2.7.1). 
Microinjection needles were prepared using a PD-5 double-stage horizontal puller (Narishige). 
Microinjection was performed using a 40x oil immersion objective of a TCS SP2 Laser Scanning Confocal 
Microscope (Leica) equipped with an Transjector 5246 (Eppendorf). The cells were prepared for 
microinjection by plating 0.5-1 ml of wild type or transfected cells suspended in MEM in a 35 mm glass 
bottom dish (MatTek). The cells were incubated overnight at 37 °C and 5 % CO2 and subjected to 
microinjection the next day. 
The protein solution was concentrated to 6-10 mg/ml using Vivaspin protein concentrators (GE Healthcare) 
and then centrifuged at 13.000 rpm at 4 °C for 5 min to remove small particles and aggregates. 0.5 l of the 
solution was loaded into the injection needle by pipetting into the blunt end of the capillary. The capillary 
was mounted onto the capillary holder and the needle tip positioned a few m above the cell plane using 
the Eppendorf Micro manipulator 5171. The compensation pressure (Pc) was set to 50 hPa ensuring a slow 
continuous flow from protein solution out of the needle tip to prevent needle blockage. Proper needle 
function was confirmed by verifying the constant leakage of fluorescent protein in the appropriate 
fluorescence channel. The injection plane was set just below the top of the targeted cells. Automated 
injection of 50-150 cells was performed using the Eppendorf Transjector 5246 with the injection pressure 
(Pi) set at 100-180 hPa and an injection time (ti) of 0.2-0.4 s. After injection, the cells were incubated for 
1-2 h at 37 °C and 5 % CO2 to allow prenylation of the reconstituted C-termini through the endogenous 
cellular prenylation machinery. 
2.7 Microscopy 
2.7.1 Confocal laser scanning and fluorescence lifetime microscopy setup 
Confocal laser scanning microscopy (CLSM) and fluorescence lifetime imaging microscopy (FLIM) were 
carried out using a FlouView FV1000 (Olympus) equipped with a time-correlated single-photon counting 
(TCSPC) LSM Upgrade Kit (PicoQuant). Cell images were collected through a 60x/1.35 UPlanSApo oil 
immersion objective (Olympus). Ni-NTA beads were imaged through a 40x/1.35 UPlanSApo air objective 
(Olympus). All measurements were carried out in an incubation chamber at 37 °C. Lasers used for excitation 
and settings for detection are listed below (Table 2-23). For live cell imaging the incubator was additionally 
supplemented with 5 % CO2.  
For FLIM measurements the samples were exited with a 470 nm pulsed diode laser (PicoQuant) at 36 % and 
a repetition rate of 40 MHz. Photons were collected by a single-photon counting avalanche photodiode 
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(PDM Series, MPD, PicoQuant) and timed using a time-correlated single-photon counting module (PicoHarp 
300, PicoQuant) after being spectrally filtered using a narrow-band emission filter (HQ 525/15, Chroma) 
over a course of approximately 2 min with 1-2·105 photons. The FLIM data was subsequently analyzed as 
described in section 2.7.5. 
Table 2-23: FlouView FV1000 settings for fluorescence confocal microscopy. 
Fluorophore Laser  ex (nm) Dichroic mirror (nm) 
Barrier Filters 
settings (nm) 
BFP FV5-LD405 405 SDM510 425-475 
EGFP Argon Laser GLG 3135 488 SDM560 505-550 
mCitrine Argon Laser GLG 3135 488 SDM560 515-560 
Tide Fluor 3 DPSS 85-YCA-020-230 561 Mirror 585-685 
Tide Fluor 4 DPSS 85-YCA-020-230 561 Mirror 575-675 
mKate2 DPSS 85-YCA-020-230 561 Mirror 585-685 
Mero61 DPSS 85-YCA-020-230 561 Mirror 610-710 
Mero87 DPSS 85-YCA-020-230 561 Mirror 610-710 
2.7.2 Live cell imaging using fluorescence recovery after photobleaching (FRAP) and 
photoactivatable fluorescent proteins 
Fluorescence recovery after photobleaching (FRAP) and photoactivatable fluorescent proteins (paFPs) are 
powerful tools to examine and quantify dynamic processes in cells with a high spatio-temporal resolution. 
In this thesis FRAP and paFPs were used to characterize the cycling of Rab1 between the Golgi compartment 
and its cytoplasmic fraction. 
The FRAP and photoactivation experiments were carried out using a TCS SP5 microscope (Leica) equipped 
with a 63x/1.4 HCX PL APO ( blue) oil immersion objective (Leica). Lasers and settings used for fluorophore 
excitation, bleaching, photoactivation and the respective detection filter settings are listed below (Table 
2-24). All measurements were carried out in an incubation chamber at 37 °C and 5 % CO2. 
Table 2-24: TCS SP5 settings for bleaching and photoactivation settings. 
Excitation of Laser  ex (nm) 
Barrier Filters 
settings (nm) 
BFP Cube 1162002/AF 405 415-475 
EGFP Argon Laser LGK 7872 ML05 488 505-555 
Tide Fluor 3 561 DPSS YLK 6120 T02 561 595-685 
mKate2 561 DPSS YLK 6120 T02 561 595-685 
Bleaching of EGFP Argon Laser LGK 7872 ML05 488 - 
Photoactivation of paGFP Cube 1162002/AF 405 - 
The general setup of a FRAP routine includes: (1) pre-bleaching imaging, (2) bleaching of the designated 
regions of interest (ROI) and (3) post-bleaching imaging to monitor the fluorescence recovery in the 
bleached area. 
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In this thesis FRAP measurements were performed to examine the role of Rab1 and its regulators on the 
transport processes that are directed towards the Golgi. To this end, the entire fluorescently tagged Rab1 
population on the Golgi membrane was bleached. The following recovery of EGFP-Rab1 on the Golgi is then 
exclusively governed by vesicular and/or GDI-mediated transport from the cytoplasm to the Golgi. The 
appropriate ROI was identified by expression of the Golgi marker mKate2-giantin. At least three images 
were collected before bleaching, followed by extensive irradiation (10 repetitions over 12 s) with maximal 
laser power at 488 nm (100 %, Argon Laser LGK 7872 ML05). After bleaching, the fluorescence recovery was 
monitored over a period of at least 400 s with images collected every 2-10 s. The obtained fluorescence 
profiles were analyzed as described below (2.7.3). 
The procedure for fluorescence loss after photoactivation experiments is similar to the previously described 
FRAP setup. Instead of a bleaching step, a fluorophore population is activated at a predefined ROI and the 
subsequent depletion from this area and/or the resulting increase in fluorescence at a different site is 
monitored. As for FRAP, a photoactivation procedure consists of three steps: (1) image acquisition before 
activation, (2) activation of the photoactivatable fluorophore at the predefined ROI and (3) imaging of the 
redistribution of the now fluorescent protein population.  
In the pre-activation step for each experiment, three images were collected. Photoactivation of paGFP-Rab1 
was performed through irradiation at 405 nm with 30-50 % of the maximal laser intensity (Cube 
1162002/AF). Post activation images of paGFP-Rab1 and mKate2-giantin were collected every 2 seconds 
over a period of at least 300 s. 
The activation of paGFP-Rab1 was used in two complementary experiments that visualize the depletion of 
Rab1 from the Golgi compartment and delivery of Rab1 from its cytoplasmic fraction to the Golgi 
respectively. To observe the transport originating from the Golgi, paGFP-Rab1 localized on the organelle 
was photoactivated and the subsequent depletion of Golgi fluorescence analyzed as described below 
(2.7.4), yielding the observed kG-C rate. Conversely, transport from cytoplasm to Golgi was followed by photo 
activating the cytoplasmic fraction of paGFP-Rab1 and monitoring the subsequent increase in fluorescence 
on the Golgi compartment, yielding the observed kC-G for cytoplasm to Golgi transport (2.7.4).  
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2.7.3 Fluorescence recovery after photobleaching (FRAP) analysis 
For FRAP analysis the ROIs were identified through comparison of the pre-bleached image with the first 
image after the bleaching sequence. The mean fluorescence intensity on the Golgi was determined using 
the FRAP profiler plugin of the ImageJ Software, corrected for bleaching against the fluorescence intensity 
of the whole cell and normalized using Eq. 2-13: 
0pre
0
norm
II
I)t(I
)t(I


  
Eq. 2-13 
Here I(t) is the fluorescence intensity at time t, 
0I  the initial residual fluorescence after bleaching and Ipre is 
the mean intensity preceding photobleaching. The recovery of the mean fluorescence in the bleached 
region was fitted to the single exponential function Eq. 2-14.  
 tknorm obse1I)t(I    Eq. 2-14 
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2/1
k
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t   
Eq. 2-15 
Inorm corresponds to the fluorescence intensity at time t, I is the fluorescence intensity reached after 
completed recovery and kobs is the observed rate constant for fluorescence recovery. From this and using 
Eq. 2-15 the half-time of the fluorescence recovery (t1/2) and the rate constant for the trafficking of 
fluorophores to the bleached region KG-C = kobs can be extracted. 
2.7.4 Fluorescence loss/increase after photoactivation analysis  
For photoactivation of paGFP-Rab1, the ROI was identified by using mKate2-giantin as a Golgi marker. For 
both experimental procedures (2.7.2), the mean fluorescence paGFP-Rab1 intensity on the Golgi was 
quantified as the ratio of paGFP to mKate2-giantin to account for changes in Golgi structure over the time 
course of the experiment (Eq. 2-16) and normalized as described previously (Eq. 2-13). 
mKate
paEGFP
)t(I
)t(I
)t(I   Eq. 2-16 
To determine kC-G for the Rab1 flux from the cytoplasm to the Golgi site, the observed fluorescence increase 
at the Golgi following photoactivation at the cytoplasm was fitted by the single exponential function (Eq. 
2-14). 
For the reverse process of Rab1 trafficking from the Golgi membrane to the cytoplasm, the fluorescence 
depletion from the Golgi after activation was monitored. The resulting curve was fitted by the a single 
exponential function (Eq. 2-17) to yield kG-C as kobs. 
tk
norm
obseAI)t(I    Eq. 2-17 
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2.7.5 FLIM analysis and image processing 
FLIM data was analyzed via a customized MATLAB script using global analysis.171 For analysis of the observed 
lifetime for individual cells and at subcellular resolution, intensity and lifetime images generated by the 
global analysis script were further processed using ImageJ as described in the following. 
To segment the cells from the background the intensity images where thresholded and a binary mask 
generated. The background was then removed through multiplying the mask with the lifetime map and the 
background set to “Not a Number”. The average lifetime of the cell or a specific are (e.g. the Golgi apparatus) 
was then determined using the ROI tool for the respective image section.  
For figure display, the lifetime images were smoothed with a filter that replaces each pixel with the average 
of its 3 × 3 neighborhood, a LUT was applied and the displayed lifetime range set as indicated in the 
respective calibration bar. 
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3 Results and discussion 
3.1 Development and characterization of small GTPase FRET sensors 
Small GTPases regulate a great variety of highly dynamic biological processes such as signal transduction, 
cytoskeleton rearrangement, nuclear transport or membrane trafficking. Thus, sensors providing insight 
into the spatiotemporal aspects of GTPase activity have been a major interest in the field. A common 
methodology is based on effector domains that report on GTPase activation through specific binding to the 
GTP-bound protein (1.3). However, this approach is limited by the prerequisite of a suitable effector domain 
for each target GTPase and therefore not versatile. Furthermore, direct observation of the nucleotide 
governed conformational change upon GTPase activation would be advantageous as it preserves the 
proteins ability to bind to its effectors and interact with its regulatory partners. 
To address this need, novel and universally applicable conformational sensors for GTPase activity (COSGAs) 
were developed and characterized in this thesis. The COSGA sensor principle was first established using 
Rab1b (referred to as Rab1) and later successfully expanded to the small GTPase KRas4b (referred to as 
KRas). 
3.1.1 FRET sensor design 
GTPases undergo significant changes in structural flexibility and conformation upon nucleotide exchange 
and effector binding (1.1.1). The sensor developed and characterized in this thesis is based on an 
intramolecular FRET that directly reports on conformational changes within the protein fold. 
A basic scheme of the sensor design is depicted in Figure 3-1. The FRET pair is generated by decorating the 
GTPase with two fluorophores, using a combination of protein engineering and chemical labeling. The donor 
fluorophore of the intramolecular FRET pair is introduced by genetically fusing a fluorescent protein to the 
N-terminus of the GTPase. The FRET acceptor, a small organic dye, is attached in the protein fold by site-
specific cysteine labeling (2.4.1).  
The acceptor labeling sites were selected based on the following criteria: (1) Does the protein site undergo 
significant conformational changes upon nucleotide exchange? (2) Is the residue at this positon crucial for 
native protein functioning and its interaction with regulatory partners? (3) Is the labeling site solvent 
accessible to allow efficient labeling? 
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Figure 3-1: FRET sensor design. 
(A) The sensor design combines an N-terminal fluorescent protein (green) with a small organic acceptor dye introduced 
in to the GTPase fold (gray). The organic dye is introduced by site-specific cysteine labeling at the positions indicated in 
turquoise. (B) Conformational changes in the switch regions of Rab1 in GTP- and GDP-bound states. Switch I and II are 
highlighted in red and orange respectively. The bound guanine nucleotide is depicted in beige with atoms highlighted 
in red (oxygen), blue (nitrogen) and orange (phosphorous).  
Acceptor sites for Rab1 sensor 
For the Rab1 sensor T34 was initially selected as an acceptor labeling site, because it is located in the switch I 
region and not directly involved in the interaction with Rab1 regulators or effectors. To identify additional 
labeling positions that undergo changes in flexibility and conformation upon GTP binding, molecular 
dynamics (MD) simulations were performed by Dennis Krüger. More specifically, the root mean square 
fluctuation (RMSF) of GTP- and GDP-bound Rab1 (based on PDB ID: 3NKV) were compared to identify hot 
spots of changes in flexibility. In addition to the expected maxima in RMSF at the switch regions and the 
flexible C-terminus, the interswitch region showed a substantial change in RMSF between the two 
nucleotide bound protein forms (Figure 3-2). After excluding protein sites that are vital for protein function 
or unfavorably buried in the protein fold, S36 in the switch I and D53 and G54 in the interswitch region were 
chosen as labeling sites in addition to T34. 
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Figure 3-2: Molecular dynamics (MD) simulations of the root mean square fluctuation (RMSF) in GTP- and GDP- bound 
Rab1. 
MD simulations of Rab1 were based on the X-ray structure of Rab1 bound to GppNHp (PDB ID: 3NKV). For the MD 
simulations AMP at Y77 was removed and GppNHp was substituted for either GDP or GTP. Here switch regions are 
highlighted in red (switch I) and orange (switch II) respectively. Acceptor labeling sites are marked in turquoise.  
Crucial for efficient energy transfer is the distance and orientation of the two fluorophores in a FRET pair. 
For maximal sensitivity the distance between the two FRET partners should be as close as possible to R0 
(1.2.1). R0 for FRET pairs utilized in this thesis was determined in section 2.5.4.4. An approximation of the 
distances between the fluorescent protein chromophore to the EGFP C-terminus (RFP) and of the Rab1 
N-terminus to the acceptor labeling site (Racceptor) were estimated from available structural data of Rab1 
(PDB ID: 3NKV) and EGFP (PDB ID: 2Y0G) using the software PyMOL. The last structurally resolved Cof EGFP 
and the first resolved Cof Rab1 were defined as the respective termini. Residues in between the termini 
were designated part of the linker, leading to a total linker length of 14 amino acids. The length of the 
proteinaceous linker region was approximated using a freely jointed chain of C atoms described by Eq. 3-1: 
nbCR 0nkerlin   Eq. 3-1 
Here n is the number of amino acids, b0=3.8 Å is the average distance between Catoms and Cn=2.3 is the 
characteristic ratio.172 The estimated total donor to acceptor distances (RD-A) for selected acceptor labeling 
positions in Rab1 are summarized below (Table 3-1). The obtained values are close to the calculated 
R0 = 53-60 Å of the FRET pairs utilized for the sensor constructs (2.5.4.4). This indicates that the chosen 
intramolecular FRET pair assembly should display efficient FRET and be suitable to report conformational 
changes in the protein fold. 
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Table 3-1: Donor acceptor distances.   Table 3-2: Truncated linker constructs. 
R (Å) T34 S36 D53 G54  R (Å) T34 S36 D53 G54 
Racceptor 31.8 32.1 12.8 10.8  Racceptor 31.8 32.1 12.8 10.8 
Rlinker 21.6  Rlinker 8.2 
RFP 24.5  RFP_D11 14.9 
RD-A 77.9 78.2 58.9 56.9  RD-A 65.8 66.1 46.8 44.8 
For sensor optimization, constructs with a shortened linker region were prepared to shift the donor 
acceptor distance even closer to R0 in order to increase the dynamic range. It has been shown previously 
that fluorescent proteins can be truncated at their termini without losing their favorable fluorescent 
properties.173 This property was exploited by truncating the EGFP and mCitrine C-termini by eleven amino 
acids to minimize the flexible linker region between the fluorescent protein and the GTPase domain. The 
resulting donor to acceptor distances are summarized in Table 3-2. 
Acceptor sites for KRas sensor 
Based on the acceptor sites that proved sensitive towards the bound nucleotide in the Rab1 constructs, the 
FRET sensor design was expanded to KRas. Potential labeling sites in KRas were identified through structural 
alignment of the available crystal structures for Rab1 (PDB ID:3NKV ) and KRas (PDB ID: 4LRW) (Figure 3-3). 
 
Figure 3-3: Structural alignment of Rab1 (PDB ID: 3NKV) and KRas (PDB ID: 4LRW). 
(A) Detailed view of labeling sites in switch I and (B) interswitch region of Rab1 (gray, PDB ID: 3NKV) and KRas (light 
blue, PDB ID: 3LRW). Labeling sites are highlighted in turquoise (Rab1) and pink (KRas) respectively. The bound guanine 
nucleotide is depicted in beige with atoms highlighted in red (oxygen), blue (nitrogen) and orange (phosphorous). 
Based on the structural alignment, three positions in the switch 1 (D30, E31 and D33) and two positions in 
the interswitch region (G47 and D48) were selected. Their sensitivity towards GEF-mediated nucleotide 
exchange was examined using the catalytic domain of SOS, a Ras GEF. (3.1.4). Similarly to Rab1, Dennis 
Krüger performed MD simulations for GDP and GTP-bound KRas based on the available crystal structure 
(PDB ID: 3GFT). The simulation indicated an additional potential site at position E107 for labeling. 
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3.1.2 Site-specific protein labeling with cysteine reactive dyes 
A crucial feature of the described FRET sensors is the site-specific introduction of a small organic dye directly 
in the protein fold. For this purpose, cysteine labeling with thiol-reactive dyes proved to be a promising 
approach. Cysteine displays a unique combination of high nucleophilic reactivity and low natural 
occurance.174 Additional advantages are the straight forward introduction of labeling sites through site-
directed mutagenesis (2.2.1.3) and the abundance of commercially available thiol-reactive dyes.  
However, when using a cysteine mediated labeling strategy, naturally occurring cysteines in the small 
GTPases and the fluorescent proteins have to be considered. It is crucial for site-specific labeling, that other 
potentially reactive sites, e.g. native cysteines, do not interfere with labeling. Natural occurring cysteines 
are rarely surface exposed and therefore exhibit only limited reactivity towards thiol-reactive probes.175 To 
overcome these limitations the labeling reaction can be kinetically controlled176,177 or the potentially 
interfering amino acids can be removed by site directed mutagenesis. Here these strategies were employed 
to achieve site-specific maleimide-mediated labeling. 
Native cysteines - fluorescent proteins 
EGFP and mCitrine contain two natural cysteines, one at position 
48 and one at position 70.178,179 C70 is positioned on the inner 
helix, buried in the -barrel. Thus, it is less likely to interfere with 
site-specific labeling. The second cysteine, C48, is located on the 
third -strand and partially solvent accessible. It could 
potentially be modified by thiol-reactive probes. To assess the 
extent of unspecific labeling at this site, wild type GFP was 
incubated with a thiol reactive probe under the same conditions 
used for labeling and the extent of labeling was quantified by 
SDS-PAGE. Figure 3-4 depicts the position of the two natural 
occurring cysteines in the crystal structure of EGFP (PDB ID: 
4EUL). 
 
Figure 3-4: Cysteine positions in crystal structure of EGFP (PDB ID: 4EUL). 
The cysteine residues are highlighted and labeled in yellow. C48 is partially solvent accessible and located on the third 
-strand of the barrel structure. C70 is positioned on the inner helix. The chromophore is depicted in white, with oxygen 
and nitrogen atoms colored in red and blue, respectively. 
  
  
3 Results and discussion  
 
 -58- 
Native cysteines - Rab1  
Wild type Rab1 contains three cysteines, C23 is buried in the protein fold and two surface-exposed 
cysteines, C200 and C201 located at the very C-terminus (Figure 3-5). The two C-terminal cysteines would 
interfere with site-specific labeling and are crucial for proper GTPase functioning in the cellular context. 
These residues have to remain intact to be available for prenylation that facilitates membrane attachment. 
To preserve these crucial prenylation sites, the Rab1 C-terminus was truncated by two amino acids and 
genetically fused to an intein. After labeling with the acceptor dye the two cysteines were reintroduced 
through native chemical ligation (NCL) (2.4.3).  
 
Figure 3-5: Cysteine positions in crystal structure of Rab1 (PDB ID: 3NKV) and KRas4b (PDB ID: 4QL3). 
The cysteine residues are highlighted and labeled in yellow. The switch I and II regions are highlighted in red and orange, 
respectively. The bound guanine nucleotide is depicted in beige with atoms highlighted in red (oxygen), blue (nitrogen) 
and orange (phosphorous).  
Native cysteines - KRas 
KRas4b contains three cysteines in the GTPase-fold and a CAAX motif at its C-terminus (Figure 3-5). It has 
been previously reported that mutations of C51 and C118 to serine and C80 to leucine, respectively, do not 
alter the GTPase’s structure or its ability to be activated through interaction with SOS.124 Based on this study 
the natural cysteine residues were removed by site-directed mutagenesis to generate a cysteine free KRas 
construct. Analogous to Rab1, the C-terminal cysteine was removed by truncating the CAAX motif and later 
reconstituted through NCL after labeling.  
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Kinetic labeling of acceptor sites 
In general, cysteines at the protein surface have a certain propensity to react with the maleimide probes 
used to introduce the acceptor dyes. This reactivity however, is not uniform and the differences in reaction 
velocity can be exploited to achieve site-specific labeling despite multiple reactive sites. 
To assess the extent of undesired labeling of natural occurring cysteine residues in the fluorescent proteins, 
wild type GFP was incubated under the same conditions (2.4.1) as used for labeling the EGFP/mCitrine-
tagged sensor constructs (Figure 3-6 A and B).  
As indicated by the fluorescent bands in Figure 3-6 B, labeling of GFP was negligible for incubation times of 
up to 1 h (< 10 %). Even after incubation for 10 h, less than 17 % of the wild type GFP was labeled by the TF3 
dye. In contrast, labeling of the cysteine sites identified for acceptor labeling (T34C, S36C, D53C and G54C) 
was typically completed (>90 %) within 30-60 min (Figure 3-6 C and D) under the same conditions. This is 
indicated by the saturation of the fluorescence intensity in the SDS-Page (Figure 3-6 C and D). 
 
Figure 3-6: Site-specific labeling of EGFP-Rab1 constructs with thiol-reactive dyes. 
(A) Quantification of labeling progression for GFP (green) and EGFP-Rab1T34C2 (black) incubated with 1.5 eq Tide 
Fluor 3 maleimide. (B) SDS-PAGE of GFP labeling. The labeling mixture was quenched with β-mercaptoethanol after the 
indicated incubation times. Upper panel: Coomassie blue staining. Lower panel: excitation with UV light prior to 
Coomassie staining. (C) Quantification of labeling progression for EGFP-Rab1 mutants incubated with 1.5 eq Tide Fluor 
3 maleimide. (D) SDS-PAGE of EGFP-Rab1T34C2 labeling. Labeling mixture was quenched with β-mercaptoethanol 
after the indicated incubation times. Upper panel: Coomassie blue staining. Lower panel: excitation with UV light prior 
to Coomassie staining. For labeling quantification, the relative protein amount was determined from the Coomassie 
blue stained image using the software ImageJ. 
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Collectively, these results indicate that tentative acceptor labeling sites can be specifically addressed by 
maleimide-mediated labeling. Undesired labeling of the fluorescent protein that could interfere with the 
FRET signal read out or lead to loss of fluorescence from the fluorescent proteins is negligible under the 
used labeling conditions. Furthermore, the labeling reaction proceeds quickly and efficiently at neutral pH 
and room temperature, conditions that are beneficial to the overall stability of the protein constructs. 
Sensor population is uniformly labeled 
As stated previously, site-specific and homogenous labeling of the GTPase sensor is crucial for reliable FRET 
quantitation. Quantitative labeling in a 1:1 ratio was confirmed through LC-ESI-MS (2.5.4, 5.2) and 
absorption spectroscopy (Table 3-3, 2.5.2). 
The deconvoluted ESI-MS spectra display single peaks for the protein constructs before incubation with the 
respective acceptor dye. After labeling the peaks shift to a higher mass indicating covalent binding of a single 
dye moiety (Figure 3-7).  
 
Figure 3-7: ESI-MS of site-specific labeling of GTPase constructs with thiol-reactive acceptor dye. 
LC-ESI-MS of (A) EGFP-Rab1T34C2-MESNA and (B) EGFP-KRasD30C4-MESNA before and after (C)-(D) labeling with 
1.2 eq Tide Fluor 3 maleimide. Mobs: observed weight, Mcal: theoretical weight. 
Additionally, typical donor to acceptor ratios were determined by absorption spectroscopy (2.5.2). The 
ratios range around 0.90 to 1.10, indicating an approximately 1:1 ratio of donor to acceptor dye per 
molecule (Table 3-3). A ratio significantly above 1 would suggest undesired labeling of additional sites, e.g. 
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natural cysteines in the fluorescent protein or the GTPase. Ratios well below 1 would indicate incomplete 
labeling of the protein. 
Table 3-3: Labeling ratio determined by absorption spectroscopy. 
Sensor construct 
Labeling site [EGFP/mCitrine] 
(mM) 
[TF3/TF4]  
(mM) 
Donor/acceptor ratio 
EGFP-Rab1-MESNA T34C 0.0200 0.0183 1.09 
 S36C 0.0285 0.0255 1.12 
 D53C 0.0174 0.0176 0.99 
 G54C 0.0101 0.0119 0.84 
 T34C_Q67L 0.0178 0.0195 0.96 
EGFP-KRas D30C 0.0680 0.0650 1.05 
 E31C 0.0294 0.0271 1.08 
EGFP11-KRas D30C 0.0210 0.0200 1.05 
 E31C 0.2093 0.2208 0.95 
mCitrine11-KRas E31C 0.0540 0.0530 0.98 
Collectively, the ESI-MS and absorption spectroscopic data indicate that the sensor population is uniformly 
and quantitatively labeled with a single acceptor dye. 
Sensitized emission spectra of labeled sensor 
Labeling progression and energy transfer from the donor to the acceptor fluorophore was confirmed by 
fluorescence spectra. Spectra collected at different time points during labeling show a time-dependent 
increase in acceptor emission with concomitant decrease in the donor emission, a characteristic feature of 
FRET (Figure 3-8 A).  
As expected, energy transfer via FRET is more pronounced in constructs with a shorter linker region between 
the fluorescent protein and the GTPase (Figure 3-8 B). In comparison to the unlabeled donor only probes, 
the FRET constructs exhibit a significantly increased acceptor emission while donor emission is strongly 
reduced. 
 
Figure 3-8: Fluorescence spectra of FRET sensor constructs. 
(A) Fluorescence spectra of 200 nM EGFP-Rab1T34C incubated with 300 nM Tide Fluor 3 maleimide collected at 
indicated time points. (B) Overlay of spectra of 200 nM EGFP-Rab1T34C-TF3 (black) and 200 nM EGFP11-Rab1T34C-
TF3 (pink). (C) Spectrum of 200 nM mCitrine11-KRasD30C-TF3. Fluorescence spectra were obtained with excitation set 
to 480 nm and emission collected at 490-700 nm. 
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3.1.3 Native chemical ligation for C-terminal reconstitution  
Prenylation of C-terminal cysteine residues is a critical feature for proper GTPase functioning in cells. These 
lipid moieties are crucial for membrane attachment and the subcellular localization of the small GTPases. 
Furthermore, correct prenylation is essential for the interaction with regulators such as RabGDI.180 After 
labeling, the truncated C-terminal amino acids were reintroduced by NCL181 (2.4.3) to reconstitute full 
functionality.  
To this end the truncated GTPase was genetically fused to an intein domain. After purification (2.3) the 
protein constructs were obtained with a C-terminal MESNA-thioester (2.3). The thioester-moiety is 
unreactive towards thiol-reactive dyes, e.g. maleimides, but can undergo efficient NCL with peptides that 
carry an N-terminal cysteine. For NCL the proteins were transferred into thiol-free labeling buffer, 
concentrated and mixed with thiol-free buffer containing MPAA, TCEP and the appropriate small peptide, -
CC for Rab1 or -CVIM for KRas constructs respectively. Finally, the NCL mixture was incubated overnight on 
ice (Figure 3-9, for a detailed protocol see 2.4.3).  
 
Figure 3-9: Scheme of native chemical ligation for reconstituting GTPases’s C-terminus. 
The C-terminal amino acids, -CC (Rab1) and -CVIM (KRas4b) were ligated with the GTPase thioester constructs through 
NCL as described in 2.4.3. Fluorescent protein (green), GTPase (gray): switch I (red), switch II (orange), acceptor labeling 
site (pink). Chemical structures are drawn for C-terminal thioester moiety (-MESNA) and amino acids (-CC, -CVIM) 
respectively. 
Successful conversion to the full length GTPase was confirmed by LC-ESI-MS (Figure 3-10, 2.5.4 and 0). The 
observed shift to a higher mass in the deconvoluted ESI-MS spectra suggest ligation with the C-terminal 
cysteine motifs -CC or –CVIM, respectively.  
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Figure 3-10: ESI-MS spectra of GTPase-thioesters and NCL products. 
LC-ESI-MS of (A) EGFP-Rab1T34C-TF3-MESNA and (B) EGFP-KRasD30C-TF3-MESNA before and (C) EGFP-Rab1T34C-TF3-
CC, (D) EGFP-KRasD30C-TF3-CVIM after NCL with reconstituted C-terminus. Mobs: observed weight, Mcal: theoretical 
weight. 
3.1.4 Rab1 FRET sensor - GEF-mediated nucleotide exchange 
The Rab1 sensor’s sensitivity towards its nucleotide binding state was initially tested by GEF-mediated 
nucleotide exchange. Besides evaluating the response in regard to dynamic range and sensitivity, the 
interaction with the respective GEF was compared to the wild type protein to assess possible effects of the 
introduced modifications. 
For Rab1, the GEF domain of the Legionella pneumophila GEF DrrA340-53371,78,182 (referred to as DrrA or 
DrrA340-533) was used to characterize the sensors response to GDP to GTP exchange by fluorescence 
spectroscopy as described in 2.5.4.2. Nucleotide exchange was initiated through addition of varying 
amounts of DrrA340-533 to 200 nM Rab1 sensor in the presence of 100 M GTP. The change in FRET efficiency 
was monitored by sensitized emission. The donor EGFP was excited at 480 nm and the acceptor emission of 
Tide Fluor 3 was detected at 580 nm (2.5.4.2). 
Previous studies utilizing mant-labeled nucleotides71 or the intrinsic Rab1 tryptophan fluorescence183, 
reported that the nucleotide exchange rate increased dramatically upon DrrA340-533 addition (Figure 3-11 A, 
B and C). Here, this is indicated by the drop or increase in FRET signal. After the fluorescence signal is 
saturated, indicating completion of nucleotide exchange, further addition of DrrA340-533 or GTP does not 
result in any further signal changes (Figure 3-11 A, B, C and Appendix). 
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Figure 3-11: Rab1 FRET sensors are sensitive to DrrA-mediated nucleotide exchange. 
Addition of 100 M GTP and 50 nM DrrA340-533 to (A) 200 nM GDP-bound EGFP-Rab1T34C-TF3 (B) 200 nM GDP-bound 
EGFP-Rab1G54C-TF3 and (C) EGFP11-Rab1T34C-TF3 results in a steep decrease (T34C and 11-T34C) or increase 
(G54C) of the detected sensitized emission signal. Changes in FRET efficiency were observed by sensitized emission with 
donor excitation at 480 nm and acceptor emission collected at 580 nm. (D) By plotting kobs against [DrrA340-533] the 
catalytic efficiency can be extracted as the slope of a linear fit. Obtained kcat/KM values are summarized in Table 3-4. 
The changes in FRET signal were fitted with a single exponential function (Eq. 2-8) to obtain the observed 
first order rate constants kobs. As described in 2.5.4.2, the catalytic efficiency for the GEF mediated 
nucleotide exchange reaction can be extracted as the slope of a linear fit of kobs plotted against the GEF 
concentration (Figure 3-11 D, Eq. 2-7). The obtained catalytic efficiencies and the observed relative changes 
of the fluorescence signal are summarized in Table 3-4.  
Table 3-4: Catalytic efficiencies and dynamic range for DrrA-mediated nucleotide exchange. 
Sensor construct Labeling site kcat /KM (M·s)-1 ISE (%) 
EGFP-Rab1-MESNA T34C (3.06 ± 0.08)×105 -9  
 S36C (1.73 ± 0.02)×105 -10 
 D53C (5.4 ± 0.6)×105 +9 
 G54C (4.2 ± 0.3)×105 +11 
EGFP11-Rab1-MESNA T34C (4.9 ± 0.2)×105 -21 
Rab1wt183,184 - 2×105 - 
The obtained catalytic efficiencies for the sensor constructs are in good agreement with the previously 
reported value wild type Rab171,183. This indicates that the interaction between DrrA340-533 and the modified 
Rab1 is not significantly impaired by the implemented modifications.  
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While the crystal structure of Rab1 in complex with DrrA340-533 185 shows that the P-loop, switch I and II and 
the interswitch regions of the GTPase are involved in crucial interactions with the GEF-domain (Figure 3-12), 
mutation and labeling at switch I did not have a marked effect on DrrA-mediated nucleotide exchange. For 
comparison, AMPylation at Y77186 and phosphocholination at S76183 in the switch II region of Rab1 lead to 
a drop in the catalytic efficiency for DrrA-mediated nucleotide exchange by 3- and 5-fold, respectively. 
Figure 3-12: Crystal structure of 
nucleotide free Rab13-174 in complex with 
DrrA340-533 (PDB ID: 3JZA). 
The Rab1 structure is shown in gray and 
DrrA is colored in purple. The Rab1 
labeling sites are highlighted and labeled 
in turquoise. The switch I and II regions 
are colored in red and orange respectively 
The P-loop is marked in green. 
DrrA forms contacts with Rab1 at two 
primary interaction sites. These 
interactions open the GTPase’s nucleotide 
binding pocket, thereby facilitating the 
release of the bound nucleotide.  
At interaction site 1, DrrA contacts the P-
loop and switch II region of Rab1. At the 
second interface DrrA binds to the switch I 
region and completely distorts the 
nucleotide binding pocket. Some switch I 
residues are displaced by ~30 Å. The 
acceptor labeling positions T34 and S36 lie 
directly in this interface. The complex 
structure reveals direct and water 
mediated polar interactions between the 
Rab1 residues T34 and S36 with DrrA.71 
 
In contrast, the catalytic efficiencies for DrrA340-533 -mediated nucleotide exchange of the acceptor labeled 
Rab1 constructs are slightly higher than the values reported for nucleotide exchange of unmodified 
Rab1.71,183 Possibly mutation and labeling reduce the GTPase’s affinity towards the bound nucleotide, 
thereby accelerating the GEF-mediated nucleotide exchange.  
All four tested Rab1 sensor constructs displayed an overall change in sensitized emission signal of about 
9-10 %. It is of interest to note that the fluorescence signal upon nucleotide exchange decreased for the 
switch I acceptor constructs T34C and S36C but showed an increase for the interswitch mutants D53C and 
G54C (Table 3-4). A drop in the sensitized emission signal, as observed for the switch I mutants, indicates 
reduced FRET efficiency upon nucleotide exchange from GDP to GTP. A possible cause for the decrease in 
FRET could be the more rigid conformation of the switch I region in the GTP-bound state. The more defined 
structure might force the acceptor dye to adopt a position less favorable for efficient energy transfer.  
The FRET sensor reports on both directions of nucleotide exchange. The initial fluorescence signal is partially 
restored after addition of excess GDP to GTP-bound Rab1 in the presence of DrrA (Figure 3-13 A and B). Two 
factors attribute to only a partial recovery of the initial fluorescence intensity: Firstly, GEFs act as general 
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catalyst for nucleotide exchange. As the initially added GTP is still present, the GEF accelerates the 
establishment of the Rab:GDP/GTP equilibrium. Secondly, the nucleotides exhibit an ‘inner filter effect’ (loss 
of fluorescence due to absorption of excitation light) resulting in reduced overall emission. This is especially 
relevant for measurements with high concentrations of nucleotides present. 
When GDP instead of GTP is added to the GDP-bound Rab1 sensor in presence of the GEF, the FRET signal 
does not change (Figure 3-13 C). These findings further confirm that the observed signal changes upon 
addition of DrrA340-533 and GTP are indeed directly linked to nucleotide-binding state of the GTPase and are 
not caused by the GTPase-GEF interaction. 
 
Figure 3-13: FRET sensor is specific and sensitive to GEF-mediated nucleotide exchange.  
Addition of increasing amounts of GTP and GDP in turns to 50 nM DrrA340-533 and (A) 200 nM GDP-bound EGFP-
Rab1T34C-TF3 or (B) 200 nM GDP-bound EGFP11-Rab1T34C-TF3 respectively. The observed initial signal change upon 
GDP to GTP exchange is reversed through addition of excess GDP. (C) Addition of 50 nM DrrA340-533 and 100 mM GDP 
to 200 nM EGFP-Rab1S36C-TF3 does not result in FRET signal change. Changes in FRET efficiency were observed by 
sensitized emission with excitation at 480 nm and emission collected at 580 nm. 
Analogous experiments were performed using the sensor constructs featuring a shorter linker region variant 
(3.1.1). Compared to the initial construct the dynamic range increased from 9 % to 20 %, while maintaining 
similar values for the catalytic efficiency for the GEF-mediated nucleotide exchange (Table 3-4, Figure 3-11). 
The increased dynamic range can be attributed to the shortened distance between the donor and acceptor 
fluorophore. In this construct, the distance of the FRET pair is closer to R0 where EFRET = 0.5 and the response 
of FRET to distance is maximal (1.2.1).  
However, DrrA is not the physiological GEF for Rab1 in mammalian cells and thus these experiments can 
only suggest preserved GTPases regulation in vivo. The native GEF in eukaryotes for Rab1 activation is the 
multisubunit Transport Protein Particle (TRAPP) complex. The catalytic efficiency of the bacterial protein 
DrrA is about 150-fold higher than for the TRAPP complex (kcat/KM = 1·103 (M·s)-1)75. 
In the Rab1:Drra and the Rab1:TRAPP complex, the two labeling sites in the switch I region of the GTPase 
(T34 and S36) lie in close proximity to the GTPase-GEF interface as can be judged from the crystal structures 
(Figure 3-12 and Figure 3-14). More specifically, the YPT1 switch I residues 37–45 directly contact the C-
terminus of Bet3-A. However, residues T34 and S36 are not resolved in the crystal structure, indicating 
conformational flexibility.67 
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Figure 3-14: Crystal structure of nucleotide 
free YPT1 in complex with a TRAPP 
subassembly (PDB ID: 3CUE)67. 
The YPT1 structure is colored in gray and the 
TRAPP subunits directly interacting with the 
GTPase are shown in purple. The 
corresponding labeling sites are highlighted 
and labeled in turquoise. The switch I and II 
regions are colored in red and orange 
respectively The P-loop is marked in green. 
The TRAPP complex forms its primary contacts 
with YPT1 at the central -sheet as well as at 
the switch I and II, and the P-loop. Similar to 
DrrA, these interactions distort the nucleotide 
binding pocket thereby facilitating the release 
of the bound nucleotide.  
The acceptor labeling positions T34 and S36 lie 
in the Bet3-A-switch I interface yet there exact 
positions are not resolved in the complex 
structure, indicating a certain degree of 
flexibility. D53 and G54 are facing away from 
the interacting surface.  
 
Similar to the Rab1-DrrA complex, the interswitch labeling sites at D53 and G54 are facing away from the 
binding site and should therefore have no significant impact on the GTPase-GEF contact. Based on the 
aforementioned structural similarities, the endogenous GEF activity should be largely retained towards the 
Rab1 constructs.  
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3.1.5 Rab1 FRET sensor - GAP-induced GTP hydrolysis 
GTPase-activating proteins (GAPs) are the regulatory counterpart of GEFs. GAPs attenuate GTPase signaling 
by accelerating the slow intrinsic GTPase activity. The bound GTP is hydrolyzed to GDP, thereby converting 
the “active” GTP-bound Rab1 to its “inactive” GDP-bound complement. To ensure full biological 
functionality of the Rab1 constructs, GTP-hydrolysis mediated by the GAP domain of TBC1D20 
(TBC1D201-362, (Tre-2, Bub2, and Cdc16)) was examined by monitoring the FRET signal change through 
fluorescence spectroscopy (2.5.4.2).  
 
Figure 3-15: Rab1 FRET sensor reports on TBC1D20 induced GTP hydrolysis. 
(A) Addition of 1 M TBC1D201-362 to 200 nM GTP-bound EGFP-Rab1T34C-TF3 restores the initial FRET signal intensity. 
(B) Addition of 1 M TBC1D201-362 to 200 nM GppNHp-bound EGFP-Rab1T34C-TF3 fails to reverse the initial FRET signal 
drop. (C) Addition of 1 M TBC1D201-362 to 200 nM GTP-bound EGFP11-Rab1T34C-TF3 restores the initial FRET signal 
intensity. Subsequent addition of TBC1D20 does not yield further changes in fluorescence signal. (D) The observed rate 
constant of GTP hydrolysis depends on TBC1D201-362 concentration. (Inset) By plotting kobs against [TBC1D201-362] the 
catalytic efficiency can be extracted as the slope of the linear fit (solid blue line). Changes in FRET efficiency were 
observed by sensitized emission with excitation at 480 nm and emission collected at 580 nm. 
To this end, 200 nM Rab1 sensor was incubated with 10 nM DrrA340-533 in the presence of 100 M GTP. The 
exchange of bound GDP for GTP to GTP was followed by sensitized emission until completion. GAP-mediated 
hydrolysis of the Rab1-bound GTP was then initiated through addition of excess TBC1D201-362. The initial 
FRET signal intensity is restored (Figure 3-15 A and C) through the GAP induced GTP hydrolysis. This converts 
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“active” GTP-bound Rab1 to “inactive” GDP-bound GTPase restoring the initial nucleotide state of the Rab1 
sensor. 
For the T34C sensor the changes in FRET signal for varying amounts of TBC1D201-362 were fitted with a single 
exponential function (Eq. 2-8) to obtain the respective observed first order rate constants kobs. The catalytic 
efficiency for the GAP-induced GTP hydrolysis were then extracted as the slope of a linear fit of kobs plotted 
against the TBC1D201-362 concentration (Figure 3-15 D).  
To compare the measured catalytic efficiency with the properties of the unmodified GTPase, a similar 
experiment was performed using mantGTP loaded Rab1 (Figure 5-10 E and F). In comparison to wild type 
Rab1 (kcat/KM = (2.8 ± 0.4)·105 (M·s)-1), the catalytic efficiency observed for EGFP-Rab1T34C-TF3 (kcat/KM = 
(1.2 ± 0.07)·105 (M·s)-1) is reduced by a factor of 2.3. For comparison, AMPylation at Y77 and 
phosphocholination at S76 in the Rab1 switch II region lead to a reduction in kcat/KM for TBC1D20-induced 
GTP-hydrolysis by 20- and 4-fold, respectively.183,186 
The available crystal structure of the Rab1-TBC1D20 complex indicates that S36 is directly involved in the 
GTPase-GAP interaction (Figure 3-16).41 Furthermore, the structural data confirms that the residues 
modified for acceptor labeling are not directly involved in nucleotide hydrolysis. 
Figure 3-16: Crystal structure of 
Rab13-174:GDP in complex with TBC1D201-305 
(PDB ID: 4HLQ).41 
The Rab1 structure is shown in gray and 
TBC1D20 is colored in yellow. The Rab1 
labeling sites are highlighted and labeled in 
turquoise. The switch I and II regions are 
colored in red and orange respectively The P-
loop is marked in green. The bound guanine 
nucleotide is depicted in beige with atoms 
highlighted in red (oxygen), blue (nitrogen) 
and orange (phosphorous).  
TBC1D20 forms direct contacts with the 
nucleotide and binds to the switch I and II and 
the P-loop of Rab1. 
From the four acceptor labeling sites, only S36 
lies directly in the GTPase-GAP interface. 
T34C, D53 and G54 are facing away from the 
interacting surface. 
 
 
To further ascertain that the observed FRET responses are indeed caused by GAP induced GTP hydrolysis, 
the experiments were repeated using the non-hydrolysable GTP analog GppNHp (Figure 3-15 B). As 
expected, in this case TBC1D201-362 failed to reverse the FRET signal change in all Rab1 constructs (Figure 
5-10). Collectively, these experiments demonstrate that the constructs serve as efficient FRET sensors for 
Rab1 activation and deactivation while largely preserving the proteins interaction with its regulatory 
partners, GEFs and GAPs. 
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3.1.6 Rab1 FRET sensor - effector binding 
Interaction with effector proteins is another hallmark of GTPase function. Effector proteins discriminate 
between the two nucleotide states of the GTPases through interaction with the proteins switch regions. 
Most importantly, GTP locks the switch regions in a well-defined, ordered state.12 This GTP-induced 
conformation preforms the GTPase’s structure in the GTPase:effector complex, resulting in a higher affinity 
of the effector to the GTP-bound form. 
To confirm that the introduced modifications on Rab1 do not interfere with native effector binding, the 
interactions of GTP-bound Rab1 constructs with the Rab-binding domains of OCRL1 (OCRL1539–901)187 and 
the Legionella pneumophila effector LidA (LidA201-583)184 were examined. To this end, the dissociation 
constants (KD) were determined by equilibrium titration using sensitized emission and fluorescence 
polarization (2.5.4.3). Increasing amounts of the effector domain were titrated to a fixed concentration of 
Rab1 sensor (100-500 nM). The resulting changes in FRET signal (S36, D53 and G54) or fluorescence 
polarization (T34C) were plotted against the concentration of titrant and the KD was extracted by fitting with 
the quadratic equation Eq. 2-11 as described in section 2.5.4.3. 
It should be noted, that in contrast to the transient interaction with GEFs and GAPs in the experimental 
setups described here, GTP-bound Rab1 forms a stable complex the effector domains. Thus, binding of the 
effector proteins may also affect the FRET signal. Indeed, changes in the FRET signal were observed for all 
Rab1 constructs and upon binding of both effector proteins with the exception of the T34C construct binding 
to OCRL. 
OCRL1 
Initially, the effect of OCRL1539–901 binding to the Rab1 constructs was examined through sensitized emission. 
The observed maximal changes in fluorescence signal and obtained KD values are summarized in Table 3-5. 
Interestingly, a significant drop in FRET signal (10-12 %) is observed upon OCRL1 binding for S36C, D53C and 
G54C, but not for the T34C construct (Figure 3-17). Fluorescence spectra collected before and after effector 
binding showed an increase in donor emission with concomitant decrease in acceptor emission, a 
characteristic feature for changes in FRET efficiency (Figure 3-17 B inset and Figure 5-11). To exclude that 
the lack of signal change for T34C was caused by impeded effector binding, the titration experiment was 
repeated using fluorescence polarization (Table 3-5, Figure 5-11). In this case, OCRL1 binding was detected 
as an increase in polarization of the EGFP fluorescence signal. 
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Table 3-5: KD valued determined for binding od Rab1 sensor with Rab-binding domains of OCRL1 and LidA. 
 OCRL1539–901 LidA201-583 
Labeling site I (%) KD (M) I (%) KD (nM)
T34C - 4.9 ± 0.8* -30 < 10  
S36C -12 1.5 ± 0.3 -20 < 10  
D53C -10 2.2 ± 0.4 -23 < 10  
G54C -11 2.9 ± 0.7 -24 < 10  
*determined by fluorescence polarization 
 
Figure 3-17: Titration of increasing amounts of OCRL1 to Rab1 FRET sensor constructs. 
(A) After nucleotide exchange trough addition of 100 nM DrrA340-533 and 100 M GTP, increasing amounts of OCRL1539–
901 were added to 200 nM GTP-bound EGFP-Rab1S36C-TF3. (B) By plotting the change in fluorescence against the 
effector protein concentration, KD can be obtained through fitting with a quadratic equation as described in in 2.5.4.3 
(solid orange line). (Inset) Fluorescence spectra of EGFP-Rab1S36C-TF3 before (solid black line) and after (solid blue 
line) binding of OCRL1539–901. (C) Addition of OCRL1539–901 to 200 nM GDP-bound EGFP-Rab1S36C-TF3 does not lead to 
significant changes in the fluorescence signal. (D) Addition of increasing amounts of OCRL1539–901 to 200 nM GTP-bound 
EGFP-Rab1T34C-TF3 does not lead to significant changes in the fluorescence signal. Changes in FRET efficiency were 
observed by sensitized emission with excitation at 480 nm and emission collected at 580 nm. Fluorescence spectra were 
obtained with excitation set to 480 nm and emission collected from 490-700 nm. 
The obtained dissociation constants for OCRL1539–901 binding are in good agreement with the previously 
reported value of 3.7 M for wild type Rab1.187 The S36C, D53C and G54C constructs display a slightly lower 
KD (1.5-2.9 M), while the KD for T34C is slightly increased (4.9 M, obtained through fluorescence 
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polarization). Furthermore, OCRL1 did not bind to a GDP-bound Rab1 sensor, confirming effector binding 
only to the active, GTP-bound sensor (Figure 3-17 B and C). This specificity towards the active state is an 
essential feature of the native Rab-effector interaction. 
The crystal structure of Rab8 in complex with OCRL supports the observation that the chosen labeling sites 
in the switch I and the interswitch region do not compete with effector binding (Figure 3-18).187 While OCRL 
forms contacts with the switch I, switch II and the interswitch region of Rab8, the residues corresponding 
to the acceptor labeling sites T34, S36, D53 and G54 in Rab1 are not directly involved in effector binding.  
Figure 3-18: Crystal structure of 
Rab8a6-176:GppNHp in complex with OCRL540-
678 (PDB ID: 3QBT).187 
The Rab8 structure is shown in gray the OCRL 
structure is colored in brown. The labeling 
sites corresponding to T34, S36, D53 and G54 
in Rab1 are highlighted and labeled in 
turquoise. The switch I and II regions are 
colored in red and orange respectively. The P-
loop is marked in green. The bound guanine 
nucleotide is depicted in beige with atoms 
highlighted in red (oxygen), blue (nitrogen) 
and orange (phosphorous). 
OCRL forms direct contacts with the switch I 
and II and the interswitch region of Rab8.  
None of the four acceptor labeling sites lie in 
the GTPase-effector interface.  
 
 
 
 
The primary interactions are mediated by E30, I41-I43 in the switch I and F45-T49 in the interswitch region, 
as well as R89, F70 and Y77 in the switch II region of the GTPase. The interswitch labeling positions at D53 
and G54 are located on the opposite side of the Rab1-effector interface.  
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LidA  
In addition to binding of the human effector protein OCRL, the interaction of the bacterial ”supereffector” 
LidA (LidA201-583) with the Rab1 FRET sensor was characterized.184  
Upon addition of LidA, all sensor constructs showed a 20 to 30 % decrease in FRET signal (Figure 3-19 and 
Table 3-5). In line with previous reports, the obtained dissociation constants are well below 10 nM. The 
exceptionally high affinity of LidA towards Rab1 prevents a more accurate assessment of the KD by 
fluorescence titration.184 In contrast to the typical nucleotide dependent binding of effector proteins, LidA 
binds to both GDP- and GTP-bound Rab1 with high affinity (Figure 3-19 and Figure 5-12). Due to this 
promiscuous binding behavior LidA was termed to be a Rab “supereffector”.184 
 
Figure 3-19 : Titration of increasing amounts of LidA to Rab1 FRET sensor constructs. 
After nucleotide exchange trough addition of 100 nM DrrA340-533 and 100 M GTP, increasing amounts of LidA201-583 
were added to (A) 200 nM GTP-bound EGFP-Rab1T34C-TF3. By plotting the change in fluorescence against the effector 
protein concentration, KD can be obtained through fitting with a quadratic equation as described in in 2.5.4.3 (solid 
orange line). (Inset) Fluorescence spectra of EGFP-Rab1T34C-TF3:GTP before (solid black line) and after (solid blue line) 
binding of LidA201-583. After addition of 100 nM DrrA340-533 and 100 M GDP, increasing amounts of LidA201-583 were 
added to (B) 200 nM GDP-bound EGFP-Rab1G54C-TF3. (Inset) Fluorescence spectra of EGFP-Rab1G54-TF3:GDP before 
(solid black line) and after (solid blue line) binding of LidA201-583. Original titration data can be found in 0. Changes in 
FRET efficiency were observed by sensitized emission with excitation at 480 nm and emission collected at 580 nm. 
Fluorescence spectra were obtained with excitation set to 480 nm and emission collected from 490-700 nm. 
Possible detrimental effects of the sensor modifications on LidA binding would probably be masked by the 
exceptionally high affinity of the effector towards Rab1. This is in keeping with the observation by Schoebel 
et.al. that AMPylation of the protein at residue Y77, located directly in the interaction interface, did not 
affect LidA binding to the extent that the binding affinity could be quantified accurately.184 
Crystal structures of LidA in complex with Rab8184 and Rab1188 reveal an extraordinarily large GTPase-
effector binding interface. The acceptor labeling sites in the switch I and the interswitch regions in Rab1 are 
not involved in LidA binding (Figure 3-20). Residues D53 and G54 are facing away from the Rab1-LidA 
contacting sites.  
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Figure 3-20: Crystal structure of 
Rab8a6-176:GppNHp in complex with LidA201-583 
(PDB ID: 3TNF).184 
The Rab8 structure is shown in gray, the LidA 
structure is colored in brown. The labeling sites 
corresponding to T34, S36, D53 and G54 in Rab1 
are highlighted and labeled in turquoise. The 
switch I and II regions are colored in red and 
orange respectively. The P-loop is marked in 
green. The bound guanine nucleotide is depicted 
in beige with atoms highlighted in red (oxygen), 
blue (nitrogen) and orange (phosphorous). 
LidA forms direct contacts with the switch I and 
II and the interswitch region of Rab8.  
None of the four acceptor labeling sites clash 
with the bound effector. 
 
 
 
In summary the tested Rab1 constructs are effective reporters of their nucleotide state and effector binding 
while largely maintaining their native interactions with GEFs, GAPs and effector proteins. 
General considerations 
The common binding mode of effector proteins with GTPases involves interactions with the switch I, switch 
II and the interswitch region.8 The conformational state of these regions convey the protein’s nucleotide 
binding state, e.g. if the GTPase is in the active, GTP-bound or in the inactive, GDP-bound configuration. The 
effector proteins tested in this thesis included the human effector OCRL1 which exhibits the quintessential 
effector behavior by discriminating between the GDP- and the GTP-bound GTPase and the Legionella 
effector LidA which displays exceptional Rab-binding properties by binding to both, the GDP and GTP-bound 
GTPase with high affinity (KD < 10 nM). Binding of both effector proteins was not significantly affected by 
the modification associated with the Rab1 sensors. However, these two effector proteins can only reflect a 
small fraction of possible interactions Rab proteins encounter in the cellular environment. Binding of the 
human effector Mical-3 to activated Rab1, for instance, was completely abolished after AMPylation of the 
switch II residue Y77.189 However, in this case the AMPylation site is directly located in the Rab-effector 
interface.190 Conversely, the acceptor labeling sites of the FRET constructs do not lie in the interface of any 
reported Rab-effector complex structure (Figure 3-21).  
Another aspect of the Rab1 sensor that should be considered, is the fluorescent protein at the N-terminus. 
The bulky fluorophore could severely impact effector binding of GTPase-effector pairs that involve the 
GTPase’s N-terminal region, as recently reported for the Mical (molecules interacting with CasL) effector 
family.190 
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Figure 3-21: Overlay of available crystal 
structures of Rab:effector complexes. 
The structure of Rab1 in the Rab1:LidA complex 
(PDB ID: 3SFV) is shown in gray. The effector 
structures in surface representation are 
highlighted according to the indicated color 
scheme.  
The labeling sites T34, S36, D53 and G54 in 
Rab1 are highlighted and labeled in turquoise. 
The switch I and II regions are colored in red 
and orange respectively.  
Switch I is involved in Rab-effector interaction, 
but the residues T34 and S36 do not form direct 
contacts in the complex structures with 
effector proteins. The interswitch labeling sites 
D53 and G54 are facing away from the main 
GTPase-effector interaction sites. 
 
Another interesting finding of the experiments is the collective decrease in FRET efficiency upon effector 
binding for all Rab1 constructs independent of the labeling position within the protein (Table 3-5). This 
overarching tendency points towards a common mechanism for the influence of GTPase-effector 
interaction on the FRET signal. It could be speculated that the drop in FRET signal is caused by the effector 
limiting the available space for the N-terminally attached donor fluorophore. Effector binding might push 
the donor fluorophore away from the acceptor labeling site and thus leads to an increase in distance or an 
unfavorable orientation of the FRET dipoles (1.2.1). This notion is further supported by the observation that 
LidA with its exceptionally extensive GTPase-effector interface184 leads to a much larger reduction in FRET 
efficiency than binding of the smaller effector domain of OCRL (Figure 3-22).  
 
 
Figure 3-22: Surface representation of OCRL (PDB ID: 3QBT) and LidA (PDB ID: 3TNF) in complex with Rab8. 
The Rab8 structures are shown in cartoon representation (gray), the effector structures (A) OCRL and (B) LidA are 
displayed as surface representations (g). The N-terminus of the Rab proteins is highlighted and labeled in yellow. The 
surface representation highlights the extensive interaction interface formed by LidA in complex with Rab8 and the steric 
hindrance of between of N-terminal modifications (e.g. N-terminal tagging with fluorescent proteins). 
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3.1.7 Characterization of Rab1 FRET sensor by FLIM-FRET on Ni-NTA beads 
After evaluation by fluorescence spectroscopy, the constructs were immobilized on Ni-NTA beads and 
assessed by fluorescence lifetime imaging microcopy (FLIM). FLIM-FRET is an alternative method to 
traditional sensitized emission and ratiometric imaging of FRET. A significant advantage of FLIM in 
comparison to conventional FRET imaging is that it does not rely on changes in fluorescence intensity and 
thus does not need to be corrected for artifacts resulting from changes in local fluorophore concentration 
or donor fluorescence bleed through.191 Changes in FRET efficiency can be directly extracted from the 
fluorescence lifetime of the donor fluorophore.  
For in vitro FLIM imaging, the Rab1 constructs were immobilized on Ni-NTA beads through an N-terminal 
His-tag (2.4.5). Immobilization lead to a high signal to noise ratio. To examine the sensors response to GEF-
mediated nucleotide exchange the Rab1 constructs were incubated with DrrA340-533 in GTP-containing buffer 
prior to immobilization. For effector binding, OCRL1539-901 or LidA201-583 was added after activation by DrrA340-
533 and GTP (2.4.5). After washing, the protein loaded beads were suspended in GTPase buffer and 
transferred onto a glass object slide for subsequent FLIM measurements (2.7.1).  
  
Figure 3-23: Bright light, fluorescence and lifetime images of donor only sample 
EGFP-Rab1 immobilized in Ni-NTA beads.  
(A) Bright-field, (B) EGFP fluorescence and (C) donor lifetime image of His-EGFP-
Rab1D53C immobilized on Ni-NTA beads. (D) Quantification of the fluorescence 
lifetime for EGFP-Rab1T34C (first lane) and EGFP-Rab1D53C (second lane) 
constructs, without acceptor dye, when bound to GDP (gray), incubated with 
DrrA340-533 and GTP (orange) or DrrA340-533, GTP and LidA201-583 (teal). Error bars: 
mean ± s.d. (n=5-7 with > 15 beads). Two-tailed t-test: n.s.: not significant. False 
color calibration bar for lifetime images as reference. Scale bar: 100 m. 
 
Figure 3-23 displays typical bright-field, fluorescence and lifetime images of EGFP-Rab1D53C immobilized 
on Ni-NTA beads. The confocal fluorescence and lifetime images show circles of high fluorescence intensity 
representing the cross section of the protein immobilized on the beads surface. To analyze the collected 
FLIM data by global analysis171, donor only samples lacking the acceptor dye were collected using EGFP-
Rab1 constructs (Figure 3-23). Additionally, the two donor only samples (EGFP-Rab1T34C and EGFP-
Rab1D53C) served as negative controls for GTPase activation and effector binding. As expected, no changes 
in donor lifetime were observed when these constructs were subjected to GEF-mediated nucleotide 
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exchange or effector binding (Figure 3-23 D). The observed average lifetime of about 2.3 ns is in keeping 
with previously reported lifetimes for EGFP in vitro.192 
  
Figure 3-24: FLIM of GDP- and GTP-bound EGFP-Rab1-TF3 immobilized on Ni-NTA beads.  
FLIM image of His-EGFP-Rab1T34C-TF3 immobilized on Ni-NTA beads in (A) GDP buffer and (B) after incubation with 
DrrA340-533 and GTP. (C) Quantification of EGFP-Rab1-TF3 lifetime for the T34C, S36C, D53C and G54C constructs when 
bound to GDP (gray) or after incubation with DrrA340-533 and GTP (orange). Error bars: mean ± s.d. (n = 5-7 with > 15 
beads). Two-tailed t-test: n.s.: not significant, ***: p < 0.001. False color calibration bar for lifetime images as reference. 
Scale bar: 100 m. 
When testing the FRET constructs in the FLIM setup, only the T34C construct displayed a significant change 
(> 0.1 ns) in EGFP fluorescence lifetime upon GEF-mediated GDP to GTP exchange (Figure 3-24). The increase 
in donor lifetime correlates with the decrease of FRET efficiency observed sensitized emission (3.1.4). 
Similarly, binding of OCRL1 led to a substantial increase of the fluorescence lifetime in the D53C but not in 
the T34C construct (Figure 3-25). Due to their diametric sensitivity in the FLIM-FRET measurements, T34C 
and D53C can be used as complements for detecting GTPases activation and effector binding, respectively. 
  
Figure 3-25: FLIM of effector free and OCRL-bound EGFP-Rab1-TF3 immobilized on Ni-NTA beads.  
FLIM image of His-EGFP-Rab1D53C-TF3 immobilized on Ni-NTA beads after incubation with (A) DrrA340-533 and GTP and 
(B) DrrA340-533, GTP and OCRL1539–901. (C) Quantification of EGFP-Rab1-TF3 lifetime for the T34C and D53C bound to GTP 
(gray) or after incubation with DrrA340-533, GTP and OCRL1539–901 (orange). Error bars: mean ± s.d. (n = 5-7 with > 15 
beads). Two-tailed t-test: n.s.: not significant, ***: p < 0.001. False color calibration bar for lifetime images as reference. 
Scale bar: 100 m. 
In agreement with the results obtained by sensitized emission, all Rab1 constructs displayed a substantial 
increase in donor lifetime when incubated with the Legionella effector LidA201-583. The D53C and the G54C 
constructs showed the largest increase in donor lifetime upon LidA binding (> 0.2 ns). 
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Figure 3-26: FLIM of effector free and LidA-bound EGFP-Rab1-TF3 immobilized on Ni-NTA beads.  
FLIM image of His-EGFP-Rab1G54C-TF3 immobilized on Ni-NTA beads after incubation with (A) DrrA340-533 and GTP and 
(B) DrrA340-533, GTP and LidA201-583. (C) Quantification of EGFP-Rab1-TF3 lifetime for the T34C and D53C bound to GTP 
(gray) or after incubation with DrrA340-533, GTP and LidA201-583 (orange). Error bars: mean ± s.d. (n=5-7 with > 15 beads). 
Two-tailed t-test: ***: p < 0.001, **: p < 0.01, *: p < 0.05. False color calibration bar for lifetime images as reference. 
Scale bar: 100 m. 
The results obtained in vitro, indicated that the Rab1 constructs might be suitable for visualizing Rab1 
activity in living cells using FLIM-FRET. As the next step, the FRET sensor constructs were introduced to living 
cells.  
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3.1.8 Localization of Rab1 sensor in vivo 
Correct subcellular localization is essential for proper GTPase functioning. In cells the C-terminal cysteines 
of Rab proteins are post-translationally modified with one or two geranylgeranyl moieties by Rab 
geranylgeranyltransferase (RabGGTase) with the support of the Rab escort protein (REP). The C-terminal 
prenyl anchors facilitate membrane attachment through hydrophobic interaction with the lipid bilayer. 
To retain proper function of the Rab1 constructs in cells, the two C-terminal cysteines were reconstituted 
through NCL as described in 3.1.3. The full-length constructs were then introduced into HeLa cells by 
microinjection (2.6.4). Immediately after injection the Rab1 sensor fluorescence was distributed 
homogenously in the cell. After incubation for 30-60 min at 37 °C and 5 % CO2, the EGFP and Tide Fluor 3 
fluorescence enriched at a perinuclear structure, which largely colocalized with the Golgi marker 
BFP-Giantin. (Figure 3-28). Enrichment at the Golgi apparatus is consistent with the localization of wild type 
Rab1193, suggesting that the reconstituted Rab1 constructs are successfully prenylated by the cellular 
machinery and function properly in living cells.  
Figure 3-27: Subcellular localization of Rab1 FRET 
sensor after microinjection in HeLa cells. 
Fluorescence images of (A) EGFP-Rab1T34C-TF3 (B) 
EGFP-Rab1S36C-TF3 and (C) EGFP-Rab1D53C-TF3 after 
microinjection into HeLa cells. In both fluorescence 
channels enrichment at the Golgi is observed. Left 
panel: EGFP fluorescence, right panel: TF3 fluorescence. 
Excitation and emission filter settings as described in 
2.7.1. Scale bars: 10 m. 
As expected for a unimolecular FRET sensor, the donor and acceptor fluorescence colocalize well. It should 
be noted however, that prolonged incubation (> 2-3 h) after microinjection leads to formation of puncta 
that are observed exclusively in the TF3 channel, possibly due to degradation of the protein. 
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Figure 3-28: Subcellular localization of Rab1 FRET sensor in HeLa cells expressing BFP-giantin. 
Fluorescence image of EGFP-Rab1T34C-TF3 after microinjection into HeLa cell expressing BFP-giantin. (A) BFP- (B) 
EGFP-, (C) TF3-channel and (D) overlay. Correlation of the Golgi marker BFP-Giantin with the sensor fluorescence 
confirms Golgi localization. Excitation and emission filter settings as described in 2.7.1. Scale bar: 10 m. 
As Rab proteins membrane localization depends on post translational modification of one or two C-terminal 
cysteine residues with isoprenyl moieties. Constructs lacking the C-terminal cysteines lose their Golgi 
localization and are homogenously distributed in the cell (Figure 3-29). 
Figure 3-29: Subcellular localization of Rab1 FRET sensor 
with truncated C-terminus in HeLa cells. 
Fluorescence image of EGFP-Rab1T34C2-TF3 after 
microinjection into HeLa cell (A) EGFP- and (B) TF3-
channel. Truncation of the two C-terminal cysteines leads 
to loss of Golgi localization of Rab1 FRET sensor constructs. 
Excitation and emission filter settings as described in 2.7.1. 
Scale bar: 10 m. 
 
In keeping with previous reports on the significance of GEF activity in Rab membrane targeting54, the Rab1 
sensor constructs also lose their predominant localization to the Golgi organelle when injected into cells 
expressing the GEF-domain of the Legionella protein DrrA340-533 (Figure 3-30). The DrrA340-533 construct is 
lacking its C-terminal P4M-domain that conveys plasma membrane localization in full length DrrA78, thus 
BFP-DrrA340-533 sequestered the Rab1 construct to the cytosol and the nucleus.  
 
Figure 3-30: Subcellular localization of Rab1 FRET sensor in HeLa cells expressing BFP-DrrA340-533. 
Fluorescence image of EGFP-Rab1T34C-TF3 after microinjection into HeLa cell expressing BFP-DrrA340-533 (A) BFP- (B) 
EGFP-, (C) TF3-channel and (D) overlay. Ectopic expression of BFP-DrrA340-533 distorts sensor targeting from Golgi to the 
cytosol and nucleus. Excitation and emission filter settings as described in 2.7.1. Scale bar: 10 m.  
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3.1.9 FRET sensor reveals nucleotide state of Rab1 in living cells 
The Rab1 sensor was microinjected into living cells (2.6.4) to examine Rab1 activation in vivo. As described 
in the methods section, the cells were imaged using lifetime microscopy (2.7.2). The fluorescence lifetime 
was determined using global analysis.171 The T34 construct was mainly used for imaging Rab1 activity in live 
cells.  
FLIM-FRET of GDP- and GTP-bound Rab1 sensor in live cells 
To correlate observed lifetimes to the appropriate nucleotide binding state, reference measurements of 
sensor variants that are predominantly active or inactive were used. A constitutively active Q67L mutant 
and cells expressing BFP-DrrA340-533 served as references for the active, GTP-bound sensor. A C-terminal 
truncated sensor construct was employed as a references for predominantly inactive, GDP-bound sensor. 
The Q67L mutation lacks a prominent glutamine that is involved in the intrinsic hydrolysis of GTP and 
stabilization of the GTPase-GAP interaction41,43, leading to constitutively active, GTP-bound EGFP-
Rab1T34C(Q67L)-TF3 (Figure 3-31 E-G). As a second reference for the GTP-bound state, the T34C sensor was 
injected into HeLa cells expressing BFP-DrrA340-533. BFP-DrrA340-533 expression results in ubiquitous activation 
of the Rab1 pool (Figure 3-31 A-D).54 The donor lifetime obtained from these two experiments represents 
the lifetime for GTP-bound, active Rab1 sensor GTP = 2.05 ± 0.03 ns (18 cells) (Figure 3-34 A).  
 
Figure 3-31: FLIM of EGFP-Rab1T34C-TF3 and EGFP-Rab1T34C(Q67L)-TF3 in vivo. 
Fluorescence image of EGFP-Rab1T34C-TF3 after microinjection into HeLa cell expressing BFP-DrrA340-533 (A) EGFP-, (B) 
TF3- and (D) BFP-channel. (C) Corresponding FLIM image. Fluorescence image of EGFP-Rab1T34C(Q67L)-TF3 after 
microinjection into wild type HeLa cell (E) EGFP- and (F) TF3-channel. (G) Corresponding FLIM image. False color 
calibration bar for lifetime images as reference. Scale bar: 10 M.  
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As a control, a donor only construct (EGFP-Rab1) was injected into cells expressing BFP-DrrA340-533. In this 
case no significant increase in donor lifetime was observed in BFP-DrrA340-533 transfected cells (Figure 5-15 
and Figure 5-16). 
To determine the fluorescence lifetime of the GDP-bound sensor EGFP-Rab1T34C2-TF3, a sensor construct 
lacking the two prenylatable C-terminal cysteines, was injected into wild type HeLa cells. Without the C-
terminal cysteine residues the protein cannot attach to membranes, excluding it from regulation by GEFs 
and GAPs. This is evident from the cytoplasmic Rab1 localization (Figure 3-32). In agreement with previous 
in vitro results, the donor lifetime of the GDP-bound sensor is reduced in comparison to the activated, GTP-
bound construct. The average lifetime was determined to be GDP = 1.88 ± 0.08 ns (15 cells) (Figure 3-34).  
 
Figure 3-32: FLIM of EGFP-Rab1T34C2-TF3 in vivo. 
Fluorescence image of EGFP-Rab1T34C2-TF3 after microinjection into wild type HeLa cell (A) EGFP- and (B) TF3-
channel. (C) Corresponding FLIM image. False color calibration bar for lifetime images as reference. Scale bar: 10 M. 
Quantification of Rab1 activity in live cells 
Using these GDP and GTP values as reference for the fluorescence lifetime of GDP and GTP-bound sensor 
respectively, the obtained fluorescence lifetime for the Rab1 sensor in cells can be correlated to the local 
Rab1 activity.  
In the FLIM images each color coded pixel correlates to a fluorescence lifetime that is determined through 
the collected photons at this position. The average fluorescence lifetime at this position is composed of two 
fractions. One fraction represents the GDP-bound sensor and the other fraction correlates to the GTP-bound 
Rab1 FRET sensor. Assuming that the observed lifetime is a linear combination of these two sensor species 
the proportion of GDP to GTP-bound Rab1 can be calculated using the following relation: 
GTPGDPobs yx  with yx1   
GDPGTP
GDPobsx


  
Eq. 3-2 
Here obs is the lifetime of the FRET sensor at a specific location in the cell. The variable x correlates with the 
fraction of GTP-bound sensor and y with the fraction of GDP-bound sensor. GDP and GTP are the 
fluorescence lifetimes for sensor species bound exclusively to GDP or GTP, respectively.  
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As described earlier, the EGFP-Rab1T34C-TF3- CC construct enriches at the Golgi membrane in Hela cells 
(Figure 3-33). Interestingly Golgi-bound sensor displays a significantly lower lifetime than the cytoplasmic 
sensor fraction (Figure 3-33 C and F, Figure 3-34 A).  
 
Figure 3-33: FLIM of EGFP-Rab1T34C-TF3 injected into wild type HeLa cells. 
Fluorescence image of EGFP-Rab1T34C-TF3 after microinjection into wild type HeLa cell (A)/(D) EGFP- and (B)/(E) TF3-
channel. (C)/(F) Corresponding FLIM image. False color calibration bar for lifetime images as reference. Scale bar: 
10 M. 
The observed average lifetimes of cyto = 2.02 ± 0.04 ns and Golgi = 1.95 ± 0.07 ns (18 cells) indicate that Rab1 
is predominately in the GDP-bound state when localized to the Golgi and largely in the GTP-bound state in 
the cytoplasm (Figure 3-34 B).  
Using Eq. 3-2 the proportion of Rab1:GDP and Rab1:GTP can be estimated. Using this approximation, about 
80 % of the Rab1 pool is GTP-bound in the cytoplasm, while only 40 % of the Golgi localized Rab1 molecules 
are GTP-bound (Figure 3-34 B). It should be noted that the obtained fluorescence lifetimes differ 
significantly from cell to cell, resulting in considerable variance of the determined GDP/GTP percentages. 
However, when directly comparing the lifetime of the cytoplasmic and the Golgi fraction in a cell, the sensor 
lifetime at the Golgi membrane is always substantially lower than in the cytoplasmic fraction. This difference 
from cytoplasmic to Golgi localized sensor fraction is not observed for the T34C(Q67L) construct (Figure 
3-34 A). In another control experiment using EGFP-Rab1, a construct without the acceptor dye, the 
difference in fluorescence lifetime between Golgi and cytoplasm is not significant (Figure 5-16). 
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Figure 3-34: Quantification of Rab1 nucleotide binding state in vivo. 
(A) Quantification of EGFP lifetime for T34C sensor constructs in cells. Orange and blue dots denote cytoplasmic and 
Golgi-localized protein fractions, respectively. (n = 7-25 cells, individual data points are plotted, box plots: - median, -- 
mean, upper hinge 75th percentile, lower hinge 25th Percentile, whiskers: s.d.. Two-tailed t-test, ***: p < 0.001) (B) 
Quantification of GTP- and GDP-bound fraction of cytoplasmic and Golgi-localized Rab1 sensor. Each dot represents one 
cellular FLIM measurement. 
Here the aforementioned observation that the cytoplasmic Rab1 fraction is predominantly active/GTP-
bound whereas Rab1 localized to the Golgi compartment is largely inactive/GDP-bound, is discussed in light 
of the current model for the spatial Rab cycle regulating vesicular transport (Figure 3-35).4,46  
Rab1 regulates the ER to Golgi transport94,97,194-198, thus the ER represents the donor compartment while 
the Golgi membrane correlates to the acceptor membrane. After microinjection the Rab1 construct binds 
to REP, is prenylated by RabGGTase and delivered to its donor membrane, the ER. At the ER the GTPase 
encounters GEFs and is subsequently activated. Following activation Rab1 binds/recruits effector proteins, 
such as p11597, at the ER exit sites (ERES) and locates to budding vesicles.199 The vesicular, activated Rab1 is 
then transported to the target membrane at the Golgi site, possibly undergoing an additional vesicular 
fusion/budding step at the ER-Golgi intermediate (ERGIC) compartment.198 Vesicles originating at the ERES 
and the ERGIC require the action of the Rab1 specific GEF the TRAPP (transport protein particle) 
complexes.74 After delivery to the Golgi, the vesicles fuse with the acceptor membrane through Rab1 
mediated interactions with the tethering proteins p11597 and GM13094 and the Golgi resident giantin200. To 
close the spatial cycle Rab1 is deactivated by GAPs, thereby disrupting effector binding and enabling 
extraction by GDI. From the cytoplasm Rab1 is delivered to the ER membrane and can re-enter the ER to 
Golgi trafficking cycle.  
In context of this model, the predominantly active Rab1 sensor in the cytoplasm (~ 80 % GTP-bound, Figure 
3-34) can be attributed to the Rab1 population undergoing vesicular transport. Thus GDI-bound, inactive 
Rab1 represents about 20% of the Rab1 present in the cytoplasm. The Golgi compartment on the other 
hand serves as the acceptor compartment, where Rab1 is inactivated after vesicular fusion and thus features 
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a high GAP activity. This is in agreement with the observation that the Rab1 sensor is predominantly (~60 %) 
GDP-bound at the Golgi site. Together with the enrichment of Rab1 at the Golgi apparatus, this suggest that 
the Golgi compartment serves as the Rab1 reservoir in cells.  
 
Figure 3-35: Rab1 cycling regulates vesicular transport between the ER and Golgi compartment. 
Injected Rab sensor associates to REP and is prenylated through interaction with RabGGTase. The prenylated Rab1 
sensor is then delivered to the ER, attaches to the membrane and is activated upon encountering a GEF, e.g. TRAPP. 
The GTP-bound Rab1 constructs then recruit/bind effector proteins to the ERES sites/budding vesicles. Guided by the 
recruited effector proteins, the Rab loaded vesicles enter the cytoplasm, resulting in the predominantly active Rab1 
sensor population. Upon fusion with the Golgi membrane, the GTPase is inactivated through GAP-mediated GTP 
hydrolysis. 
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3.1.10 Rab1 FRET sensor reports on effector binding in living cells  
When examining the different Rab1 FRET constructs in vitro, S36C, D53C and G54C proved to be effective 
reporters of OCRL1 binding while the T34C construct displayed no sensitivity towards OCRL1 (3.1.6 and 
3.1.7). Thus in addition to probing the Rab1 nucleotide state in living cells using EGFP-Rab1T34C-TF3 (3.1.9), 
EGFP-Rab1S36C-TF3 and EGFP-Rab1D53C-TF3 were used to assess, whether the sensors are suitable 
reporters of effector binding in living cells. 
To this end, the modified Rab1 constructs were introduced into Hela cells with or without expression of 
BFP-OCRL1539–901. Consistent with the in vitro results, the donor lifetime increased significantly for the S36C 
and D53C constructs in cells expressing the OCRL1, but not for the T34 construct (Figure 3-37 and Figure 
5-14).  
 
Figure 3-36: Rab1 FRET sensor reports on OCRL1 binding in vivo. 
Fluorescence and FLIM images of EGFP-Rab1S36C-TF3 after microinjection into (A)-(D) wild type HeLa cell or (E)-(H) 
HeLa cell expressing BFP-OCRL1539–901. (A)/(E) BFP- (B)/(F) EGFP-, (C)/(G) TF3-channel and (D)/(H) FLIM. Ectopic 
expression of BFP-OCRL1539–901 results in higher donor lifetime of EGFP-Rab1S36C-TF3 sensor indicating effector binding. 
False color calibration bar for lifetime image as reference. Scale bars: 10 μm. 
BFP-OCRL1 colocalized with the Rab1 sensors at the perinuclear region. Overexpression of the OCRL1 
effector domain appeared to disrupt the Golgi organelle into smaller fragments that are distributed within 
the cytoplasm (Figure 3-36 E-G and Figure 5-13). This effect of OCRL overexpression on the Golgi structure 
has been reported previously.201 To ensure that the observed increase in donor lifetime was indeed caused 
by OCRL1 - Rab1 sensor interaction and not through other factors such as expression of an additional 
fluorescent protein, the experiment was repeated with the donor only construct EGFP-Rab1 (Figure 3-37 C 
and Figure 5-13). As expected, the same fluorescence lifetimes were observed for the EGFP-Rab1 constructs 
in the presence and the absence of BFP-OCRL1 expression (Figure 3-37 C). 
Collectively these findings clearly indicate that the described Rab1 sensor is an effective reporter of effector 
binding in living cells. 
  
3 Results and discussion 
 
-87- 
 
Figure 3-37: Quantification of FRET sensor donor lifetime in wild type and BFP-OCRL transfected HeLa cells. 
Quantification of EGFP lifetime of (A) S36C, (B) T34C and (C) donor only sensor constructs. n = 5-12, individual data 
points are plotted, box plots: - median, □ mean, upper hinge 75th percentile, lower hinge 25th percentile, whiskers: 
s.d.. Two-tailed t-test: n.s.: not significant, **: p < 0.01, *: p < 0.05. 
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3.1.11 KRas FRET sensor - GEF-mediated nucleotide exchange 
After establishing a FRET sensor for Rab1 activity, the sensor principle was expanded to the small GTPase 
KRas. Suitable acceptor labeling sites were identified as described in 3.1.1. To allow site-specific labeling 
with the acceptor dye, all naturally occurring cysteines were substituted appropriately. Analogous to the 
Rab1 sensor, the KRas sensors sensitivity towards its bound guanine nucleotide was initially tested by GEF-
mediated GDP to GTP exchange in vitro. Besides evaluating the dynamic range and sensitivity, the 
interaction with the respective GEF was compared to the wild type protein. 
For KRas the GEF domain of SOS202-204 (referred to as SOS564-1049 or SOS) was used to characterize the sensors’ 
response to GDP/GTP exchange by fluorescence spectroscopy. An independent assay, using mantGDP 
(2.5.4.2), was utilized to examine the function of the KRas mutants. GEF-mediated nucleotide exchange was 
initiated through addition of varying amounts of SOS564-1049 to 200 nM KRas sensor in the presence of 
100 M GTP. Constructs with a shortened linker region between the fluorescent protein and the GTPase 
domain (EGFP11 and mCitrine11, 5.1) were also tested. This shortens the donor-acceptor distance and 
fixes the fluorophores relative orientation for an improved dynamic range (2.5.4.4). 
Assessment of GEF-mediated nucleotide exchange by mantGDP assay  
As an initial test, the nucleotide exchange activity of SOS564-1049 towards the KRas mutants (D30C, E31C, 
D33C, D47C, G48C and E107C) and unmodified KRas wild type was examined using mantGDP. By adding 
SOS564-1049 in the presence of excess GTP, the bound mantGDP is released into the solution, causing a 
decrease in the mant fluorescence signal. The signal decrease can be fitted by a single exponential function 
to obtain the observed first order rate constant kobs (Eq. 2-8). As described in 2.5.4.2 the catalytic efficiency 
can then be extracted as the slope of a linear fit of kobs plotted against [SOS564-1049] (Figure 5-17). The 
obtained catalytic efficiencies are summarized below (Table 3-6). The fluorescence profiles and linear 
regression for kcat/KM can be found in the appendix (5.6). 
Table 3-6: Catalytic efficiencies for SOS564-1049-mediated nucleotide exchange using mantGDP fluorescence. 
KRas construct Labeling site kcat /KM (M·s)-1 (kcat /KM (M·s)-1)wt / kcat /KM (M·s)-1 
EGFP-KRas D30C (1.58 ± 0.25)×104 3.3 
 E31C (0.31 ± 0.06)×104 16.9 
 D33C (0.17 ± 0.04)×104 30.8 
 D47C (0.59 ± 0.08)×104 8.9 
 G48C (8.38 ± 0.07)×104 0.6 
 E107C (0.21 ± 0.01)×104 24.9 
KRas wt - (5.23 ± 0.03)×104 1 
It is important to note that SOS564-1049 features an allosteric Ras-binding site, which has a profound effect on 
its GEF activity.203,204 The affinity of KRas to the catalytic site increases significantly when GDP:KRas, and to 
an even greater extent when GTP:KRas, is bound to the distal allosteric site of SOS564-1049.205,206 Due to the 
complex interplay of GDP/GTP-bound KRas concentration and the catalytic SOS564-1049 domain one has to be 
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cautious when comparing the absolute values obtained using experimental setups. It is however, possible 
to compare the relative performance of SOS564-1049 towards the tested KRas mutants and the wild type KRas. 
Except from G48C, all KRas mutants displayed a significantly reduced catalytic efficiency for SOS564-1049-
mediated nucleotide exchange. The smallest decrease, by a factor of three, was observed for D30C, while 
the largest drop in catalytic efficiency was observed for the D33C mutant with a reduction by a factor of 
around 30. For the EGFP-KRasG48C construct, SOS564-1049 displayed a slightly higher kcat /KM. The rate of 
mantGDP release from KRas in the presence of 1 M GEF, kobs = 0.02-0.06 s-1, is in the same order of 
magnitude (0.01-0.06 s-1) as reported previously for mantGDP release (against unmodified GDP) with a total 
KRas concentration of 1 M.205 
KRas FRET sensor is sensitive towards GEF-mediated nucleotide exchange 
The KRas constructs FRET signal response was assessed via sensitized emission, as described in 2.5.4.2. To 
this end, varying amounts of SOS564-1049 were added to 200 nM KRas FRET sensor in the presence of excess 
GTP. The change in FRET efficiency was monitored by sensitized emission with the donor EGFP, EGFP11 or 
mCitrine11 excited at 480 nm and the acceptor emission detected at 580 nm for Tide Fluor 3 or 614 nm 
for Tide Fluor 4, respectively (2.5.4.2). 
 
Figure 3-38: KRas FRET sensor reports on SOS-mediated nucleotide exchange. 
(A) Addition of SOS564-1049 to 200 nM EGFP-KRasD30C-TF3 induces rapid nucleotide exchange in the presence of excess 
GTP (100 M). (Inset) Fluorescence spectra of EGFP-KRasD30C-TF3 before (solid black line) and after nucleotide 
exchange (solid orange line). (B) The observed rate constant for nucleotide exchange depends on SOS564-1049 
concentration. (Inset) By plotting kobs against [SOS564-1049] the catalytic efficiency can be extracted as the slope of the 
linear fit (solid blue line). FRET was monitored with excitation set to 480 nm and emission collected at 580 nm. 
Similar to the Rab1 sensor, the FRET signal of the KRas sensor drops upon addition of the GEF, indicating 
accelerated nucleotide exchange. The obtained fluorescence curves can be fitted with a single exponential 
function to obtain a observed first order rate constant kobs (2.5.4.2). The catalytic efficiency can then be 
extracted as the slope of the linear fit of kobs plotted against [SOS564-1049] (Figure 3-38 B and Table 3-7). 
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Table 3-7: Catalytic efficiencies for SOS564-1049-mediated nucleotide exchange using sensitized emission. 
Sensor construct Labeling site kcat /KM (M·s)-1 (kcat /KM (M·s)-1)wt / kcat /KM (M·s)-1 
EGFP-KRas-TF3 D30C (0.73 ± 0.06)×104 7.2 
EGFP11-KRas-TF3 D30C (0.8 ± 0.2)×104 6.5 
mCitrine11-KRas-TF4 D30C (0.8 ± 0.1)×104 6.5 
 E31C (0.26 ± 0.06)×104 20.1 
KRas wt - (5.23 ± 0.03)×104 1 
Of all tested KRas constructs only the D30C and E31C constructs displayed substantial change in FRET 
efficiency upon SOS-mediated nucleotide exchange. For both mutants the sensitized emission signal drops 
following GDP to GTP exchange. Fluorescence spectra collected before and after nucleotide exchange show 
an increase in donor emission and concomitant decrease in acceptor fluorescence (Figure 3-38 A inset and 
Figure 5-18 insets). The obtained catalytic efficiencies are consistent for all three D30C constructs suggesting 
that shortening of the linker does not impair the KRas-SOS interaction. In contrast to the Rab1 sensor, the 
dynamic range did not improve significantly for the constructs with shortened linker regions between the 
fluorescent protein and the GTPase domain. It should be noted that the relative change in fluorescence 
signal increased with higher SOS564-1049 concentrations (Figure 5-18 insets). Presumably, this concentration 
dependent behavior can be attributed to binding of the KRas constructs to the allosteric or the catalytic SOS 
sites. For the E31C mutant, only the mCitrine11 construct displayed a sizeable change in FRET efficiency. 
However, the observed signal drop was only minor when observed by sensitized emission, yet up to 25 % 
(Figure 5-18 M inset) when monitored through donor emission. A similar pattern was observed for 
EGFP11- KRasD30C-TF3 and to a lesser extent for mCitine11-KRasD30C-TF4 (Figure 5-18 A, D and G). In 
comparison to wild type KRas, the observed nucleotide exchange rate was reduced by a factor of 7 for the 
D30C constructs and a factor of 20 for the E31C construct (Table 3-7). 
As expected, SOS mediates nucleotide exchange in both directions. After completed GDP to GTP exchange, 
addition of excess GDP partially restores the initial fluorescence signal intensity, indicating that GTP is 
exchanged for the more abundant GDP (Figure 3-39). This further confirms that the observed FRET signal 
change is indeed governed by the bound nucleotide and not caused by the GTPase-GEF interaction. 
Figure 3-39: KRas FRET sensor is reversible. 
Increasing amounts of GTP and GDP are added in turns to 
200 nM GDP-bound EGFP-KRasD30C-TF3 and 1 M 
SOS564-1049. The observed initial signal change upon GDP 
to GTP exchange is partially reversed through addition of 
excess GDP. FRET was monitored by excitation set at 480 
nm and emission collected at 580 nm. 
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SOS564-1049 features a catalytic and a distal allosteric Ras-binding site, the affinity towards either of these 
sites depends on the nucleotide-binding state of the GTPase.203,204 Furthermore, binding of Ras:GTP at the 
allosteric site accelerates the nucleotide exchange activity at the catalytic site.204,206 The physiologically most 
relevant scenario constitutes binding of GTP-bound Ras to the allosteric site, leading to increased affinity of 
the catalytic site towards inactive, GDP-bound Ras, thereby generating a positive feedback for rapid GTPase 
activation.203,204,206 A comprehensive review of this intricate interplay is not the focus of this thesis. 
However, the implications of binding to either sites for the FRET signal and the effect of modified switch I 
residues on the interaction with the catalytic SOS site are of importance and are discussed here. The 
following conclusions are inferred from the complex structure of SOS566-1046 bound to nucleotide-free HRas 
at the catalytic site and activated HRas:GNP at the distal allosteric site (Figure 3-40).205  
 
Figure 3-40: Crystal structure of SOS566-1046 in complex with nucleotide free HRas bound at the catalytic site and 
HRas:GNP bound to the allosteric site (PDB ID: 1NVW).203  
The HRas structures are shown in cartoon representation (gray), the SOS structure is displayed in surface representation 
(beige). The switch I and II regions are colored in red and orange respectively. The P-loop is marked in green. The N-
terminal regions of the HRas proteins are highlighted in yellow. The acceptor labeling sites are colored in turquoise.  
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The binding affinity of Ras:GDP to either SOS site is relatively low (KD > 50 M)205,206. Thus, binding of the 
GDP-bound species should therefore be negligible in the present experimental setup. However, upon 
nucleotide exchange the affinity increases (KD ∼ 10 M)205,206 and could potentially lead to binding of a 
significant amount of then GTP-bound KRas molecules to the allosteric site of SOS. Due to the interaction 
between the allosteric SOS site with the switch I region and the position of the N-terminus in close proximity 
to the GEF surface, this could have an impact on the observed FRET signal. However, an effect on the FRET 
signal was not observed in the conditions used in this work. Furthermore, excess GDP (Figure 3-39) and 
GAP-induced GTP hydrolysis (Figure 3-41) restore the initial fluorescence signal, clearly indicating that the 
observed FRET signal change is indeed reporting on the nucleotide binding state of the KRas sensor. 
Besides a possible corruption of the FRET signal through binding at the allosteric site, the resulting 
stimulation of the nucleotide exchange activity at the catalytic SOS site could complicate the kinetic analysis 
of the nucleotide exchange activity.  
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3.1.12 KRas FRET sensor - GAP-induced GTP hydrolysis 
In an effort to test if the KRas sensors are susceptible to GAP-mediated deactivation, activated KRas was 
incubated with an excess of the p120 GAP domain (referred to as RasGAP714-1047 or RasGAP) and the FRET 
signal change was monitored through sensitized emission (2.5.4.2). 
 
Figure 3-41: KRas FRET sensor reports on RasGAP-induced GTP hydrolysis. 
(A) Addition of 2 M RasGAP714-1047 to 200 nM GTP-bound EGFP-KRasD30C-TF3 reverses the initial drop in FRET signal 
intensity upon nucleotide exchange. (B) Addition of 2 M RasGAP714-1047 to 200 nM GppNHp-bound EGFP-KRasD30C-
TF3 fails to reverse the change in fluorescence signal. Changes in FRET efficiency were observed by sensitized emission 
with excitation at 480 nm and emission collected at 580 nm. 
200 nM KRas sensor were activated through addition of 1 M SOS564-1049 in the presence of 100 M GTP. 
After completion of the nucleotide exchange, 2 M of RasGAP714-1047 were added (Figure 3-41 and Figure 
5-19). As expected, the change in FRET signal after GDP to GTP exchange, was reversed through addition of 
RasGAP, restoring the initial signal intensity. The experiments were repeated using the non-hydrolysable 
GTP analog GppNHp instead of GTP (Figure 3-41 B), to ascertain that the observed FRET response was 
indeed caused by GTP hydrolysis,. In this case, RasGAP714-1047 failed to reverse the FRET signal change. 
To assess the influence of the introduced modifications on the GAP kinetics, the catalytic efficiencies of 
EGFP-KRasD30C-TF3, mCitrine11-KRasE31C-TF4 and wild type KRas were determined as described 
previously (3.1.5). In comparison to KRaswt (kcat/KM =(1.4 ± 0.3) ·105 (M·s)-1), the catalytic efficiency observed 
for EGFP-KRasD30C-TF3 (kcat/KM =(8 ± 1)·105 (M·s)-1) is reduced by a factor of 1.7 (Figure 5-20 A, B and E,F). 
For mCitrine11-KRasE31C-TF4 (kcat/KM =(4.3 ± 0.4)·104 (M·s)-1) the catalytic efficiency drops by a factor of 
31 (Figure 5-20 C and D). Note that a similar decrease was observed in the GEF assay for these mutants 
(3.1.11), the GEF-mediated nucleotide exchange of the D30C mutant was slightly impaired (by a factor of 6-
7 in the GEF essay) while the E31C mutation reduced the catalytic performance of SOS by a factor of >20. 
Simultaneous decrease in both GEF and GAP activities towards the KRas constructs may lead to a balanced 
effect in the KRAs function in cells. 
The crystal structure of the HRas-RasGAP complex reveals that the residues E31 and D30 are located in the 
GTPase-GAP interface but their side chains are not directly involved in interactions with the RasGAP protein 
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(Figure 3-16).39 However, the main chain carbonyl group of E31 is involved in binding the catalytic arginine 
finger via a water molecule. This involvement in the HRas-RasGAP contact site could explain the marked 
reduction in GAP-mediated GTP hydrolysis for the E31 construct.  
Figure 3-42: Crystal structure of HRas1-166:GDP 
in complex with p120 GAP714-1047 (PDB ID: 
1WQ1).39  
The HRas structure is shown in gray and RasGAP 
is colored in yellow. The HRas labeling sites are 
highlighted and labeled in turquoise. The switch 
I and II regions are colored in red and orange 
respectively. The P-loop is marked in green. The 
bound guanine nucleotide is depicted in beige 
with atoms highlighted in red (oxygen), blue 
(nitrogen) and orange (phosphorous).  
Residues from switch I and II region and the P-
loop of HRas are involved in the in GTPase-GAP 
interaction. 
The two acceptor labeled residues lie directly in 
the HRas:RasGAP interface but do not form 
direct contacts with the GAP molecule in this 
structure. The main chain carbonyl group of E31 
contacts a water molecule in the interaction 
interface. 
 
 
Collectively, these experiments demonstrate that the KRas sensors serve as efficient reporters for KRas 
activation and deactivation. While the interaction with its regulatory partners is preserved, the kinetics are 
significantly reduced for the E31C construct.  
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3.1.13 KRas sensor reports on EGF-induced activation in vivo 
In wild type cells KRas4b enriches on the plasma membrane where it can be activated by SOS in response 
to upstream signals such as growth factor stimulation. KRas4bs localization at the plasma membrane is 
governed by electrostatic interaction between a polybasic stretch at the proteins C-terminal region with 
negatively charged phospholipids in the inner plasma membrane leaflet207 and by hydrophobic interactions 
via a farnesylated C-terminal CAAX box. 
After labeling, the KRas construct’s C-terminus was reconstituted by NCL (3.1.3) with the respective 
tetrapeptide (-CVIM) to allow protein prenylation in cells. Following microinjection, the cells were incubated 
for 30-60 min to facilitate prenylation of the reconstituted C-terminus by the endogenous prenylation 
machinery. After incubation the sensor constructs accumulated at the plasma membrane, suggesting 
proper prenylation in cells (Figure 3-43 A-C and Figure 3-44). In contrast, injection of a KRas construct, 
lacking the –CAAX motif, led to cytosolic localization (Figure 3-43 D). 
 
Figure 3-43: KRas FRET sensor injected into MDCK and COS-7 cells. 
Fluorescence images of (A) mCitrine-KRasD30C-TF4-CVIM and (B) EGFP-KRasD30C-TF3-CVIM after injection into MDCK 
cells. In both channels sensor enrichment at the plasma membrane is observed. (C) mCitrine-KRasE31C-TF4-CVIM after 
microinjection into COS-7 and (D) EGFP-KRasD30C4-TF3 CVIM after microinjection into MDCK cells. mCitrine-
KRasE31C-TF4 -CVIM enriches at the COS-7 plasma membrane. EGFP-KrasD30C4-TF4 in homogenously distributed in 
cytoplasm. Left panels: mCitrine (yellow)/EGFP (green), right panels: TF4 (purple)/TF3 (red) fluorescence. Excitation and 
emission filter settings as described in 2.7.1. Scale bars: 10 m. 
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Figure 3-44: C-terminal –CAAX motif is 
essential for KRas plasma membrane 
localization. 
Upper panel: Fluorescence images and lower 
panel: corresponding intensity profile plots of 
(A) mCitrine-KRasD30C-TF4-CVIM and (B) 
EGFP-KRasD30C4-TF3 after injection into 
MDCK cells. mCitrine-KRasD30C-TF4 displays 
high intensity at the plasma membrane as 
indicated by red arrows in the fluorescence 
image and the fluorescence intensity profile 
plot along the indicated cross section (red 
line). For EGFP-KrasD30C4-TF4 the sensor 
fluorescence is homogenously distributed in 
the cell cytoplasm. Due to reduced cell 
thickness, lower intensity is observed at the 
cell edges (indicated by the red arrows along 
the indicated cross section (red line)). 
Excitation and emission filter settings as 
described in 2.7.1. Scale bars: 10 m. 
 
 
Addition of epidermal growth factor (EGF) to cell medium triggers cell proliferation. This process is mediated 
by the transmembrane EGF receptor (EGFR). Upon EGF binding the receptor dimerizes and undergoes 
autophosphorylation, inducing the formation of signaling complexes (Figure 1-7 C). Here, EGF stimulation 
was used to observe activation of the KRas sensor in cells.  
In vitro KRas activation through SOS-mediated nucleotide exchange resulted in a decrease in FRET efficiency, 
evident as a drop in sensitized emission signal (3.1.11). Thus, an increase in donor fluorescence lifetime in 
FLIM measurements upon KRas activation would be expected.  
To increase the cells’ sensitivity towards EGF stimulation, they were serum starved overnight (0.5 % serum) 
prior to microinjection and imaging. Stimulation of microinjected cells with EGF (100 ng/ml) led to a rapid 
increase of the donor fluorescence lifetime in both MDCK and COS-7 cells, indicating EGF induced KRas 
activation (Figure 3-45 and Figure 3-46). KRas activation in MDCK cells occurred predominantly at the 
plasma membrane as indicated by the higher fluorescence lifetime observed in these areas (Figure 3-45 C).  
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Figure 3-45: Imaging of EGF induced KRas activation in cells by FLIM. 
(A) Confocal images of mCitrine-KRasE31C-TF4-CVIM injected into serum starved MDCK cells. FLIM images of mCitrine 
lifetime (B) before and (C) 5 min after EGF stimulation. False color calibration bar for lifetime images as reference. Scale 
bar: 20 m. 
Activation at the plasma membrane is consistent witch EGFR-Grb2 mediated SOS recruitment.  
The sensor response upon EGF stimulation was monitored in batch experiments for multiple cells over a 
time course of >20 min with FLIM images collected every 1-2 min. For analysis the injected cells were 
separated from the background using a binary mask generated by intensity thresholding. Lifetime profiles 
were generated by selecting single cells as ROIs and using the ImageJ software to determine the average 
lifetime at each time point. For control experiments, EGF stimulation was repeated with cells injected with 
donor only constructs (Figure 5-21 A and B), constructs lacking the C-terminal prenylation motif (Figure 5-21 
C and D) and cells treated with the EGFR kinase inhibitor Erlotinib (Figure 5-21 E and F).208,209 In contrast to 
the intact sensor constructs, no significant change in donor lifetime was observed in these control 
experiments (Figure 3-46). 
 
Figure 3-46: Quantification of fluorescence lifetime change after EGF stimulation 
Colored lines represent individual cell lifetime changes of MDCK cells injected with (A) mCitrine-KRasE31C-TF4-CVIM or 
(B) EGFP-KRasD30C-TF3-CVIM respectively. The black arrow at t=0 s indicates addition of 100 ng/ml EGF to cell medium. 
Black lines with error bars represent mean ± s.d. (n=12-13 cells). Blue line and red line with error bars represent control 
measurements of donor only constructs (mean ± s.d. (n =13 cells)) or cells treated with Erlotinib (mean ± s.d. (n=14 
cells)), respectively. Two-tailed t-test: *: p < 0.05, **: p < 0.01, ***: p < 0.001. 
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KRas activity peaks at 5 min after EGF stimulation. In most cases the initial increase in KRas activation was 
sustained over the time course of 20 min (Figure 3-46 B). Rapid and persisting increase in Ras activity upon 
continuous EGF stimulation is consistent with previous reports using HRas sensors.210 Western blot analysis 
of KRas activation in PANC-1 cells using the Ras binding domain of c-Raf revealed maximal KRas activation 5 
min after EGF treatment and gradual decline of the GTP bound KRas fraction after about 15 min.211 
EGF-induced membrane ruffles displayed increased fluorescence intensity at the edge of the cell, indicating 
KRas enrichment. However, in contrast to HRas that is activated at the free cell edge149, KRas activity is lower 
at this area (Figure 3-47 A-D). The opposing gradients of H- and KRas activity imply different mechanisms 
for regulating each Ras isoform. Furthermore, unstimulated COS-7 cells displayed an activity gradient with 
lower lifetime at the cell edges (Figure 3-47 F and H). The difference in lifetime between cell edge and center 
persisted throughout EGF stimulation while the overall KRas activity increased as indicated by higher donor 
lifetime (Figure 3-47 H). This activity gradient may be caused by a negative feedback on KRas activation from 
the signaling of actin rearrangement.  
 
Figure 3-47: KRas sensor enriches at membrane ruffles, but does not display increased KRas activity. KRas activity 
exhibits a gradient in COS-7 cells. 
(A) Intensity and (B) FLIM image of EGFP-KRasD30C-TF3 after EGF stimulation in a serum starved COS-7 cell. Arrow 
indicates membrane ruffling. Profiles of fluorescence intensity (C) and fluorescence lifetime (D) along the indicated line 
in (A) and (B). (E) Intensity and (F-G) FLIM image of EGFP-KRasD30C-TF3-CVIM in serum starved COS-7 cells (F) before 
and (G) 11 min after EGF stimulation. (H) Quantification of the fluorescence lifetime along the indicated cross section 
(red line) in (E) and (F). Lifetime plot before (black) and after (orange) EGF stimulation. False color calibration bar for 
lifetime images as reference. Scale bar: 20 m.  
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3.2 Rab1 trafficking 
While fulfilling their regulatory roles in vesicular trafficking most Rab proteins travel from one subcellular 
compartment to another. To re-enter their functional cycle, they have to return to their initial membrane. 
This highly dynamic process is linked to the GTPase’s activation/deactivation cycle and is tightly regulated 
by GEFs and GAPs. This spatial cycling further depends on binding of solubilization factors such as GDI and 
REP (Figure 1-6). 
Here, the dynamics of Rab1 trafficking between the cytoplasmic pool and the Golgi organelle were 
examined using fluorescence recovery after photobleaching (FRAP) and photoactivation experiments. The 
kinetics of Rab1 delivery to the Golgi membrane were studied by two complementary approaches: (1) by 
FRAP of the Golgi localized Rab1 fraction and (2) by photoactivation of the cytoplasmic Rab1. The opposite 
direction of Rab1 trafficking, originating at the Golgi membrane, was investigated by localized activation of 
paGFP-Rab1 at the Golgi membrane (3.2.2). 
3.2.1 Characterization of Rab1 trafficking from cytoplasm to Golgi 
kC-G determined by Golgi bleaching 
To obtain the apparent rate constant of Rab1 trafficking from the cytoplasm to the Golgi, Golgi-localized 
EGFP-Rab1 was bleached by extensive irradiation with maximal laser power. The course of a typical Golgi 
bleaching experiment of EGFP-Rab1 is depicted below (Figure 3-48). 
 
Figure 3-48: Bleaching of EGFP-Rab1wt at the Golgi body. 
(A) Scheme depicting a typical bleaching experiment to determine kC-G for Rab1 trafficking from cytoplasm to Golgi. (B) 
Exemplary EGFP fluorescence images of a cell expressing EGFP-Rab1wt. The bleached area is circled in red. After 
bleaching the fluorescence intensity increases at the region of interest (ROI, dashed red line) on the Golgi was followed 
by time-lapse imaging. Scale bar: 20 m. 
For image analysis, the mean fluorescence intensity at the Golgi was determined using the FRAP profiler 
plugin of ImageJ and normalized to the prebleach intensity as described in the method section (2.7.3). A 
typical FRAP profile is displayed in Figure 3-49. 
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Figure 3-49: Exemplary intensity profile of EGFP-Rab1 during Golgi FRAP experiment. 
The graph depicts the course of the average EGFP-Rab1wt intensity at the marked ROI (dashed red line) during a typical 
bleaching experiment. The fluorescence intensity at the ROI was normalized to the prebleach intensity. 
After photobleaching the fluorescence intensity partially recovers and reaches a plateau. The recovery curve 
can be fitted with the single exponential function Eq. 2-14 to obtain the apparent rate constant kobs for Rab1 
flux from the cytoplasm to the Golgi organelle. 
 tknorm obse1I)t(I    Eq. 2-14 
obs
2/1
k
)2ln(
t   
Eq. 3-3 
Here, Inorm is the fluorescence intensity at time t, I is the fluorescence intensity reached after completed 
equilibration and kobs is the observed rate constant for fluorescence recovery. Using Eq. 2-15, the half-time 
of the fluorescence recovery (t1/2) can be calculated from kobs. The apparent rate constant kC-G for Rab1 
delivery from the cytoplasm to the Golgi was obtained as the average of 3-6 recovery curves fitted 
individually. Due to the fluidity of Golgi-bound proteins it is crucial that bleaching of the Golgi localized 
material is complete to exclude attenuation of the observed recovery through lateral diffusion of 
unbleached Golgi localized EGFP-Rab1. 
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kC-G for Rab1wt trafficking from cytoplasm to Golgi by FRAP 
After bleaching of EGFP-Rab1 on the Golgi the recovery of fluorescence intensity reached a plateau after 
approximately 200 s at about 50 % of the initial prebleach intensity (Figure 3-50 A). The average apparent 
rate constant for EGFP-Rab1 delivery from the cytoplasm to the Golgi was determined as 
kC-G = (1.6 ± 0.4)·10-2 1/s. The corresponding recovery half-time is t1/2 = 43 s. 
 
Figure 3-50: Recovery curves for EGFP-Rab1wt photobleaching at the Golgi and average kC-G. 
(A) Plot of normalized average EGFP intensity at Golgi ROI during FRAP experiment. Each line represents one bleaching 
experiment. (B) Plot of individual (gray lines) and average (black circles, mean ± s.d.) recovery curves. kC-G was obtained 
as the average of individual kobs values. kobs was determined for each recovery curve by fitting with the monoexponential 
function (Eq. 2-14). 
When performing FRAP experiments, the contribution of newly synthesized protein and photobleaching 
through continuous time-lapse imaging have to be considered. The observed recovery of fluorescence after 
photobleaching could result from protein redistribution of fluorescent protein localized outside the 
bleaching ROI and/or newly protein synthesized in the ROI. By comparing the kinetics of EGFP-Rab1wt 
recovery in untreated and in cells treated with the protein synthesis inhibitor cycloheximide, the effect of 
protein synthesis on the course of fluorescence recovery can be assessed. As can be discerned from the 
obtained recovery curves (Figure 5-22) and the corresponding apparent rate constants 
(kC-G = (1.8 ±0.4)·10-2 1/s), the newly synthesized EGFP-Rab1wt did not affect the fluorescence recovery of 
EGFP-Rab1 after Golgi photobleaching. 
To evaluate the effect of photobleaching during imaging, the FRAP experiment was repeated omitting the 
bleaching step. Over the time course of time-lapse imaging the fluorescence intensity decreased by less 
than 5 % of the initial value (Figure 5-23). Thus, photobleaching during imaging can be neglected. 
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kC-G determined by fluorescence localization after photoactivation (FLAP) 
In a complementary approach kC-G for Rab1 trafficking from the cytoplasm to the Golgi was determined by 
fluorescence localization after photoactivation (FLAP). specific photoactivation of the cytoplasmic Rab1 
fraction,  
The cytoplasmic area of cells expressing paGFP-Rab1 was irradiated at 405 nm. The subsequent increase of 
paGFP-Rab1 fluorescence at the Golgi was then monitored by time-lapse imaging (2.7.3). The course of a 
typical experiment with paGFP-Rab1 photoactivation in the cytoplasm is depicted in Figure 3-51. 
 
Figure 3-51: Photoactivation of paGFP-Rab1wt in the cytoplasm. 
(A) Scheme depicting a typical photoactivation experiment for determining kC-G for cytoplasm to Golgi trafficking. (B) 
Exemplary fluorescence images of a cell expressing paGFP-Rab1wt. Upper panel paGFP-Rab1 fluorescence, lower panel 
overlay with Cherry-Rab1wt. The area selected for irradiation is highlighted (dashed blue). After photoactivation, the 
fluorescence intensity increase at the region of interest (ROI, dashed red line) on the Golgi was followed by time-lapse 
imaging. Scale bar: 10 m.  
After photoactivation the fluorescence intensity on the Golgi membrane increases and reaches a plateau 
upon completed equilibration. After normalization, the course of the intensity increase can be fitted with 
the single exponential equation Eq. 2-14 (2.7.4) yielding the apparent rate constant kobs for Rab1 flux from 
the cytoplasm to the Golgi. 
 tknorm obse1I)t(I    Eq. 2-14 
The apparent rate constant kC-G was obtained as the average of individual fits of at least three 
measurements. An exemplary fluorescence intensity profile for the described photoactivation experiment 
is displayed in Figure 3-52.  
  
3 Results and discussion 
 
-103- 
 
Figure 3-52: Exemplary intensity profile of paGFP-Rab1 at the Golgi following photoactivation in the cytoplasm. 
The graph depicts the course of the average paGFP-Rab1wt intensity at the marked ROI (dashed red line) during a typical 
photoactivation experiment. The fluorescence intensity at the ROI was normalized to the intensity prior to irradiation.  
In contrast to the FRAP experiments, the observed fluorescence increase on the Golgi cannot be distorted 
through lateral diffusion of Golgi residing Rab1 or newly synthesized paGFP-Rab1 as these molecules remain 
“invisible” throughout the experiment. 
kC-G for Rab1wt trafficking from cytoplasm to Golgi by photoactivation 
Photoactivation of paGFP-Rab1wt in the cytoplasm leads to increasing fluorescence on the Golgi organelle 
(Figure 3-53). In agreement with the previous FRAP experiments the intensity reached saturation after 
about 170-180 s following activation. 
 
Figure 3-53: Fluorescence intensity increase at Golgi following photoactivation of paGFP-Rab1wt in the cytoplasm. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation in the cytoplasm. Each line 
represents a single photoactivation experiment. (B) Plot of individual (gray lines) and average (black circles, mean ± s.d.) 
intensity curves. kC-G was obtained as the average of individual kobs values. kobs was determined for each curve by fitting 
with the monoexponential function (Eq. 2-14). 
The average rate of paGFP-Rab1 delivery from the cytoplasm was determined with kC-G = (1.9 ± 0.4)·10-2 1/s 
and a corresponding half-time of t1/2 = 36 s. These values are in good keeping with the rate constant 
obtained via the corresponding FRAP experiment (kC-G, FRAP = (1.6 ±0.4)·10-2 1/s, t1/2 = 43 s).  
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Effect of impaired Rab1 functioning on cytoplasm to Golgi transport kinetics 
Rab1 delivery to the Golgi organelle is mediated by two pathways: a non-vesicular pathway facilitated by 
GDI62,197,212,213 and a vesicular pathway derived from the ER-Golgi transport194,195,214 (Figure 3-54). Both 
pathways contribute to the observed rate constant for Rab1 delivery from the cytoplasm to the Golgi (kC-G). 
 
Figure 3-54: Rab1 trafficking from cytoplasm to Golgi. 
Delivery of Rab1 to the Golgi membrane is mediated by GDI-based transport and vesicular transport. Here, the effect 
of impaired Rab1 deactivation (Rab1Q67L), abolished GDI-binding (Rab1D44N), disrupted vesicular transport 
(nocodazole treatment) and PRA1 knock-down on the kinetics of Rab1 delivery to the Golgi membrane were examined. 
To assess the effect of impaired GTPase functioning on Rab1 trafficking from cytoplasm to Golgi, the FRAP 
and photoactivation experiments were repeated with: (1) the constitutively active Rab1Q67L mutant41,43, 
(2) the GDI-binding deficient mutant Rab1D44N212, (3) after treatment with nocodazole139,140 and (4) in PRA1 
knock-down cells215. The obtained rate constants for cytoplasm to Golgi delivery (kC-G) are summarized in 
Figure 3-55. Furthermore, the relative fluorescence intensity of Rab1 localized to the cytoplasm compared 
to the Golgi was quantified. 
 
Figure 3-55: Summary of obtained rate constants kC-G. 
Summary of the apparent rate constants for cytoplasm to Golgi trafficking for Rab1 wild type, Rab1Q67L, Rab1D44N, 
Rab1 wild type in cells treated with nocodazole and in PRA1 knock-down cells.  
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Inhibition of GTPase cycle suppresses Rab1 delivery to Golgi and leads to accumulation of 
enlarged vesicles  
Rab1 activity is critical for biogenesis and maintenance of a functional Golgi.216 When the ability of Rab1 to 
interact with effector proteins is inhibited, e.g. through TBC1D20 overexpression, dominant-negative 
mutants or Rab1 depletion, the ER to Golgi transport is blocked and the Golgi organelle disintegrates.193,216 
The effects of expressing the predominantly active mutant Rab1Q67L are not as severe. The Golgi organelle 
remains largely intact and ER to Golgi transport is preserved.216 However, the cells display a different 
phenotype than cells expressing wild type Rab1 (Figure 3-56 and Figure 3-57) and the kinetics of Rab1 
delivery from the cytoplasm to the Golgi membrane are significantly slowed (Figure 3-55).  
 
Figure 3-56: Rab1Q67L expression led to increased cytosolic localization and the formation of enlarged vesicles. 
Fluorescence images of HeLa cells expressing (A) EGFP-Rab1wt and (B) EGFP-Rab1Q67L. For (B) two parts of the image 
were enlarged (Box 1 and 2) Vesicular structures are highlighted by white arrows. (C) Ratio of the average EGFP 
fluorescence at Golgi to cytoplasm. Error bars: mean ± s.d. (n=3-7). Two-tailed t-test: ***: p < 0.001. Excitation and 
emission filter settings as described in 2.7.1. Scale bars: 10 m. 
Expression of Rab1Q67L led to the formation of enlarged vesicles in the cytoplasm. Furthermore, the 
relative fluorescence intensity of the cytoplasm compared to the Golgi was significantly increased in 
comparison to cells expressing wild type Rab1 (Figure 3-56). The same observation was made after 
photoactivation of paGFP-Rab1Q67L in the cytoplasm (Figure 3-57). 
Figure 3-57: Following photoactivation of 
paGFP-Rab1Q67L enlarged vesicles in the 
cytoplasm become visible. 
Fluorescence images of HeLa cells 
expressing paGFP-Rab1Q67L after 
photoactivation. Boxed images are 
enlarged in the inset. Insets show vesicular 
structures in the cytoplasm. Excitation and 
emission filter settings as described in 
2.7.1. Scale bars: 10 m. 
 
Rab1Q67L showed a significantly reduced kC-G rate of (1.0 ± 0.4)·10-2 1/s when compared to wild type Rab1 
(kG-C,wt = (1.9 ± 0.4)·10-2 1/s). In the analogous FRAP experiments, kC-G was also reduced with 
kC-G,wt = (1.6 ± 0.4)·10-2 1/s and kC-G,Q67L = (1.1 ± 0.4)·10-2 1/s, respectively.  
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In contrast to its dominant-negative mutant, RabQ67L maintains the ability to interact with its effector 
proteins and thus can drive ER-mediated vesicular transport. Rab1Q67L overexpressing does not interfere 
with Golgi biogenesis, however the reduced kinetics in Rab1 delivery to the Golgi membrane suggest that 
compromised Rab1 deactivation prevents efficient spatial cycling of Rab1. 
The enrichment of enlarged vesicular structures further suggests, that constitutively active Rab1 leads to 
(partially) defective vesicular transport. Rab1 activity at ER exit sites is regulated by its GAP TBC1D20. It is 
plausible to assume that TBC1D20 activity is targeted towards maintaining the local Rab1 activity at a level 
that allows for sufficient assembly of transport vesicles by continuous Rab1 deactivation. Thus, persistent 
Rab1Q67L activity could bypass the regulatory role of TBC1D20 at the ER, leading to the formation of 
vesicles that cannot proceed properly in vesicular transport (Figure 3-58).  
 
Figure 3-58: Model for effect of constitutively active Rab1Q67L on ER to Golgi trafficking. 
Rab1Q67L cannot be effectively deactivated by the ER localized GAP TBC1D20, possibly leading to increased vesicle 
formation at ER exit sites. Due to low affinity of GDI towards GTP-bound Rab1, GDI-mediated transport is abrogated. 
An alternative explanation is that high Rab1 activity leads to continuous recruitment of effector proteins 
and thus initiates vesicle budding at sites that are usually not involved in the formation of transport vesicles.  
Another critical interaction that depends on the nucleotide binding state of the GTPase, is its extraction of 
membrane bound Rab1 through GDI. The affinity of GDI towards Rab proteins is reduced by three orders of 
magnitude between the inactive GDP-bound and active GTP-bound GTPase.63 Thus, constitutively active 
Rab1Q67L cannot be efficiently extracted by GDI and remains attached to membranes. According to these 
findings, delivery of Rab1Q67L to the Golgi should be exclusively mediated by the vesicular transport 
pathway.  
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GDI-binding deficiency leads to slower kinetics of Rab1 delivery to Golgi  
The switch I mutant Rab1D44N is unable to associate with GDI but retains its initial membrane targeting 
through prenylation and interaction with REP (although reduced to about 50 % in comparison to wild type 
Rab1).212,217 Based on the current model of Rab cycling, this inability to be recycled through GDI-mediated 
membrane extraction should result in a “dead end” for Rab1 at the Golgi membrane. 
Here, Rab1D44N delivery to the Golgi membrane was observed after photobleaching at the Golgi membrane 
(Figure 5-27). However, the kinetics were significantly reduced from kC-G = (1.6 ± 0.4)·10-2 1/s for the wild 
type protein to kC-G = (1.0 ± 0.4)·10-2 1/s for Rab1D44N. It can be speculated that the maintained ER to Golgi 
transport can be attributed to endogenous Rab1. It has been suggested in a previous report that continuous 
delivery of newly prenylated Rab1D44N to the ER donor compartment would allow for at least one “round” 
of vesicular delivery.212 The observed rate constant for Rab1D44N delivery is in keeping with that of another 
GDI-binding deficient mutant, Rab1Q67L (kC-G, Q67L ≈ 1·10-2 1/s , Figure 3-55).  
When comparing the Golgi to cytoplasmic localization, EGFP-Rab1D44N is significantly more abundant in 
the cytoplasm than Rab1wt (Figure 3-59). As the cytosol should be completely devoid of any GDI-bound 
Rab1D44N212, the accumulation of EGFP-Rab1D44N in the cytoplasm most likely arises from unprenylated 
species. It should be noted, that D44 is located directly in the Rab-effector interface and it cannot be 
excluded that Rab1D44N interferes with downstream effector binding. However, retained ability to 
facilitate ER to Golgi transport suggests that interaction with effectors crucial for vesicular transport is 
partially maintained. 
 
Figure 3-59: Rab1D44N displays increased cytosolic protein localization. 
Fluorescence images of HeLa cells expressing (A) EGFP-Rab1wt and (B) EGFP-Rab1D44N. (C) Ratio of the average EGFP 
fluorescence at Golgi to cytoplasm. Error bars: mean ± s.d. (n=6-7). Two-tailed t-test: ***: p < 0.001. Excitation and 
emission filter settings as described in 2.7.1. Scale bars: 10 m. 
In paGFP-Rab1D44N transfected cells, activation of the cytoplasm did not lead to a significant increase in 
GFP fluorescence at the Golgi. The fluorescence intensity generated through photoactivation was not 
sufficient to result in a significant increase at the Golgi ROI. This deficiency can be attributed to the abolished 
binding of prenylated Rab1D44N to GDI. Thus, only unprenylated Rab1 that cannot attach to the Golgi 
membrane and a small amount of newly synthesized REP-bound Rab1 are present in the cytoplasm.212  
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Disrupted vesicular transport leads to Golgi fragmentation and slows Rab1 delivery to the Golgi  
To assess the effect of abolished vesicular transport on Rab1 trafficking, Rab1 transfected cells were treated, 
with nocodazole, which prevents microtubule polymerization. Due to interrupted ER to Golgi transport the 
Golgi apparatus disintegrates and ministacks form at the ER exit sites (Figure 3-60).139 These stacks 
continuously exchange Golgi resident enzymes through ER transport. The observed fluorescence recovery 
kinetics after photobleaching were slowed down from kC-G = (1.6-1.9)·10-2 1/s for untreated cells to 
kC-G, FRAP = (0.9 ± 0.3)·10-2 1/s and kC-G, paGFP = (1.2 ± 0.3)·10-2 1/s respectively after nocodazole treatment. This 
indicates that vesicular transport via microtubules plays an important role in Rab1 trafficking towards the 
Golgi organelle. However, it is evident that nocodazole treatment did not completely eliminate incoming 
Golgi traffic. The exchange rate of Golgi resident proteins between peripheral Golgi stacks is to slow (~2 h 
till equilibration)139 to account for the comparably fast fluorescence recovery observed for Rab1 (t1/2 = 70 s). 
The fluorescence recovery can presumably be attributed to GDI-mediated transport. 
Figure 3-60: Nocodazole treatment interferes with 
microtubule polymerization resulting in Golgi 
fragmentation. 
Fluorescence images of HeLa cells expressing EGFP-
Rab1wt (A) before and (B) after nocodazole treatment 
Following nocodazole treatment EGFP-Rab1wt localizes 
to small fragments that are scattered over the cell. 
Excitation and emission filter settings as described in 
2.7.1. Scale bars: 10 m. 
 
 
PRA1 is important for Rab1 delivery to the Golgi 
PRA1 is the human homologue of yeast Yip3, which was the first protein shown to exhibit GDF activity.66 It 
has been hypothesized that PRA1 fulfills a similar role for Rab:GDI complexes. In PRA1 knock-down cells 
Rab1 maintained its Golgi localization (Figure 3-61) and the Golgi to cytoplasm intensity ratio remained 
unchanged. However, the rate of Rab1 delivery to the Golgi was significantly reduced 
(kC-G, FRAP = (0.8 ± 0.2)·10-2 1/s and kC-G, paGFP = (0.7 ± 0.1)·10-2 1/s) in the PRA1 knock-down cells (Figure 5-28 
and Figure 3-55). These findings suggest that PRA1 plays an essential role in Rab1 membrane delivery, 
potentially by acting as a GDF towards the GDI:Rab1 complex. 
Figure 3-61: Rab1wt retains Golgi 
localization in PRA1 knock-down cells. 
Fluorescence images of EGFP-Rab1wt 
expressed in (A) wild type and (B) PRA1 
knock-down HeLa cells. (C) Ratio of the 
average EGFP fluorescence at Golgi to 
cytoplasm. Error bars: mean ± s.d. (n=6-
7). Two-tailed t-test: n.s.: not 
significant. Excitation and emission filter 
settings as described in 2.7.1. Scale 
bars: 10 m. 
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3.2.2 Rab1 trafficking from Golgi to Cytoplasm 
The kinetics of Rab1 trafficking originating from the Golgi were examined through specific activation of 
paGFP-tagged Rab1 localized at the Golgi. After activation through UV irradiation, the depletion of GFP 
fluorescence was monitored by time-lapse imaging. The course of a typical photoactivation experiment is 
depicted below (Figure 3-62). 
 
Figure 3-62: Photoactivation of paGFP-Rab1wt at the Golgi. 
(A) Scheme depicting a typical photoactivation experiment for determining kG-C. (B) Exemplary fluorescence images of 
a cell expressing paGFP-Rab1wt and the Golgi marker mKate2-giantin. Upper panel paGFP-Rab1 fluorescence, lower 
panel overlay with mKate2-giantin. The area selected for irradiation is highlighted (dashed blue). After photoactivation 
the fluorescence intensity decrease at the Golgi membrane was followed by time-lapse imaging. Scale bar: 10 m.  
After photoactivation the initial fluorescence intensity in the Golgi decreases over time while the 
fluorescence in the cytoplasm increases. The gradual fluorescence depletion can be fitted with the single 
exponential function Eq. 2-17 to obtain the apparent rate constant kobs for Rab1 departing from the Golgi. 
tk
norm
obseAI)t(I    Eq. 2-17 
Here Inorm is the fluorescence intensity at time t, I is the fluorescence intensity reached after completed 
equilibration and kobs is the observed rate constant. kG-C for Golgi derived Rab1 trafficking was obtained as 
the average of individual fits of data from at least three recovery experiments. A representative 
fluorescence intensity profile obtained for the described photoactivation experiment is depicted in Figure 
3-63. 
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Figure 3-63: Exemplary intensity profile of paGFP-Rab1 at the Golgi after photoactivation. 
The graph depicts the course of the average pGFP-Rab1wt intensity at the marked ROI (dashed red line) after a typical 
photoactivation experiment. The fluorescence intensity at the ROI was normalized to the intensity prior to irradiation.  
Rab1wt 
For wild type EGFP-Rab1 the following fluorescence profiles (Figure 3-64) with an average rate constant 
kG-C= (0.3 ± 0.1)·10-2 1/s were obtained. As anticipated, the depletion rate of Rab1 is significantly lower than 
the rate of Rab1 delivery to the Golgi (kG-C ≈ 1.5-2.0·10-2 1/s). This surplus of Rab1 influx leads to the 
seemingly stationary localization of Rab1 at the Golgi membrane in the steady state. However, the 
previously described findings indicating rapid Rab1 influx and the continuous depletion of Rab1 from the 
Golgi underscore the highly dynamic nature of Rab1 trafficking. 
 
Figure 3-64: Fluorescence intensity decrease at Golgi following photoactivation of paGFP-Rab1wt. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation. Each line represents a single 
photoactivation experiment. (B) Plot of individual (gray lines) and average (black circles, mean ± s.d.) intensity curves. 
kC-G was obtained as the average of individual kobs values. kobs was determined for each curve by fitting with the 
monoexponential function (Eq. 2-14).  
No increase in paGFP fluorescence could be observed in the control experiment lacking the activation step, 
thereby ruling out unintended activation of paGFP through light exposure during imaging (Figure 5-24).  
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Effect of impaired Rab1 functioning on transport exiting the Golgi 
The effect of impaired GTPase functioning on Rab1 trafficking originating from the Golgi was assessed by 
FLAP experiments utilizing: (1) the constitutively active Rab1Q67L mutant41,43, (2) the GDI-binding deficient 
mutant Rab1D44N212, (3) after treatment with nocodazole139,140 and (4) in PRA1 knock-down cells215. The 
obtained rate constants for Rab1 traffic exiting the Golgi, kG-C are summarized in Figure 3-65. 
 
Figure 3-65: Summary of obtained kG-C. 
Summary of the apparent rate constants for Golgi to cytoplasm trafficking for Rab1 wild type, Rab1Q67L, Rab1D44N, 
Rab1 wild type in cells treated with nocodazole and in PRA1 knock-down cells. 
Trafficking from the Golgi is significantly accelerated for Rab1Q67L 
For the dominant-active Q67L mutant the kG-C was significantly increased (0.6 ± 0.1)·10-2 1/s in comparison 
to Rab1wt (kG-C = (0.27 ± 0.1)·10-2 1/s) (Figure 5-32) and large vesicular structures enrich in the cytoplasm 
(Figure 3-56 and Figure 3-57). Rab1 recycling from the Golgi is believed to be largely governed by GDI-
mediated transport. GDI-mediated membrane extraction/transport is expected to be impeded due to 
Rab1Q67L being constitutively active. Possibly, the rate increase in trafficking exiting the Golgi can be 
attributed to a shift from (slower) GDI-governed Rab1 recycling to a higher percentage of membrane 
derived-vesicular transport from the Golgi. As speculated earlier, high Rab1 activity could lead to the 
formation of transport vesicles at sites that are usually not destined for Rab1 mediated vesicular budding. 
Thus, the observed increase might be attributed to a rise in Golgi-derived vesicular trafficking.  
Disrupted vesicular transport does not change kinetics of Rab1 trafficking out of the Golgi  
The observed rate constant for paGFP-Rab1 depletion from the Golgi after nocodazole treatment 
kC-G = (0.26 ± 0.1)·10-2 1/s is nearly identical to untreated cells (Figure 3-65). Presumably, the retained 
outgoing Rab1 trafficking can be attributed to GDI-mediated transport.  
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GDI-binding deficiency - Rab1D44N 
The GDI-binding deficient Rab1 mutant D44N, displays similar kinetics for Rab1 trafficking departing from 
the Golgi (kG-C = (0.24 ± 0.07)·10-2 1/s) as wild type Rab1 kG-C = (0.27 ± 0.1)·10-2 1/s (Figure 5-34). To date, 
Rab1 recycling after completed transport has been generally attributed to GDI-mediated transport. As GDI-
binding is abolished through the D44N mutation, Rab1 exiting then Golgi membrane should only be possible 
through membrane dependent trafficking.  
Indeed, vesicular and tubular structures originating from the Golgi membrane are observed exiting the Golgi 
after photoactivation. Similar observations were made for wild type Rab1, indicating that Golgi derived 
membrane-associated Rab1 transport is not limited to the GDI-binding deficient mutant. In combination 
with the increased kG-C for the Q67L mutant these findings suggest that membrane derived transport has to 
be considered as a crucial contributor for Rab1 traffic departing from the Golgi organelle.  
Possibly, these polymorphic tubular structures represent ER-Golgi intermediate compartments (ERGIC), also 
referred to as vesicular tubular clusters (VTCs). Generally, VTCs are believed to form through fusion of newly 
budded COPII vesicles. They are involved in the anterograde ER to the Golgi transport and the retrograde 
recycling transport pathways.218,219 VTCs mature through recycling and recruitment of specific proteins and 
the exchange of COPII for the COPI coat complex.138,220 This implicates Rab1 involvement in the retrograde 
transport and could explain depletion from the Golgi organelle independent of GDI-mediated transport. 
 
Figure 3-66: Tubular and vesicular structures exiting the Golgi after photoactivation. 
Fluorescence images of HeLa cells expressing (A) EGFP-Rab1wt and (B) EGFP-Rab1D44N. White arrows indicate tubular 
structures exiting the Golgi during time-lapse imaging. Excitation and emission filter settings as described in 2.7.1. Scale 
bars: 5 m. 
PRA1 is not essential for Rab1 trafficking from the Golgi 
The kinetics of Rab1 trafficking from the Golgi are not significantly altered in PRA1 knock-down cells with 
kC-G = (0.31 ± 0.03)·10-2 1/s (Figure 5-35). This suggests that, the proposed GDF activity of PRA1 regulates the 
delivery of Rab1 to the Golgi membrane. e.g. by assisting in the release of Rab1 from the GTPase:GDI 
complex, but not the retrieval of Rab1 from the Golgi.  
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3.2.3 GTPase cycle drives Rab1 spatial cycle 
Based on the current model of Rab-regulated vesicular transport, Rab1 trafficking should occur via two 
distinct pathways: vesicular trafficking between the ER and the Golgi, driven by membrane-associated 
Rab1194,216 and membrane-independent transport mediated by GDI196,213. GDI-mediated trafficking is 
believed to enable recycling of Rab1 from membranes to the cytosol. Recycling to the ER is necessary to 
facilitate multiple rounds of Rab1 regulated ER to Golgi transport.212 Both trafficking pathways are governed 
by the nucleotide state of the GTPase. GDI only binds to the inactive, GDP-bound GTPase with high affinity63, 
while vesicular ER to Golgi transport strongly depends on activated, GTP-bound Rab1. Rab1 activation is 
required to recruit and interact with effector proteins that are critically involved in the successive transport 
steps.214,216 Thus, the GTPase’s ability to switch between its two nucleotide states is crucial to proceed 
through all steps of its spatial cycle. Furthermore, the importance of the inherent switching ability of 
GTPases for initial membrane targeting has been demonstrated in experiments using Rab5 covalently locked 
in its active or inactive state.55 
Overall, the performed FRAP and FLAP experiments underscore the highly dynamic nature of Rab1 
trafficking between the Golgi and the cytoplasm. The rate for Rab1 delivery onto the Golgi is about 5-6-fold 
higher than for Rab1 traffic departing the Golgi and leads to the observed enrichment of Rab1 at the Golgi 
organelle (Figure 3-67). The high turnover of Rab1 molecules localized at the Golgi, suggests that Rab1 
molecules undergo multiple rounds of ER to Golgi transport. This is further supported by the unchanged 
cycling kinetics and maintained Golgi structure in cells treated with the protein synthesis inhibitor 
cycloheximide (Figure 5-22). 
Overexpression of GTPase cycling deficient mutants of Rab1, e.g. the constitutively active Rab1Q67L or 
dominant-negative Rab1N121I, severely impacts ER to Golgi transport and Rab1’ spatial cycling. 
Overexpression of Rab1N121I leads to abrogated Golgi biogenesis216,221, while Rab1Q67L expression results 
in the formation of enlarged vesicular structures in the cytoplasm (Figure 3-57). More specifically, 
Rab1N121I expression has been shown to arrest VSV G transport at ER exit sites and leads to Golgi 
“fragmentation”.216 The scattered Golgi arises from abolished vesicular transport between ER and Golgi, 
resulting in the formation of Golgi ministacks at ER exit sites. In accordance with the hypothesis that 
defective Rab1 activation leads to arrested ER- to Golgi-transport, the same phenotype is observed when 
Rab1 is depleted by siRNA or the negative Rab1 regulator TBC1D20, a ER-associated GAP, is 
overexpressed.216 Fragmentation of the Golgi organelle is also observed when cells are treated with 
nocodazole, an inhibitor of microtubule polymerization (Figure 3-60).139  
The effect of the Rab1Q67L mutant is less severe, as the overall Golgi structure remains intact and ER to 
Golgi transport is sustained.216 Presumably, this can be attributed to RabQ67L’s maintained ability to bind 
effector proteins that drive ER-mediated vesicular transport. However, the rate for Rab1 delivery to the 
Golgi is significantly slowed (Figure 3-55) and large vesicular structures enrich in the cytoplasm (Figure 3-57). 
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This suggest that compromised Rab1 deactivation inhibits efficient spatial cycling of Rab1, e.g. by preventing 
recycling to the ER through GDI-mediated transport.  
It can be argued, that the Rab1Q67L mutant primarily undergoes transport via the vesicular pathway, as 
GTP-bound Rab1 has a substantially lower affinity towards GDI than GDP-bound Rab1.63 Similarly, Rab1 
trafficking observed in the FRAP and FLAP experiments in the presence of nocodazole, should be largely 
derived from GDI-mediated transport, as microtubule-dependent vesicular transport is abrogated under 
these conditions (Figure 3-67). 
 
Figure 3-67: Summary of Rab1 trafficking rates between Cytoplasm and Golgi. 
Summary of the obtained rate constants for Rab1 delivery from the cytoplasm to the Golgi (kC-G), as determined by FRAP 
and FLAP experiments. The opposed direction trafficking from Golgi to cytoplasm (kG-C), was assessed by photoactivation 
of paGFP-Rab1 at the Golgi, followed by time-lapse imaging to monitor the subsequent fluorescence decrease. Rab1 
trafficking is believed to occur via two key pathways, GDI-mediated transport and vesicular transport. Rates obtained 
in cells previously treated with nocodazole, should be devoid of microtubule dependent transport, limiting Rab1 
trafficking to transport via the GDI association. The constitutively active Rab1Q67L mutant should be restricted to 
membrane derived trafficking, as the GTP-bound GTPase possesses a relatively low affinity towards GDI binding. 
The crucial role of the GDI-bound Rab1 pool has been demonstrated in a previous report.196 Addition of 
Rab1:GDI to cells whose cytosol has been depleted of Rab1, restores the cell’s ability for ER to Golgi 
transport. Interestingly, addition of excess GDI has been shown to disrupt Rab1-mediated ER to Golgi 
transport by extracting Rab1 from membranes, trapping the protein in the cytosol.196 This suggests that the 
amount of available GDI in the cytosol is limited, preventing exuberant retrieval of Rab1 from membranes. 
Here, the comparable rate for Rab1 trafficking out of the Golgi for untreated cells and cells treated with 
nocodazole, is in keeping with the assumption that Rab1 recycling from the Golgi membrane is primarily 
mediated by GDI (Figure 3-67). In contrast, the rate for Rab1Q67L trafficking from the Golgi to the cytoplasm 
is about 2-fold higher than observed for wild type Rab1.  
For the Q67L mutant, the rate for Rab1 delivery towards the Golgi is significantly lower than for wild type 
Rab1. This decrease can potentially be attributed to the impeded ability of the constitutively active Rab1 to 
be recycled by GDI. Moreover, Rab1Q67L is not subject to regulation by GEFs and GAPs, disrupting its 
GTPase cycle, which is essential for efficient spatial cycling between cellular compartments. 
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4 Final discussion and perspectives 
For each scientific question the suitable tools and the right experimental setup have to be chosen. In this 
regard, each method features a unique combination of advantages and limitations that have to match the 
demands of the particular problem that needs solving. As the relevant questions become more complex and 
challenging, the arsenal of tools scientists have to their disposal has to be expanded and fitted accordingly.  
4.1 Advantages and limitations of the new sensor design 
When examining processes that require spatiotemporal resolution, the combination of fluorescence 
microscopy with FRET- or ratiometric based biosensors has proven to be especially valuable. Due to their 
key role in highly dynamic processes, GTPases have been a popular target for the development of 
biosensors. This led to the evolution of a wide range of different sensor approaches. Depending on their 
specific design, each sensor exhibits certain strengths and weaknesses as discussed in the introduction (1.3). 
The sensor design described in this thesis was developed to address some of the weaknesses of established 
sensor to allow further insight into the principles underlying GTPase functioning. Its benefits and drawbacks 
are discussed below in comparison to other established approaches.  
The distinct feature of the novel FRET probe reported in this thesis is the combination of a fluorescent 
protein with a small organic dye that is introduced directly in the GTPase fold. This unique setup allows a 
direct read out of the intrinsic conformational change upon nucleotide exchange. A detailed description of 
the architecture of the sensor design can be found in section 3.1.1. 
4.1.1 Effector-free sensing 
Most GTPase sensors reported to date rely on an indirect signal read out generated through binding of an 
engineered effector domain to the activated, GTP-bound GTPase. This is an elegant approach as it employs 
the effectors ability to differentiate between the two nucleotide states. However, this methodology is 
severely limited, as it can only be used for small GTPases where suitable effector domains are available. This 
is a rather substantial constraint as for some GTPases there are only few, if any, effectors known.84 Once 
identified, these domains have to be optimized for suitable affinity151,222,223 and dynamic range157 to work 
as efficient reporters. In contrast, the new sensor design reported here does not require the identification 
and optimization of a suitable effector affinity tag. It utilizes the conformational change within the protein-
fold as a direct indicator for GTPase activation.  
The most minimalistic GTPase sensor approaches, rely on engineered effector domains that are fused to 
fluorescent proteins and specifically translocate to regions of increased GTPase activity.224,225 A drawback 
of this bimolecular sensor methodology can arise from promiscuous binding of effector domains to multiple 
GTPases.144,226,227 While this specificity problem can be addressed by more sophisticated bi- and 
unimolecular FRET sensors, other weaknesses are inherent to the use of effector-based affinity tags. 
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One crucial drawback is that upon activation the affinity tag binds to the GTPase-effector interface, 
essentially blocking it from interaction with other binding partners. This can potentially affect downstream 
and upstream GTPase functioning and result in aberrant in vivo signaling. Especially interference with 
binding of upstream regulatory proteins such as GEFs, GAPs and solubilization factors is potentially 
problematic for proper GTPases functioning. Preservation of upstream regulation is crucial as it directly 
affects the GTPase activity that is being monitored. For instance, tightly bound effector domains compete 
with GDI binding and the deactivation through GAP proteins, leading to a high overall activation, thereby 
reducing the sensors dynamic range or slowing the signal decay after stimulated activation222. 
The risk of obstructing the GTPases interaction interface is greatly reduced by the sensor developed in 
course of this thesis. The perturbation of upstream regulation and downstream signaling is minimal. This 
claim is fully supported by the in vitro assays, demonstrating preserved regulation of multiple Rab1 and KRas 
sensor constructs by their GEFs and GAPs, as well as retained binding of the Rab1 sensors to two effector 
proteins (3.1.4-3.1.13). 
4.1.2 In vitro characterization 
A majority of FRET-based GTPase biosensors utilize a pair of fluorescent proteins in a single chain construct. 
While this allows direct genetic encoding and reliable FRET analysis, it also leads to rather large proteins 
(>90 kDa) that cannot be readily purified easily for in vitro characterization. In these cases, the sensor 
performance is evaluated primarily based on cellular assays through co expression with regulatory partners 
(e.g. GEFs and GAPs) or by using mutants that are constitutively active or nucleotide binding deficient.157,160 
Using these assays, the sensors performance can be evaluated regarding its dynamic range and these assays 
can give an indication on the GTPase sensor’s ability to be regulated by its native interaction partners. 
However, it is not possible to assess the kinetics of these interactions. Yet, kinetic parameters are decisive 
for tight spatiotemporal control as it is observed for GTPase functioning. A more thorough and quantitative 
assessment of how the implemented modifications affect the interaction between GTPases and their 
various regulatory partners is possible through in vitro fluorescence measurement.  
Here lies one of the major advantages of the sensor described in this thesis. The use of a small organic dye 
as one of the FRET partners minimizes sensor size while preserving the advantages of an unimolecular 
sensor construct. This allows for simple in vitro purification and subsequent quantitative assessment of the 
protein-protein interactions that are crucial for GTPase functioning. Still, it should be kept in mind, that in 
vitro characterization of isolated proteins and their interactions suffers from its own drawbacks. In 
particular, membrane attachment and compartmentalization can result in profound changes of protein 
behavior, which is the case for membrane associated protein such as small GTPases.228 Moreover, protein 
purification can be a tedious process in comparison to direct expression of genetically encoded sensor 
constructs in cells. In vitro characterization might not be practical for all protein targets, especially if post-
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translational modifications are essential for the protein-protein interactions. However, if feasible, direct and 
specific assessment in a well-defined setup is particularly useful when modifications can lead to functional 
defects. The cause of these deficiencies can then be identified more easily by systematically dissected the 
numerous interactions that are involved in GTPases signaling.  
Regulation by GEFs and GAPs 
Since the described FRET sensor design requires a modification within the protein fold, it is especially 
important to ensure that the GTPases retain their native fold and ability to be governed by upstream 
regulators and to bind to downstream effectors. Consequently, the sensors for Rab1 and KRas were 
examined regarding their sensitivity towards GEF-mediated nucleotide exchange and GAP-induced GTP 
hydrolysis (3.1.4/3.1.5 and 3.1.11/3.1.12). In addition, binding of two effector domains to the Rab1 sensor 
was quantified (3.1.6). In the case, of Rab1 the observed catalytic efficiencies are in keeping with the values 
observed for the wild type protein, suggesting that the modifications do not affect the function of the 
switch I or interswitch region, respectively. In contrast, the KRas mutants (E31C and D33C) (Table 3-6) and 
to an even greater extent the acceptor dye labeled constructs (Table 3-7), displayed a significant reduction 
in the catalytic efficiency for SOS-mediated nucleotide exchange. A similar decrease was detected for GAP-
induced GTP hydrolysis by RasGAP (Figure 5-20). Activation and deactivation were not completely abolished 
but severely slowed. These subtle deficiencies would likely go unnoticed in cell based assays, where elevated 
expression of the respective GEFs and GAPs can overcompensate the described effect, leading to uniformly 
activated/deactivated sensor population.  
Interestingly, the KRas sensor did not exhibit delayed KRas activation in response to EGF stimulation in 
microinjected cells (3.1.13). In agreement with previous reports, the increase in lifetime, correlating to KRas 
activation, is observed immediately after EGF addition (Figure 3-45) and reaches its maximum at around 
5 min.211 This indicates that the reduction in efficiency for GEF and GAP regulation observed in vitro, does 
not result in perceivable changes in sensor response in vivo. It can be speculated that this lack of response 
delay can be attributed to the mechanism of EGF-induced KRas activation. It is conceivable, that the 
reduction in GEF-mediated nucleotide exchange is minor in comparison to the increase in GTPase-GEF 
interaction following the EGF induced SOS-translocation to the plasma membrane. Another explanation 
could be that along with the GEF mediated-activation, RasGAP-governed deactivation is impaired. As these 
effects would neutralize each other, no net change in EGF-induced Ras activation kinetics would be 
observed. For other small GTPases the detected reduction in activation and deactivation kinetics might 
constitute a severe obstacle for proper GTPase functioning. 
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Effector binding 
A major benefit of this new effector domain-free sensor is the retained ability to bind to endogenous 
effector proteins. While competition with endogenous effector binding in itself does not constitute a 
detriment, native interaction with downstream effector is preferable to observe native GTPase 
functioning.160 The obtained dissociation constants are in excellent agreement with previous reports and 
suggest that the Rab1 sensor is accessible for effector binding in vivo.184,187 Available structural data of Rab-
effector and KRas-effector complexes (Figure 3-21), further support this notion. As described in 3.1.6, the 
Rab1 FRET sensor constructs display remarkable changes in FRET efficiency upon effector binding. While 
this is an interesting finding, that allows for a convenient read out for the binding of effector domains 
through fluorescence titration, it also complicates the interpretation of the FRET signal if the GTPase can 
interact with multiple partners.  
This unexpected sensitivity towards effector binding can pose a problem for the interpretation of the FRET 
signal especially in complex environments such as in vivo measurements. In cells, the GTPase is likely present 
in different states of activation and bound to diverse effector proteins, if these interactions result in 
conflicting FRET responses it can be hard to distinguish the exact cause for an observed signal. Taking this 
caveat into consideration, the following conclusions can be made from the in vitro results.  
The rapid transitional interaction between the GTPases and their GEFs and GAPs did not result in changes 
in the FRET signal when monitored by sensitized emission (Figure 3-11, Figure 3-15, Figure 3-38 and Figure 
3-41). These interactions should therefore not interfere with the signal interpretation in a system with more 
than one possible interaction partner. In contrast, effector domain binding resulted in a robust decrease in 
FRET efficiency in all cases, regardless of the labeling position or which effector domain was used. With a 
notable exception of the T34C construct binding to the OCRL effector domain (Table 3-5). Probably, binding 
of effectors, regardless of the exact binding mode, exerts the same effect on FRET efficiency by pushing the 
N-terminal fluorescent protein away from the acceptor side, leading to an increased relative distance or an 
unfavorable orientation of the fluorophore dipoles (1.2.1). This assumption is supported by the more 
pronounced drop in FRET efficiency upon binding of the LidA effector domain (20-30 %) in comparison to 
OCRL binding (∼10 %). LidA features an exceptionally large GTPase-effector interface184 and it is plausible 
to assume that this extensive interaction leads to a marked distortion of the N-terminal fluorescent protein. 
Intriguingly, this consistent drop in FRET signal upon effector binding can be used to enhance the dynamic 
range of the FRET sensor signal upon GTPase activation. When choosing a sensor construct that displays a 
drop in FRET efficiency upon GTP binding, subsequent effector binding will enhance the observed FRET 
signal decrease further.  
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Binding to solubilization factors and membrane attachment 
Two key aspects of GTPase regulation that have not been addressed in the in vitro experiments, are the 
binding to solubilization factors such as GDI196 and PDE229 and the effect of membrane attachment. As both 
these interactions are mediated by posttranslational modifications, two geranylgeranyl moieties in case of 
Rab1 and a farnesyl moiety in case of KRas, in vitro reconstitution of this feature is challenging. While 
different approaches for the generation of Rab and Ras proteins with their corresponding C-terminal 
prenylanchors have been reported, ranging from semisynthetic230,231 and in vitro prenylation232 strategies 
to baculovirus-based insect cell expression systems233-235, they cannot easily be applied to the FRET sensor 
construct described here, as the prenylation would have to follow the initial acceptor dye labeling and the 
introduction of the C-terminal amino acids through NCL. Furthermore, these highly lipophilic modifications 
would lead to increasingly insoluble constructs that require the use of detergents, blocking the GTPase from 
direct interaction with solubilization factors and lipid membranes. 
A promising strategy to overcome these issues could be to use the Rab-REP interaction as a surrogate for 
GDI binding. GDI and REP are structurally alike and their interaction mode with Rab proteins is very similar 
(Figure 4-1). In contrast to GDI that requires the C-terminal prenyl-modification for tight binding, REP binds 
prenylated and unprenylated Rab proteins with high affinity.62,236 This approach could give a good indication 
if the Rab1-GDI interaction remains intact and what effect binding to the solubilization factors has on the 
FRET signal.  
 
Figure 4-1: Interaction of YPT1 with GDI (PDB ID:2BCG) and Rab7 with REP-1 (PDB ID:1VG0). 
YPT1 and Rab7 structures are shown in cartoon representation (gray), the structures of (A) GDI and (B) REP-1 are 
displayed as surface representations (beige). The N-terminus of the Rab proteins is highlighted and labeled in yellow. 
The switch I and II regions are colored in red and orange respectively. The P-loop is marked in green. The corresponding 
acceptor labeling sites in switch I and II are highlighted in turquoise. 
It can be speculated that binding to REP and GDI could exert a similar effect on the FRET signal as effector 
binding as this interaction should persist over a similar timescale and is not transient as it is for GEFs and 
GAPs. Yet, the available complex structures of YPT1:GDI and Rab7:REP-1 indicate that in this case the N-
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terminus of the GTPase is located distal to the interaction interface (Figure 4-1). This suggests that the N-
terminally attached fluorescent protein position should not be distorted through binding of the 
solubilization factors. Furthermore, the interactions with the switch I region of the GTPases are limited to 
residues downstream from the acceptor labeling sites. Thus, binding to GDI or REP should not result in major 
changes of the acceptor dye environment and orientation. This notion is further supported by the in vivo 
measurement conducted in this thesis (3.1.9). As a general observation, the in vivo lifetimes, that include 
the interaction with aforementioned REP and GDI, of GDP and GTP-bound FRET sensor (GDP = 1.88 ± 0.08 
ns and GTP = 2.05 ± 0.03 ns, 3.1.9) are consistent with the lifetimes observed for immobilized sensor on Ni-
NTA beads (GDP = 1.81 ± 0.04 andGTP = 1.98 ± 0.05, Figure 3-24). 
Immobilization on Ni-NTA beads 
Another benefit of in vitro purified sensor constructs is the possibility of immobilizing the FRET sensor on 
beads by their affinity tag. Immobilization generates probes with a high local concentration, that allow for 
a robust signal with minimal expense of protein. The high signal intensity facilitates convenient FRET read 
out by lifetime microscopy. In contrast to cell based formats, this bead-based setup generates a uniform 
sensor population in a highly controlled setting. Possible interacting partners can be applied simultaneously 
or subsequently and at predetermined concentrations. Thus, the sensor loaded beads provide a practical 
basis for screening approaches to identifying GTPase interaction partners237 or inhibitors of GTPase 
activation238. 
Another interesting application lies in the systematic mapping of signaling networks as recently described 
for HRas.239 In this report by Coyle et. al., the read out is generated through the recruitment of a 
fluorescently labeled effector domain to immobilized HRas on Ni-NTA beads upon GEF-mediated activation. 
While this is a serviceable approach to quantify the output of (competing) GEF and GAP regulation, it is 
limited when analyzing effector binding, as the reporter domain competes with the downstream effector 
binding. As effector-domain free sensing constitutes one of the major advances of the FRET design reported 
here it should be a valuable tool to address this particular aspect of GTPase signaling. 
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4.1.3 In vivo application 
Sensor delivery into cells 
A major challenge of the FRET sensor design in this work, that limits widespread in vivo application is the 
necessity to introduce the sensor into cells after in vitro purification and acceptor dye labeling. Here 
microinjection was used, a laborious method that requires specialized equipment and can only produce a 
limited number of cells for live cell imaging. Furthermore, the final sensor concentration cannot be 
effectively controlled using microinjection. It has been shown for an RhoA activation sensors, that 
overexpression can saturate the pool of available endogenous RhoGDI.153 This led to a high overall activation 
in cellular assays, due to accumulation of the sensor at the plasma membrane where it was then activated 
through interaction with GEFs. In this case, the problem was solved by reducing the biosensor concentration 
through an optimized expression system for live cell imaging.  
An indication for retained wild type like behavior is the subcellular localization observed for the GTPases 
probes in cells. As expected, Rab1 localized predominantly to the Golgi193 and KRas to the plasma 
membrane207 (3.1.8 and 3.1.13).  
Recently, new methods for efficient delivery of proteins into living cells have been reported that could 
alleviate these methodical limitations. Especially electroporation240 and cell squeezing241,242 emerge as 
powerful methods for high-throughput delivery of proteins into cells at defined concentrations.  
An alternative, more elaborate, methodology could be based on incorporation of unnatural amino acids 
through amber codon suppression243 in combination with biorthogonal in vivo labeling. This would allow for 
a purely genetically encoded sensor. After sensor expression under supplement of the unnatural amino acid, 
acceptor labeling could be accomplished in vivo by biorthogonal labeling techniques244 such as strain 
promoted azide-alkyne cycloaddition using p-azido-phenylalanine245 or Diels-Alder cycloaddition between 
Bicyclononyne lysine and tetrazine-tagged dyes246.  
Sensor localization in cells 
In order to observe natural protein behavior, a biosensor should co-localize with the endogenous protein. 
This holds particularly true for small GTPases where localization to specific membranes constitutes a crucial 
part of their functioning.1,4  
One of the first GTPase sensor designs, termed Ras and interacting protein chimaeric unit (Raichu) sensors, 
was established by Matsuda et.al. for HRas and Rap1.149 Later this approach was applied to numerous other 
small GTPases such as Rab5156 and multiple members of the Rho family151,152. The Raichu scaffold 
sandwiches the GTPase and the corresponding affinity tag between the donor and acceptor fluorophore to 
achieve maximal conformation change upon GTPase activation. As a consequence, both GTPase termini are 
blocked by the flanking domains. Obstruction of the protein termini is problematic as for most GTPases they 
are crucial for interaction with regulatory partners (such as GDIs) or mediate (reversible) membrane 
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attachment. Initially, this problem was addressed by fusing the KRas localization signal to the C-terminal 
fluorescent protein.247 The CAAX motif anchors the sensor to the plasma membrane but does not allow for 
native interaction with regulatory partners such as GDI. These artificial localization signals can target sensors 
to only a few of the various small GTPase dominions and often do not account for reversible membrane 
association. Another approach is to remove the localization signal altogether leading to cytosolic sensor 
constructs.161 It should be noted that it is not exclusively the C-terminus that mediates membrane 
association. In case of Arf6, intracellular membrane localization is mediated by a myristoylation at the N-
terminal protein end.22 Thus, the sensor approaches had to be adjusted to allow for an unmodified N-
terminus to preserve native protein localization.248,249 These examples, illustrate the restrictions that tight 
regulation by multiple interaction partners and defined subcellular localization pose on the design of small 
GTPase sensors. It also further underscores the demand for diverse and flexible sensor strategies that have 
minimal effect on native protein functioning. 
In comparison, the sensor described in course of this thesis requires only one fluorescent protein to be 
appended to the GTPase and not multiple domains (e.g. affinity tags and/or a second fluorescent protein). 
As described before, Rab1 and KRas membrane localization is in part mediated through prenylation of 
cysteine residues at their C-termini.60,207 For KRas an additional polybasic sequence located near the 
prenylated carboxyl-terminal end is required for its native localization at the plasma membrane. Thus, 
conservation of the GTPases C-terminal end was a primary objective throughout the development of the 
FRET sensor. Consequently, the fluorescent protein acting as the FRET donor, was attached at the proteins 
N-terminus. Using this strategy, the C-terminus remains unmodified and accessible for posttranslational 
modification and regulation through GDI196 and PDE229 respectively. However, to facilitate site-specific and 
uniform labeling through thiol reactive maleimide-based chemistry, all reactive surface exposed cysteines 
had to be removed. This includes the prenylatable C-terminal double cysteine motive of Rab1 and the CAAX 
motif required for KRas localization. Cysteine labeling was selected, due to its easy implementation, a 
plethora of commercially available probes and the ease of introducing new modification sites. To enable 
thiol reactive labeling while retaining native protein localization in the cellular context, the GTPases where 
C-terminally truncated and purified as a C-terminal thioester. Native chemical ligation allowed 
reconstitution of the C-terminus after in vitro acceptor labeling (2.4.3). One has to bear in mind that, NCL 
requires an additional ligation step and multiple buffer changes, that significantly reduced sensor yield. 
While, thioesters are susceptible to degradation to the non-reactive carboxylic acid, substantial degradation 
was excluded through ESI-MS analysis of the ligation product (3.1.3 and 0). Yet, even small amounts of 
unprenylatable sensor would diminish the sensors sensitivity in vivo. A C-terminal deficient sensor construct 
would be excluded from the GTPase activation cycle leading to an overall inactive sensor fraction (Figure 
3-29). This could potentially lead to a smaller overall change in FRET signal. 
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FLIM-FRET for in vivo imaging 
Another advantage of the new sensor design is that it allows for easy in vivo FRET quantification by lifetime 
microscopy.  
Because of its compatibility with conventional microscopy setups, sensitized emission remains one of the 
most popular approaches for imaging small GTPase FRET sensors in cells.157,159,250,251 When using sensitized 
emission, the FRET efficiency is determined from the ratio of acceptor to donor emission while specifically 
exciting the donor fluorophore population. A drawback of this approach is the potential signal 
contamination by spectral bleed through and cross-talk that require image corrections and the collection of 
several reference images.130 In case of bimolecular sensors, the relative concentration of the two 
fluorescently-tagged components has to be considered as well. This is especially important when bearing in 
mind the distinct subcellular localization of many small GTPases in comparison to the often cytosolic, 
unspecific localization of the engineered effector domains.  
Fluorescence lifetime imaging in contrast, allows for a more reliable FRET analysis as it only depends on the 
donor fluorophore signal. When using FLIM-FRET, the energy transfer efficiency is determined from the 
decay curve of the excited donor fluorophore population and therefore independent from acceptor 
crosstalk and probe concentration. One caveat of this method is the relatively high signal intensity required 
for reliable lifetime analysis, which can require increased sensor concentrations or prolonged exposure 
during imaging.130 However, due to its superior properties for accurate and reliable FRET quantification and 
improved accessibility through commercially available microscopy setups, FLIM-FRET is becoming 
increasingly popular for monitoring GTPase activity in live cells.210,222,252 
It should be noted that not every FRET pair is suitable for lifetime imaging. The donor fluorophore should 
be largely insensitive to its microenvironment to exclude signal artifacts through differences in local pH or 
salt concentration. This criterion strongly favors fluorescent proteins in comparison to organic dyes as their 
chromophore is shielded from its surrounding through the ß-barrel structure.253 Furthermore, the donor 
fluorophore should undergo single-exponential decay to allow for a reliable quantification of the FRET 
efficiency.171,192 
4.1.4 Sensor optimization and consideration 
Optimization is a central aspect of biosensor development. For unimolecular GTPase sensors that utilize an 
intramolecular fluorescent protein FRET pair, the starting point for optimization is shuffling of the relative 
positions of the different sensor domains to identify the most reliable and sensitive combination.254 The 
original Raichu-scaffold149 for instance has been altered multiple times to accommodate for an unmodified 
C-terminus or to identify the optimal positioning for a specific GTPase-effector domain pair251. Other 
possibilities to improve the dynamic range and sensitivity of a FRET sensor, include varied linker length and 
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flexibility159,160, modification of the spectral properties of the employed fluorescent proteins255,256 or their 
relative dipole orientation through circular permutation257,258.  
In light of these strategies, the rationales behind certain aspects of the reported sensor design and potential 
avenues for further improvement are discussed below. 
Fluorescent proteins as donor fluorophores 
The main reasons for choosing EGFP and mCitrine as the donor fluorophores of the FRET pair in this sensor, 
are the simple introduction of genetically encoded fluorescent proteins to the GTPases and their 
compatibility with fluorescence lifetime microscopy (4.1.3).  
Another benefit of genetically appending fluorophores in comparison to in vitro labeling strategies is that 
the whole protein population is essentially homogeneously labeled after purification, in contrast to chemical 
labeling that requires two dyes to be introduced in succession. If quantitative conversion of either labeling 
step is not efficiently controlled, labeling would result in a mixture of nonuniformly labeled sensor species. 
This would be particularly problematic for intensity-based FRET quantification where the observed relative 
intensity of both FRET partners greatly influence the local FRET signal read out. 
EGFP and mCitrine were chosen in particular, because of their favorable spectral properties and the 
abundance of suitable FRET acceptor fluorophores. They can be efficiently excited by the well-established 
Argon laser source and both fluorophores exhibit good photostability, brightness and a low propensity for 
oligomerization.259,260 Something that has to be kept in mind when using green and yellow fluorescent 
proteins however, is their pH sensitivity.261 This can be problematic for applications that require localization 
to acidic subcellular compartments such as lysosomes or under conditions that lead to significant changes 
in the intracellular pH.261 
As apparent in section 2.7.5 another critical property when choosing a fluorescent protein as a FRET donor 
for lifetime microcopy is its decay kinetics. FLIM monitors the average fluorescence lifetime of the donor 
fluorophore. When non-radiative energy transfer (FRET) occurs from the donor to the acceptor fluorophore 
the average lifetime of the excited donor fluorophore decreases. The extent of the lifetime shift depends 
on the respective FRET efficiency observed for the specific sensor molecule. Thus, different population of 
high and low FRET are reflected in the overall decay kinetics of the excited donor fluorophores. To accurately 
assess the different sensor populations, single exponential decay kinetics of the donor is desirable.171,192 The 
decay of mCitrine and EGFP can reliably be described by a single exponential function and they are therefore 
widely used as donors in FLIM-FRET.192,262,263 An alternative fluorescent protein with very favorable decay 
kinetics and spectral properties is mTurquoise264,265. mTurquoise exhibits a comparatively high fluorescent 
lifetime (mTurquoise ≈ 3.5 ns, EGFP ≈ 2.4 ns, mCitrine ≈ 3.0 ns, in cells)192, which should allow for an increased 
dynamic range. For the same reason the GFP variant NowGFP (NowGFP≈ 4-4.5 ns, in cells) qualifies as an 
alternative donor.255 
  
4 Final discussion and perspectives 
 
-125- 
A major disadvantage of fluorescent proteins in comparison to organic dyes is their comparably large size 
(≈25 kDa). This limits their application to the N- or C-terminus of a proteins, especially when used for labeling 
smaller proteins such as small GTPases (21-30 kDa). For larger proteins however, e.g. G-protein-coupled 
receptors266 or EPH Receptor A2262, the fluorescent proteins can be inserted into noncritical loop regions.  
An additional interesting approach for improving the dynamic range of the FRET sensor would be the use of 
circular permutated fluorescent protein variants. Through rearrangement of the N- and C-terminus the 
chromophore orientation can be altered while preserving the proteins favorable fluorescence properties.100 
As described in the introduction (1.2.1) the efficiency of the energy transfer between the two FRET partners 
depends on the relative dipole orientation of the chromophores. As changes in the relative orientation most 
likely contribute significantly to the observed FRET signal changes, optimization of the relative chromophore 
orientation in the active and inactive state of the GTPase could greatly increase the dynamic range of the 
sensor.254,258,267 
Acceptor labeling and organic dyes 
Smaller organic dyes were chosen as FRET acceptors since they have to be introduced directly in the protein 
fold to report on the conformational change upon GTPase activation. Furthermore, organic fluorophores 
feature superior spectral properties such as a wider spectral range, high photostability and increased 
brightness.268 
One problematic aspect of the used acceptor dye that needs to be addressed is the cysteine-mediated 
labeling. Due to the exposed C-terminal cysteine residues that are critical for proper GTPase functioning, 
the maleimide derived labeling strategy requires a strategic detour to allow for site-specific labeling and a 
functional C-terminus (3.1.1-3.1.3). To circumvent the rather tedious C-terminal reconstitution process and 
the need for in vitro sensor purification, in vivo labeling techniques such as FLAsH and ReAsH269 could be 
considered. A potential problem with these approaches pose the comparably large sequence modifications 
they require. Because the acceptor dye is directly introduced into the GTPase sequence, it is vital to 
minimize the effect of acceptor labeling on the protein fold and function. Furthermore, undesired side 
reactions of the Rab proteins C-terminal cysteine motifs with the thiophilic arsenic probes should be kept 
in mind when considering this labeling strategy. The criterion of site-specific labeling in the interior of the 
protein precludes the usage of other popular in vivo labeling techniques such as Halo270, SNAP271- and CLIP-
tag272 for acceptor incorporation. However, these self-labeling enzymatic domains could be used to expand 
the range of possible fluorophores at the GTPase’s N-terminus from fluorescent proteins to chemical dyes. 
As mentioned previously, an alternative, more elaborate, methodology could be based on incorporation of 
unnatural amino acids through amber codon suppression243 in combination with biorthogonal in vivo 
labeling244.  
  
4 Final discussion and perspectives  
 
 -126- 
A great advantage of the cysteines-mediated labeling methodology is the variety of commercially available 
probes and the ease of introducing new modification sites by site-directed mutagenesis. Here, maleimide 
conjugated Tide Fluor 3 and Tide Fluor 4 were used as partners for EGFP and mCitrine, respectively. They 
possess overlapping donor emission and acceptor excitation and the reactive maleimide group allows for 
efficient labeling. Other suitable candidates for acceptor dyes are the Alexa Fluor family, especially probes 
with varied linker length between the conjugation site and the fluorophore would be of interest to probe 
the effect of different linker on the FRET signal. 
Another intriguing approach would be the use of conformationally restricted dyes273 or multivalent probes 
that are locked in a defined orientation. The relative dipol-dipol orientation is a decisive factor for the 
efficiency of fluorescence energy transfer274,275 (1.2.1) and restriction of the rotational freedom could be a 
useful tool to increase the sensors dynamic range. 
Linker 
Another approach for improving a FRET sensors performance is to utilize linkers with specific characteristics. 
Linkers can be varied in length and flexibility, thereby directly affect the relative distance and orientation of 
the two FRET fluorophores.159,160 As described in and 3.1.1 the donor-acceptor distance should be as close 
as possible to the Förster distance R0 for optimal sensor sensitivity and dynamic range. Furthermore, the 
change in relative fluorophore distance between the two sensor states, here GDP and GTP-bound GTPase, 
should be as large as possible. Specialized proteinaceous linker can be used to address this aspect of the 
sensor topology. 
More specifically, the amino acids linking the fluorescent protein to the GTPases N-terminus can be probed 
for a varied chain length and flexibility. In a first attempt, the C-terminal part of the fluorescent protein was 
truncated by eleven amino acids, to shorten the flexible region, moving the two fluorophores closer 
together. This resulted in a substantial increase from ≈10 % to ≈20 % change in the sensitized emission signal 
upon nucleotide exchange (3.1.4) for the T34C construct. This indicates that probing different linker lengths 
for the distance between the N-terminal fluorescent protein and the GTPase can significantly improve the 
signal read out. 
Besides reducing the FRET pair distance by removing flexible protein segments, rigid linker can be used to 
fix fluorophores in a specific distance and orientation. This can lead to a high change in FRET signal if the 
two states of the sensor correspond to two positions that feature significantly different FRET efficiencies. 
By fixing the fluorescent protein in a defined position in relation to the GTPase-fold the relative change in 
distance and orientation of the acceptor dye upon nucleotide exchange should be increased, which could 
then lead to an improved overall FRET signal read out.  
A less conventional approach would be needed to allow for the variation of the linkage of the acceptor dye 
as it is located within the protein fold. However, as discussed for the fluorescent proteins, introduction of 
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proteinaceous linkers into noncritical sections of a protein is feasible and could be considered for this sensor 
design as well.262,266 However, this approach would be most likely be limited to only a selected few sites that 
are not directly involved in the protein functioning. Furthermore, it is likely that these sites do not undergo 
significant structural changes upon nucleotide exchange. 
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5 Appendices 
5.1 Protein and sensor construct sequences 
 
Rab1b 
        10         20         30         40         50         60  
MNPEYDYLFK LLLIGDSGVG KSCLLLRFAD DTYTESYIST IGVDFKIRTI ELDGKTIKLQ  
 
        70         80         90        100        110        120  
IWDTAGQERF RTITSSYYRG AHGIIVVYDV TDQESYANVK QWLQEIDRYA SENVNKLLVG  
 
       130        140        150        160        170        180  
NKSDLTTKKV VDNTTAKEFA DSLGIPFLET SAKNATNVEQ AFMTMAAEIK KRMGPGAASG  
 
       190        200  
GERPNLKIDS TPVKPAGGGC C 
 
KRas4b 
        10         20         30         40         50         60  
MTEYKLVVVG AGGVGKSALT IQLIQNHFVD EYDPTIEDSY RKQVVIDGET CLLDILDTAG  
 
        70         80         90        100        110        120  
QEEYSAMRDQ YMRTGEGFLC VFAINNTKSF EDIHHYREQI KRVKDSEDVP MVLVGNKCDL  
 
       130        140        150        160        170        180  
PSRTVDTKQA QDLARSYGIP FIETSAKTRQ GVDDAFYTLV REIRKHKEKM SKDGKKKKKK  
 
 
SKTKCVIM  
 
EGFP 
        10         20         30         40         50         60  
MVSKGEELFT GVVPILVELD GDVNGHKFSV SGEGEGDATY GKLTLKFICT TGKLPVPWPT  
 
        70         80         90        100        110        120  
LVTTLTYGVQ CFSRYPDHMK QHDFFKSAMP EGYVQERTIF FKDDGNYKTR AEVKFEGDTL  
 
       130        140        150        160        170        180  
VNRIELKGID FKEDGNILGH KLEYNYNSHN VYIMADKQKN GIKVNFKIRH NIEDGSVQLA  
 
       190        200        210        220        230  
DHYQQNTPIG DGPVLLPDNH YLSTQSALSK DPNEKRDHMV LLEFVTAAGI TLGMDELYK  
 
mCitrine 
        10         20         30         40         50         60  
MVSKGEELFT GVVPILVELD GDVNGHKFSV SGEGEGDATY GKLTLKFICT TGKLPVPWPT  
 
        70         80         90        100        110        120  
LVTTFGYGLM CFARYPDHMK QHDFFKSAMP EGYVQERTIF FKDDGNYKTR AEVKFEGDTL  
 
       130        140        150        160        170        180  
VNRIELKGID FKEDGNILGH KLEYNYNSHN VYIMADKQKN GIKVNFKIRH NIEDGSVQLA  
 
       190        200        210        220        230  
DHYQQNTPIG DGPVLLPDNH YLSYQSLLSK DPNEKRDHMV LLEFVTAAGI TLGMDELYK  
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Figure 5-1: Rab1b sensor constructs used in the course of this thesis. 
are indicated in different colors: blue: Hexahistidine-tag, green: EGFP, gray: Rab1b, intein: orange. Linking sections are 
displayed as single amino acid code. Acceptor labeling sites/cysteine mutations are marked with arrows and highlighted 
in yellow. 
 
 
Figure 5-2: KRas sensor constructs used in the course of this thesis. 
are indicated in different colors: blue: Hexahistidine-tag, green: EGFP, gray: Rab1b, intein: orange. Linking sections are 
displayed as single amino acid code. Acceptor labeling sites/cysteine mutations are marked with arrows and highlighted 
in yellow. 
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5.2 SDS-Gels acceptor labeling 
 
 
Figure 5-3: Site-specific labeling of His-GTPase constructs 
with thiol-reactive acceptor dye. 
SDS-PAGE of EGFP-Rab12 constructs labeling. Labeling 
mixture was quenched with β-mercaptoethanol after the 
indicated incubation time. Upper panels: Coomassie blue 
staining. Lower panel: excitation with UV light before 
staining. 
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5.3 LC-ESI-MS 
 
Figure 5-4: ESI-MS of site-specific labeling of Rab1 constructs with thiol-reactive acceptor dye Tide Fluor 3. 
ESI-MS of (A) His-EGFP-Rab1T34C, (B) His-EGFP-Rab1S36C, (C) His-EGFP-Rab1D53C and (D) His-EGFP-Rab1G54Cbefore 
and after labeling with 1.2 eq Tide Fluor 3 maleimide (2.4.1). 
 
Figure 5-5: ESI-MS of Rab1-thioester constructs after thiolysis with MESNA. 
ESI-MS of (A) EGFP-Rab1T34C-MESNA, (B) EGFP-Rab1S36C-MESNA, (C) EGFP-Rab1D53C-MESNA, (D) 
EGFP-Rab1D53C-MESNA and (E) EGFP-Rab1T34C(Q67L)-MESNA after purification (2.3.3). 
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Figure 5-6: ESI-MS of Rab1 constructs after labeling with thiol-reactive acceptor dye Tide Fluor 3 and N-terminal NCL 
with Cys-Cys. 
ESI-MS of (A) EGFP-Rab1T34C-TF3-CC, (B) EGFP-Rab1T34C(Q67L)-TF3-CC, (C) EGFP-Rab1S36C-TF3-CC and (D) 
EGFP-Rab1D53C-TF3-CC after labeling of the Rab1-MESNA constructs with thiol-reactive acceptor dye Tide Fluor 3 
(2.4.1) and N-terminal NCL with Cys-Cys (2.4.3). ESI-MS of (E) EGFP-Rab1T34C-CC, (F) EGFP-Rab1S36C-CC and (G) EGFP-
Rab1D53C-CC after NCL of the EGFP-Rab1-MESNA constructs with Cys-Cys (2.4.3).  
 
 
Figure 5-7: ESI-MS of site-specific labeling of KRas constructs with thiol-reactive acceptor dye Tide Fluor 3 or 
Tide Fluor 4. 
ESI-MS of (A) EGFP-KRasD30C-MESNA, (B) mCitrine-KRasE31C-MESNA and (C) mCitrine-KRasD30C-MESNA before and 
after labeling with 1.2 eq Tide Fluor 3/4 maleimide (2.4.1). 
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Figure 5-8: ESI-MS of KRas constructs after labeling with thiol-reactive acceptor dye Tide Fluor 3/4 and N-terminal 
NCL with the tetrapeptide -CVIM. 
ESI-MS of (A) EGFP-KRasD30C-TF3-CVIM, (B) mCitrine-KRasD30C-TF4-CVIM, (C) mCitrine-KRasE31C-TF4-CVIM after 
labeling of the KRas-MESNA constructs with thiol-reactive acceptor dye Tide Fluor 3/4 (2.4.1) and N-terminal NCL with 
the tetrapeptide -CVIM (2.4.3). ESI-MS of (D) EGFP-KRasD30C-CVIM, (E) mCitrine-KRasD30C-CVIM and (F) mCitrine-
KRasE31C-CVIM after NCL of the KRas-MESNA constructs with the tetrapeptide -CVIM (2.4.3) 
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5.4 Rab1 sensor in vitro - GEF, GAP and effector interaction 
DrrA 
 
Figure 5-9: DrrA mediated nucleotide exchange of Rab1 FRET sensors. 
Addition of 100 M GTP and 10-100 nM DrrA340-533 to 200 nM GDP-bound (A) EGFP-Rab1T34C-TF3, (C) EGFP-Rab1S36C-
TF3, (E) EGFP-Rab1D53C-TF3 and (G) EGFP-Rab1G54C-TF3 result in a steep decrease (T34C and S36C) or increase (D53C 
and G54C) of the detected sensitized emission signal. Rate constants of nucleotide exchange depend on [DrrA340-533]. 
(B) EGFP-Rab1T34C-TF3, (D) EGFP-Rab1S36C-TF3, (F) EGFP-Rab1D53C-TF3 and (H) EGFP-Rab1G54C-TF3. Changes in 
FRET efficiency were observed by sensitized emission with excitation at 480 nm and emission collected at 580 nm. 
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TBC1D20 
 
 
Figure 5-10: Fluorescence measurement of TBC1D20 induced GTP hydrolysis. 
GAP-induced GTP hydrolysis was observed through addition of 1-2 M TBC1D201-362 to (A) 200 nM EGFP-Rab1S36C-TF3 
and (C) 200 nM EGFP-Rab1D53C-TF3 constructs after DrrA340-533-mediated GDP to GTP exchange. When GDP is 
exchanged to GppNHp, TBC1D201-362 failed to reverse the FRET signal change for (B) 200 nM EGFP-Rab1S36C-TF3 and 
(D) 200 nM EGFP-Rab1D53C-TF3. Changes in FRET efficiency were observed by sensitized emission with excitation at 
480 nm and emission collected at 580 nm (E) The observed rate constant of GTP hydrolysis depends on TBC1D201-362 
concentration. To determine the catalytic efficiency 10 nM - 1 M of TBC1D201-362 were added to 1 M mantGTP:Rabwt. 
(F) By plotting kobs against [TBC1D201-362] the catalytic efficiency can be extracted as the slope of the linear fit (solid blue 
line). The change in mantGTP upon GTP hydrolysis was monitored with excitation set at 360 nm and emission at 438 
nm. 
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OCRL 
 
Figure 5-11: OCRL1 binding to Rab1 FRET-sensor constructs. 
(A) After nucleotide exchange trough addition of 100 M GTP and 25 nM DrrA340-533, increasing amounts of OCRL1539-901 
were added to 200 nM GTP-bound EGFP-Rab1D53C-TF3. By plotting the change in fluorescence against the effector 
protein concentration, KD was obtained through fitting with a quadratic equation as described in in 2.5.4.3 (solid orange 
line) for (B) 200 nM GTP-bound EGFP-Rab1D53C-TF3 and (C) 200 nM GTP-bound EGFP-Rab1G54C-TF3. (D) For 200 nM 
GTP-bound EGFP-Rab1T34C-TF3 the KD for OCRL binding was measured by fluorescence polarization with excitation at 
480 nm, emission collected at 510 nm and an interval time of 13 s. Changes in FRET efficiency (A)-(C) were observed by 
sensitized emission with excitation at 480 nm and emission collected at 580 nm.  
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LidA 
 
Figure 5-12: LidA binding to Rab1 FRET-sensor constructs. 
Addition of increasing amounts of OCRL1539-901 to (A) 100 nM GTP-bound EGFP-Rab1S36C-TF3, (C) 500 nM GTP-bound 
EGFP-Rab1S36C-TF3 or (E) 300 nM GTP-bound EGFP-Rab1G54C-TF3 after nucleotide exchange trough addition of 
100 M GTP and 100 nM DrrA340-533. By plotting the change in fluorescence intensity against the effector protein 
concentration the KD for LidA201-583 binding was obtained through fitting with a quadratic equation as described in 
2.5.4.3 (solid orange line) for (B) 100 nM EGFP-Rab1S36C-TF3, (D) 500 nM EGFP-Rab1S36C-TF3 and (F) 300 nM EGFP-
Rab1G54C-TF3. (Insets) Fluorescence spectra of (B) EGFP-Rab1S36C-TF3, (D) 500 nM EGFP-Rab1S36C-TF3 and (F) 
300 nM EGFP-Rab1G54C-TF3 before (solid black line) and after (solid teal) binding of LidA201-583. Changes in FRET 
efficiency were observed by sensitized emission with excitation at 480 nm and emission collected at 580 nm. 
Fluorescence spectra were obtained with excitation set to 480 nm and emission collected from 490-700 nm.  
  
5 Appendices  
 
 -138- 
5.5 Rab1 FRET sensor in vivo 
 
Figure 5-13: Donor only Rab1 constructs in HeLa cells expressing BFP-OCRL1. 
Fluorescence and FLIM images of EGFP-Rab1 after microinjection into (A)-(C) wild type HeLa cell and (D)-(F) cells 
expressing BFP-OCRL1539–901. (A)/(D) BFP- (B) EGFP-fluorescence and (C)/(F) FLIM images. Ectopic expression of BFP-
OCRL1539–901 does not results in higher donor lifetime of EGFP-Rab1. False color calibration bar for lifetime image as 
reference. Scale bars: 10 μm. 
 
Figure 5-14: EGFP-Rab1D53C-TF3 sensor reports on OCRL1 binding in vivo. 
Fluorescence and FLIM images of EGFP-Rab1D53C-TF3 after microinjection into a wild type and as HeLa cells expressing 
BFP-OCRL1539–901. (A)BFP- (B) EGFP-, (C) –TF3 fluorescence and (D) FLIM images. (E) Quantification of EGFP donor 
lifetime at: first two panels cytoplasmic fraction, third and fourth represent Golgi localized sensor fraction. n = 5-7, 
individual data points are plotted, box plots: - median, □ mean, upper hinge 75th percentile, lower hinge 25th percentile, 
whiskers: s.d., *: p < 0.05. False color calibration bar for lifetime image as reference. Scale bar: 10 μm. 
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Figure 5-15: Donor only Rab1 construct in HeLa cells expressing BFP-DrrA. 
Fluorescence and FLIM images of EGFP-Rab1 after microinjection into (A)-(C) cells expressing BFP-DrrA340-533 and (D)-
(F) wild type HeLa cells. (A)/(D) BFP- (B) EGFP-fluorescence and (C)/(F) FLIM images. Ectopic expression of BFP- 
DrrA340-533 does not results in higher donor lifetime of EGFP-Rab1. False color calibration bar for lifetime image as 
reference. Scale bars: 10 μm. 
 
Figure 5-16: Quantification of donor lifetime of donor only probe injected in wild type and BFP-DrrA transfected cells. 
Quantification of EGFP lifetime for T34C donor only construct in cells. Orange and blue dots denote cytoplasmic and 
Golgi-localized protein fractions. (n = 10-21 cells, individual data points are plotted, box plots: - median, upper hinge 
75th percentile, lower hinge 25th Percentile, whiskers: s.d.).Left panel: Lifetime in wild type cells, right panel: lifetime 
in BFP-DrrA340-533 transfected cells.  
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5.6 KRas sensor in vitro - GEF and GAP interaction 
SOS - mantGDP 
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Figure 5-17: SOS-mediated nucleotide exchange of mantGDP:KRas mutants.  
Addition of 100 M GTP and varying amounts of SOS564-1049 to 200 nM mantGDP-bound (A) EGFP-KRasD30C, (C) EGFP-
KRasE31C, (E) EGFP-KRasD33C, (G) EGFP-KRasD47C, (L) EGFP-KRasG48C, (N) EGFP-KRasE107C and (P)KRaswt result in a 
steep decrease of the detected mant signal. The rate constants of nucleotide exchange depend on [SOS564-1049]. The 
change in mant fluorescence upon nucleotide exchange was monitored with excitation set at 360 nm and emission at 
438 nm. The catalytic efficiency was obtained as the slope of the linear fit (solid orange line) of kobs plotting against 
[SOS564-1049]. Linear fit for obtained kobs values for (B) EGFP-KRasD30C, (D) EGFP-KRasE31C, (F) EGFP-KRasD33C (H) EGFP-
KRasD47C, (M) EGFP-KRasG48C, (O) EGFP-KRasE107C and (Q) KRaswt. 
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SOS - sensitized emission 
 
 
Figure 5-18: SOS-mediated nucleotide exchange of KRas FRET sensors. 
Addition of SOS564-1049 to 200 nM KRas FRET sensor constructs induces rapid nucleotide exchange in the presence of 
excess GTP (100 M). Typical fluorescence curves for (A) EGFP11-KRasD30C-TF3, (D) and (G) mCitrine11-KRasD30C-
TF4 (mCitrine fluorescence) and (M) mCitrine11-KRasE31C-TF4 (mCitrine fluorescence) (Insets) Fluorescence spectra 
of KRas FRET sensors before (solid black line) and after nucleotide exchange (solid orange line). (B)-(N) Rate constants 
of nucleotide exchange depend on SOS564-1049 concentration. (C)-(O) By plotting kobs against [SOS564-1049] the catalytic 
efficiency can be extracted as the slope of the linear fit (solid orange line). FRET efficiency change was monitored by 
sensitized emission (excitation set at 480 nm and emission at 580 nm (TF3)/ 614 nm (TF4) or directly from the donor 
fluorescence (mCitrine: excitation set at 480 nm and emission at 525 nm).  
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RasGAP 
 
Figure 5-19: Fluorescence measurement of RasGAP induced GTP hydrolysis. 
Addition of RasGAP714-1047 to 200 nM GTP-bound KRas Fret sensor reverses the initial drop in FRET signal intensity upon 
nucleotide exchange through SOS564-1049. Fluorescence profile for (A) EGFP11-KRasD30C-TF3, (B) mCitrine11-
KRasE31C-TF4 and (D) mCitrine11-KRaD30C-TF4 activation with subsequent deactivation through addition of 
RasGAP714-1047 monitored by donor fluorescence signal with excitation at 480 nm and emission collected at 510 nm 
(EGFP) or 525 nm (mCitrine). Fluorescence measurement of (C) mCitrine11-KRaD30C-TF4 activation with subsequent 
deactivation through addition of RasGAP714-1047 monitored by sensitized emission with excitation at 480 nm and 
emission collected at 614 nm. 
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Figure 5-20: Catalytic efficiency of RasGAP towards KRas FRET sensors. 
The observed rate constants of GTP hydrolysis depend on RasGAP714-1047 concentration. To determine the catalytic 
efficiency varying amounts of RasGAP714-1047 were added to 200 nM GTP-bound (A) EGFP-KRasD30C-TF3, (C) 
mCitrine11-KRasE31C-TF4 and (E) mantGTP-bound KRaswt. By plotting kobs against [RasGAP714-1047] the catalytic 
efficiency can be extracted as the slope of the linear fit (solid orange line). Linear fit for obtained kobs values for (B) EGFP-
KRasD30C-TF3, (D) mCitrine11-KRasE31C-TF4 and (F) KRaswt. (A) EGFP-KRasD30C-TF3 deactivation monitored by 
sensitized emission with excitation at 480 nm and emission collected at 580 nm. (C) mCitrine11-KRasE31C-TF4 
deactivation monitored by donor fluorescence with excitation at 480 nm and emission collected at 525 nm. (E) The 
change in mantGTP upon GTP hydrolysis was monitored with excitation set at 360 nm and emission at 438 nm.  
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5.7 KRas sensor in vivo 
 
 
Figure 5-21: Control experiments for EGF induced KRas activation in vivo. 
Confocal and FLIM images of donor only (A) EGFP-KRas and (C) mCitrine-KRas-CVIM in serum starved MDCK 
cells. FLIM images are shown before (upper panel, 0 min) and 5 min after EGF stimulation (lower panel). 
mCitrine lifetime before (B) and 5 min after (C) EGF stimulation. False color calibration bar for lifetime images as 
reference. Scale bars: 20 M. 
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5.8 Rab1 cycling 
Control measurements - cycloheximide treatment  
 
Figure 5-22: Recovery curves for EGFP-Rab1wt bleaching at the Golgi and average kC-G after cycloheximide treatment. 
(A) Plot of normalized average EGFP intensity at Golgi ROI during FRAP experiment. Each line represents one bleaching 
experiment. (B) Plot of individual (gray lines) and average (purple squares, mean ± s.d.) recovery curves in comparison 
to average EGFP-Rab1wt recovery in untreated cells (black circles, mean ± s.d.). kC-G was obtained as the average of 
individual kobs values. kobs was determined for each recovery curve by fitting with the monoexponential function (Eq. 
2-14). 
 
Bleaching 
 
Figure 5-23: Bleaching control of EGFP-Rab1wt on Golgi during FRAP experiment. 
Plot of normalized average EGFP intensity at Golgi ROI during FRAP experiment without bleaching step. Plot of individual 
(gray lines) and average (black circles, mean ± s.d.) fluorescence intensity in Golgi ROI. 
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Figure 5-24: Photoactivation by imaging control of paGFP-Rab1wt. 
Plot of normalized average paGFP intensity during time-lapse imaging without photo activation step. Plot of individual 
(gray lines) and average (black circles, mean ± s.d.) fluorescence intensity in cells. 
FRAP - kC-G  
Rab1 wt + nocodazole 
 
Figure 5-25: Recovery curves for EGFP-Rab1wt bleaching at the Golgi and average kC-G after nocodazole treatment. 
(A) Plot of normalized average EGFP intensity at Golgi ROI during FRAP experiment. Each line represents one bleaching 
experiment. (B) Plot of individual (gray lines) and average (purple squares, mean ± s.d.) recovery curves in comparison 
to average EGFP-Rab1wt recovery in untreated cells (black circles, mean ± s.d.). kC-G was obtained as the average of 
individual kobs values. kobs was determined for each recovery curve by fitting with the monoexponential function (Eq. 
2-14). 
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Rab1Q67L 
 
Figure 5-26: Recovery curves for EGFP-Rab1Q67L bleaching at the Golgi and average kC-G. 
(A) Plot of normalized average EGFP intensity at Golgi ROI during FRAP experiment. Each line represents one bleaching 
experiment. (B) Plot of individual (gray lines) and average (purple triangles, mean ± s.d.) recovery curves in comparison 
to average of EGFP-Rab1wt recovery in untreated cells (black circles, mean ± s.d.). kC-G was obtained as the average of 
individual kobs values. kobs was determined for each recovery curve by fitting with the monoexponential function (Eq. 
2-14). 
 
Rab1D44N 
 
Figure 5-27: Recovery curves for EGFP-Rab1D44N bleaching at the Golgi and average kC-G. 
(A) Plot of normalized average EGFP intensity at Golgi ROI during FRAP experiment. Each line represents one bleaching 
experiment. (B) Plot of individual (gray lines) and average (purple diamonds, mean ± s.d.) recovery curves in comparison 
to average of EGFP-Rab1wt recovery in untreated cells (black circles, mean ± s.d.). kC-G was obtained as the average of 
individual kobs values. kobs was determined for each recovery curve by fitting with the monoexponential function (Eq. 
2-14). 
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PRA1 knock-down 
 
Figure 5-28: Recovery curves for EGFP-Rab1wt bleaching at the Golgi in PRA1 knock-down cells and average kC-G. 
(A) Plot of normalized average EGFP intensity at Golgi ROI during FRAP experiment. Each line represents one bleaching 
experiment. (B) Plot of individual (gray lines) and average (purple triangles, mean ± s.d.) recovery curves in comparison 
to average of EGFP-Rab1wt recovery in wild type cells (black circles, mean ± s.d.). kC-G was obtained as the average of 
individual kobs values. kobs was determined for each recovery curve by fitting with the monoexponential function (Eq. 
2-14). 
Photoactivation - kC-G  
Rab1wt + nocodazole 
 
Figure 5-29: Fluorescence intensity increase at Golgi following photoactivation of paGFP-Rab1wt in the cytoplasm 
after nocodazole treatment. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation in the cytoplasm. Each line 
represents a single photoactivation experiment. (B) Plot of individual (gray lines) and average (purple squares, mean ± 
s.d.) intensity curves in comparison to average paGFP-Rab1wt activation in untreated cells (black circles, mean ± s.d.). 
kC-G was obtained as the average of individual kobs values. kobs was determined for each curve by fitting with the 
monoexponential function (Eq. 2-14). 
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Rab1Q67L 
 
Figure 5-30: Fluorescence increase at the Golgi following photoactivation of paGFP-Rab1Q67L in the cytoplasm. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation in the cytoplasm. Each line 
represents a single photoactivation experiment. (B) Plot of individual (gray lines) and average (purple squares, mean ± 
s.d.) intensity curves in comparison to average paGFP-Rab1wt activation (black circles, mean ± s.d.). kC-G was obtained as 
the average of individual kobs values. kobs was determined for each curve by fitting with the monoexponential function 
(Eq. 2-14). 
PRA1 knock-down 
 
Figure 5-31: Fluorescence intensity increase at Golgi following photoactivation of paGFP-Rab1wt in the cytoplasm of 
PRA1 knock-down cells. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation in the cytoplasm. Each line 
represents a single photoactivation experiment. (B) Plot of individual (gray lines) and average (purple triangles, mean ± 
s.d.) intensity curves in comparison to average paGFP-Rab1wt activation in wild type cells (black circles, mean ± s.d.). kC-G 
was obtained as the average of individual kobs values. kobs was determined for each curve by fitting with the 
monoexponential function (Eq. 2-14). 
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Photoactivation – kG-C  
Rab1Q67L 
 
Figure 5-32: Fluorescence intensity decrease at Golgi following photoactivation of paGFP-Rab1Q67L. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation. Each line represents a single 
photoactivation experiment. (B) Plot of individual (gray lines) and average (purple triangles, mean ± s.d.) intensity curves 
in comparison to average paGFP-Rab1wt activation (black circles, mean ± s.d.). kG-C was obtained as the average of 
individual kobs values. kobs was determined for each curve by fitting with the monoexponential function (Eq. 2-14). 
 
Rab1D44N 
 
Figure 5-33: Fluorescence intensity decrease at Golgi following photoactivation of paGFP-Rab1D44N. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation. Each line represents a single 
photoactivation experiment. (B) Plot of individual (gray lines) and average (purple diamonds, mean ± s.d.) intensity 
curves in comparison to average paGFP-Rab1wt activation (black circles, mean ± s.d.). kG-C was obtained as the average 
of individual kobs values. kobs was determined for each curve by fitting with the monoexponential function (Eq. 2-14). 
  
  
5 Appendices  
 
 -152- 
Rab1wt + nocodazole 
 
Figure 5-34: Fluorescence intensity decrease at Golgi following photoactivation of paGFP-Rab1wt after nocodazole 
treatment. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation. Each line represents a single 
photoactivation experiment. (B) Plot of individual (gray lines) and average (purple squares, mean ± s.d.) intensity curves 
in comparison to average paGFP-Rab1wt activation in untreated cells (black circles, mean ± s.d.). kG-C was obtained as 
the average of individual kobs values. kobs was determined for each curve by fitting with the monoexponential function 
(Eq. 2-14). 
 
PRA1 knock-down 
 
Figure 5-35: Fluorescence intensity decrease at Golgi following photoactivation of paGFP-Rab1wt in PRA1 knock-
down cells. 
(A) Plot of normalized average paGFP intensity at Golgi ROI following photoactivation. Each line represents a single 
photoactivation experiment. (B) Plot of individual (gray lines) and average (purple triangles, mean ± s.d.) intensity curves 
in comparison to average paGFP-Rab1wt activation in wild type cells (black circles, mean ± s.d.). kG-C was obtained as the 
average of individual kobs values. kobs was determined for each curve by fitting with the monoexponential function (Eq. 
2-14). 
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